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Abstract
The piuripotential nature of embryonic stem (ES) cells in vitro has been used to
develop model systems for the differentiation of tissue-specific lineages during
organogenesis. The differentiation of ES cells into haematopoietic lineages in vitro has
been particularly well characterised, but the successful generation of substantial
numbers of haematopoietic stem cells (HSCs) able to engraft lethally irradiated mice in
vivo has been limited. It is possible that the in vitro differentiation protocols used to
date do not provide a suitable microenvironment for HSC development from ES cells.
This thesis describes the effect of co-culturing differentiating ES cells in the presence of
embryonic tissue that was predicted to provide a more appropriate microenvironment
for haematopoietic commitment.
The aorta-gonad-mesonephros (AGM) region is the earliest site in the embryo
proper that is able to generate definitive, adult-type HSCs autonomously. Clusters of
HSCs appear in the AGM region at day 10 of gestation in the mouse, where they
proliferate before colonising the foetal liver to continue haematopoietic development.
Long term repopulating HSC activity has been found to increase within AGM region
explant cultures indicating that elements of the supporting microenvironment for
definitive HSC expansion can be captured in vitro.
In this study an explant culture system was developed to examine the inductive
properties of the AGM region on differentiating ES cells. A highly significant increase
in the number of primitive haematopoietic progenitors, as measured by in vitro colony
assays, was observed after co-culture of ES cells with the AGM region from a 10.5 day
embryo. However, engraftment in vivo of ES-derived progenitors after transplantation
was not achieved. The effect of three stromal cell lines derived from the AGM region
and foetal liver on the differentiation of ES cells in co-culture was also examined.
Although the cell lines were similar to each other in terms of the expression of surface
markers, they exhibited diverse effects on the differentiation of ES cells. Preliminary
data also suggest that the AGM region-derived factor(s) responsible for the increase in
haematopoietic differentiation of ES ceils is dependent on direct cell-ceii contact.
The AGM region culture system was also used as a novel investigative tool in
the analysis of a putative haematopoietic phenotype in a mouse mutant deficient in the
murine homologue of the ubiquitin conjugating enzyme, Ubc7, generated previously by
a gene-trapping technique. The numbers of haematopoietic progenitors in AGM
regions from wildtype, heterozygous and homozygous embryos after culture were
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The establishment of totipotent embryonic stem (ES) cell lines from
blastocysts nearly 25 years ago (Evans and Kaufman, 1981; Martin, 1981) made new
experimental approaches possible in the study of mammalian developmental biology.
ES cells can chimerise with all host tissues including the germ line when introduced
into blastocysts and have the capacity to differentiate into a large number of lineages
in vitro. These properties made it possible to study the function of genes during
development by introducing mutations into the genome of ES cells by homologous
recombination, which could be transmitted through the germ line to generate mice
with specific genetic deletions ("knock-outs"). ES cells can also differentiate into
multiple cell types in vitro and thus have provided an accessible system to study the
commitment of cells to particular lineages. Such an in vitro system is the focus of
this thesis. The differentiation of ES cells into haematopoietic cells in vitro has so
far been a powerful tool for studying developmental haematopoiesis but there are
also some limitations. For example, only a small number of cells from a particular
lineage (and this applies to all tissues) are obtained from a large number of
differentiating ES cells and the populations are very heterogenous. Improving the
directed differentiation of ES cells is important not only for optimising the
experimental system but also if ES cells are ever to be useful for tissue therapy in a
clinical setting.
The experiments described in this thesis test whether the differentiation of ES
cells into early haematopoietic progenitors can be enhanced by a novel embryonic
organ rudiment co-culture system. Therefore, this chapter will:
• Describe the haematopoietic system in adult bone marrow.
• Outline the markers and functional in vivo and in vitro assays used to identify
haematopoietic stem cells and their progeny.
• Summarise the experimental evidence that lead to the current model for the
development of the haematopoietic system in the embryo.




• Discuss haematopoietic differentiation of embryonic stem cells in vitro and the
relationship to haematopoiesis in vivo.
• Explain the aim of the experiments in this thesis.
The work was performed using the murine system and therefore the studies cited
here refer mainly to the mouse.
1.2 Haematopoiesis in the adult and the haematopoietic stem cell (HSC)
1.2.1 Bone marrow haematopoiesis
Adult blood is composed of many distinct mature cells including
erythrocytes, platelet producing megakaryocytes, macrophages, neutrophils,
eosinophils, basophils, mast cells, natural killer (NK) cells, B- and T-lymphocytes,
each with specific functions such as oxygen transport, wound clotting and immune
protection. All of these mature cells have a finite life span and are therefore
continually being replaced from a population of self-renewing, pluripotent
haematopoietic stem cells (HSCs) resident in the bone marrow. This process of
haematopoiesis by which the HSCs give rise to terminally differentiated blood cells
occurs through a descending hierarchy of progenitor cells with increasing levels of
commitment to a specific lineage accompanied by a decreased capacity for self-
renewal (Figure 1.1).
1.2.2 HSCs in the adult
At the top of the hierarchy two types of stem cells have been broadly defined
as long term and short term repopulating. Long term repopulating (LTR) HSCs
represent a very small number (approximately l per 100,000) of the nucleated cells
in adult bone marrow (Micklem et al., 1987), which can generate all the blood cells
of an individual for its entire life and self-renew to produce progeny that demonstrate
this capacity after transplantation into another individual (Morrison and Weissman,
1994). A single LTR-HSC can proliferate and differentiate to reconstitute the
haematopoietic system of a lethally irradiated recipient as demonstrated by retroviral
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Figure 1.1 The haematopoietic hierarchy. The diagram illustrates all the cell
types of the haematopoietic system in the adult. The progenitors have been
defined in terms of the cytokine combinations to which they are responsive.
Chapter One: Introduction
of LTR-HSCs in the bone marrow are quiescent at any one time despite their massive
self-renewal capacity (Cheshier et al., 1999; Jordan and Lemischka, 1990). So it is
through the expansion of the LTR-HSC progeny, the short term repopulating (STR)
HSCs capable only of transient multulineage reconstitution (Morrison et al., 1997),
that the large numbers of mature cells in the blood are generated. It is thought that
perhaps this mechanism safeguards against mutations in the most potent stem cells,
which could arise during DNA replication.
The balance between self-renewal of a HSC and differentiation into the
various haematopoietic lineages is crucial to maintain a steady state but must also be
flexible to respond to any changes in the environment, such as blood loss through
injury or low oxygen at high altitudes (Morrison and Weissman, 1994).
The gold standard assay for LTR-HSCs is their capacity for long term
reconstitution of all haematopoietic lineages after transplantation into lethally
irradiated adults including secondary and even tertiary recipients. Till and
McCulloch (Till and Mc, 1961) identified macroscopic colonies on irradiated hosts'
spleens shortly after injection of bone marrow cells. It was originally thought that
these "colony forming units in the spleen" (CFU-S) indicated the presence of HSCs,
but they have since been found to be multipotent progenitors of erythroid and
myeloid lineages with self-renewal potential and are responsible for haematopoietic
reconstitution in the short term (Jones et al., 1989). CFU-S progenitors are a
heterogenous population and activity is assessed 8-12 days post transplantation with
the most primitive progenitors giving rise to colonies at later time points (Hodgson
and Bradley, 1984).
Long term reconstitution and the CFU-S are functional assays and only
indicate retrospectively the presence of HSCs and progenitors in a given population
of cells. With monoclonal antibodies to cell surface antigens and the development of
sophisticated fluorescence activated cell sorting (FACS) technology, HSCs have
been extensively characterised. While the prospective isolation of pure HSCs is not
yet possible, due to the absence of exclusive markers and the heterogenous nature of
the stem cell compartment, populations highly enriched for LTR-HSC activity can be
4
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achieved. With no single marker exclusive to HSCs yet identified, the presence and
absence of specific combinations of surface antigens are used.
HSCs in the bone marrow can be identified by the expression of c-kit, stem
cell antigen-1 (Sca-1), low levels of Thy 1.1 and the absence of lineage associated
markers (Lin ) such as B220, Grl, Macl, Terl 19, NK1.1, CD2, CD3, CD4, CD5 and
CD8, i.e. c-kiLThyl.l'HJn Sca-1+ (KTLS) (Okada et al., 1991; Spangrude et al.,
1988). CD34, a cell surface glycoprotein discovered on human bone marrow (Civin
et al., 1984) is also associated with murine HSCs and is lost from stem and
progenitor cells as they mature (Krause et al., 1994). Much debate surrounds the
status of CD34 expression on HSCs (Goodeli, 1999). Some studies have identified
the CD34~/l0c-kit+Sca-l+lin population as the long term repopulating cells (Osawa et
al., 1996) and others have found that mobilised HSCs are CD34+ (Sato et al., 1999),
suggesting that these differences in levels of CD34 expression may be related to the
stage of stem cell activation.
It must be noted that the markers associated with HSCs are not exclusive to
these cells but are also expressed by other non-haematopoietic lineages. For
example, CD34 is expressed by vascular endothelial cells (Fina et al., 1990; Young
et al., 1995). c-kit is expressed by several cell types including germ cells (Manova et
al., 1990), melanocytes (Manova and Bachvarova, 1991), neurons (Motro et al.,
1991) and stem cells in the heart (Beltrami et al., 2003) as is Sca-1, which is
expressed, for example, on non-haematopoietic stem cells in mammary gland (Welm
et al., 2002).
Certain functional properties have also been used to identify and purify
HSCs. The resistance of quiescent HSCs to cytotoxic drugs, such as 5-Fiuorouracil
(5-FU), has been exploited to enrich HSC by elimination of the other more mature
cells (Hodgson and Bradley, 1979). The ability of HSCs to exclude fluorescent dyes
can also be used in their purification. Levels of Rhodamine-123 (Rho) uptake have
been used to separate LTR-HSCs (Rho'°) from more mature short term repopulating
progeny (Rhomed/hl) (Zijlmans et al., 1995). A population of cells termed "side
population" (SP) cells, based on their low uptake of Hoechst 33342 as determined by
dual wavelength analysis of Hoechst dye fluorescence, are highly enriched for
quiescent repopulating cells (Goodell et al., 1996). Low uptake of Hoechst 33342 in
5
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HSCs is thought to be attributed to the ABCG2 transporter that actively effluxes the
dye from the cells (Zhou et al., 2001). Dye efflux properties/SP cells have also been
found in other stem cell populations such as neural stem cells (NSCs) (Kim and
Morshead, 2003), muscle (Jackson et al., 1999), mammary gland stem cells (Welm et
al., 2002), spermatogonial stem cells (Lassalle et al., 2004) and in a subpopulation of
ES cells (Zhou et al., 2001). Therefore this is not a specific marker of HSCs, but
perhaps a marker of "sternness" a concept that has raised much interest recently (Cai
et al., 2004).
Over the last few years there have been numerous reports that HSCs can also
contribute to other, non-haematopoietic lineages and vice versa, but these findings
remain somewhat controversial (Grove et al., 2004; Wagers and Weissman, 2004).
These studies are bound by technical constraints in the purification and precise
characterisation of both donor and target cell types and the absence in many cases of
unequivocal proof of function in the target tissue, often because of low levels of
engraftment.
1.2.3 Haematopoietic progenitors
Much of what is understood about the haematopoietic hierarchy (Figure 1.1)
in the adult arose from the culture of progenitors in defined conditions in semisolid
medium. Haematopoietic progenitors can, in response to specific cytokines or
combinations of cytokines, generate colonies in vitro, which consist of the mature
cells for which they are a precursor. As differentiation proceeds the precursors
(colony forming units/cells; CFU/CFC) are increasingly lineage restricted in terms of
the cells generated in the colonies.
The most primitive progenitors measurable by colony assays (see section
1.6.4.1), are multipotent myeloid stem cells with limited self-renewal potential in
vitro, which correspond to the in vivo CFU-S assays and are the colony forming unit-
type A (CFU-A) (Pragnell et al., 1988) and the high proliferative potential-colony
forming cell (HPP-CFC) (Bradley and Hodgson, 1979). These progenitors have
some self-renewal potential in vitro, whereas the more mature CFU/CFCs do not.
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1.3 Haematopoiesis during embryonic development
Two temporally, spatially and functionally distinct waves of haematopoiesis
have been identified during embryonic development. The first wave, referred to as
primitive haematopoiesis, occurs in the extraembryonic tissues, is transient and
satisfies the developing embryos' immediate requirements for oxygen and perhaps
clearance of cell debris. The term "primitive" was originally used to describe the
first haematopoietic cells because the morphology of erythrocytes in early
mammalian embryos resembled more those found in lower vertebrates (nucleated)
than in midgestation embryos or adult animals (enucleated). The second wave,
termed definitive or adult type haematopoiesis, occurs mainly at intraembryonic sites
and generates the stem cells, which expand in numbers and then differentiate.
1.3.1 Extraembryonic haematopoiesis
The yolk sac consists of adjacent layers of extraembryonic mesoderm and
visceral (primitive) endoderm. Aggregates of mesodermal cells form the blood
islands during the neural plate stage between E7 and E7.5. From E8.0 to E9.5 the
outer cell layer of the hitherto apparently homogenous blood islands differentiate
into endothelial cells and the inner cells progressively lose their cell-cell connections
and differentiate into erythrocytes (Haar and Ackerman, 1971).
The intimate developmental relationship between endothelial and
haematopoietic cells has led to the concept of a common bipotential
"haemangioblast" precursor to both lineages, although there is as yet no direct in vivo
proof. In vitro studies with chick embryos (Eichmann et al., 1997) and murine ES
cells (Choi et al., 1998) together with the absence of both lineages in the receptor
tyrosine kinase, Flk-1, deficient mouse embryos (Shalaby et al., 1997; Shalaby et al.,
1995) support the existence of a haemangioblast.
Once the vascular connections between the yolk sac and embryo proper are
established by E8.5, the primitive erythroid cells enter the circulation where they
continue to divide and differentiate until E13 (Palis and Yoder, 2001). The primitive
nucleated erythrocytes express embryonic giobins (^, |3H i, and e) as opposed to the
adult giobins (|3-major and a) expressed by definitve enucleated erythrocytes
(Barker, 1968). It was originally thought that primitive erythroid cells were absent
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from E16, but a more recent study shows the presence of enucleated erythrocytes
expressing (3H1 suggesting that primitive erythroid cells enucleate between E12.5
and E16.5 and continue to circulate until just after birth (Kingsley et al., 2004).
As with the haematopoietic hierarchy in the bone marrow, in vitro colony
assays have been useful in examining the dynamics and potential of the blood cells
produced by the yolk sac. A primitive erythroid colony forming cell (EryP-CFC)
was identified which generates colonies of large, nucleated red cells with a distinct
timing of differentiation in culture compared with BFU-E and CFU-E (Kennedy et
al., 1997; Wong et al., 1986a; Wong et al., 1986b) and express embryonic and adult
globins in contrast to BFU-E and CFU-E, which express only adult globins (Palis et
al., 1999). The EryP-CFC emerge in the yolk sac at E7, where they expand in
numbers peaking at E8.25 and are no longer detected by E9 (Palis et al., 1999).
Primitive myeloid cells also emerge and expand in the yolk sac between E7
and 10 (Palis et al., 1999). Since only cells with a macrophage morphology are
typically observed by histology, while multiple myeloid lineages are not, it is
through the use of colony assays that the timing of the appearance of myeloid
progenitors have been determined. The first and most numerous myeloid cells in the
yolk sac are primitive macrophage progenitors (Mac-CFC) (Moore and Metcalf,
1970; Palis et al., 1999). In contrast to mature macrophages found in the tissues of
adult animals which are derived from monocytes, yolk sac derived macrophages
have an accelerated maturation bypassing the monocyte stage. Mast cell progenitors
(Mast-CFC) appear slightly later and a very small number of bipotential granulocyte-
macrophage progenitors (GM-CFC) are detected last (Palis et al., 1999). There is
also evidence of primitive yolk sac megakaryocytes, which as in the case of the
primitive macrophages, show an accelerated maturation and production of platelets
compared to their adult counterparts.
Definitive haematopoietic progenitors are also present in the yolk sac (Huang
and Auerbach, 1993), with definitive precursors overlapping temporally with the
primitive cells described above. Definitive erythroid precursors (BFU-E) arise in the
yolk sac at E8.25, increase in numbers until E9.5, enter the circulation and
differentiate, indicating that the yolk sac plays a more significant haematopoietic role
than merely the contribution of primitive erythrocytes (Palis et al., 1999). In support
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of this, HPP-CFCs have been found to be restricted to the yolk sac in the pre-
circulation embryo (Palis et al., 2001). HSCs able to engraft and contribute to
haematopoiesis in adult recipients are detected at Ell after vascular connections
have been established (Muller et al., 1994).
However, multilineage long term repopulation can be achieved from E9-10
yolk sac cells if injected into newborn pups (Yoder and Hiatt, 1997; Yoder et al.,
1997b), suggesting that an immature pre-HSC population already exists in the yolk
sac at this time and questions the criteria used to define LTR-HSCs. More
importantly, LTR-HSC activity in the yolk sac at E12 was found to increase in organ
culture showing that the mature yolk sac is capable of expanding HSCs and that they
perhaps may also be generated in this tissue (Kumaravelu et al., 2002).
1.3.2 Intraembryonic haematopoiesis
It was initially thought that HSCs originated in the yolk sac blood islands and
migrated to the foetal liver and subsequently to the bone marrow (Moore and
Metcalf, 1970). However, this idea was challenged by evidence of an
intraembryonic haematogenic site after orthotopic embryo grafting experiments in
avian and amphibian model systems (Zon, 1995). In interspecies chimeras between
chick and quail embryos generated by grafting extraembryonic tissues from one
species to the embryo body explants of the other taken before circulation is
established, the definitive haematopoiesis was found to be of intraembryonic origin
and the extraembryonic yolk sac cells showed no long term self-renewal capacity
(Dieterlen-Lievre, 1975). The mesodermal region containing the dorsal aorta was
later found to harbour the haematopoietic activity (Cormier and Dieterlen-Lievre,
1988; Dieterlen-Lievre and Martin, 1981). Similarly, grafts between the amphibian
(.Rana pipiens) yolk sac equivalent (ventral blood islands) and the cytologenetically
marked intraembryonic mesoderm containing the dorsal aorta, pronephros and liver
(dorsal lateral plate), demonstrated that the intraembryonic site is the major source of
adult haematopoiesis (Turpen et al., 1981). Haematopoietic cells have since been
identified in the floor of the dorsal aorta in Xenopus (Ciau-Uitz et al., 2000), chick
(Jaffredo et al., 1998) and zebrafish (Burns et al., 2002) embryos.
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The analogous intraembryonic region in mammals is the para-aortic
splanchnopleura (P-Sp), which develops into the aorta, gonad and mesonephros
(AGM) region. The P-Sp/AGM region extends between the fore- and hind limb buds
of the mouse embryo. The term P-Sp is used to refer to this tissue at early embryonic
stages (E7.5-9.0) when it includes the splanchnic mesoderm (mesoderm associated
with the endodermal germ layer), paired dorsal aorta, omphalomesenteric artery and
endoderm of the developing gut (Godin et al., 1995; Godin et al., 1993). During
organogenesis from E9.0, the urogenital system (pro-, mesonephros and genital
ridge) develops next to the dorsal aorta, hence the term AGM region (Medvinsky et
al., 1993).
Many studies have examined the haematopoietic activity of the P-Sp/AGM
region. CFU-S (day 8 and 11) activity was detected in embryonic AGM region at the
31-33 somite stage (early E10) and at a higher frequency than in yolk sac but was not
detected in foetal liver until 38-40 somites (late ElO/early Ell). The fall in the CFU-
S activity of the AGM region at El 1 coincides with a sharp increase in the foetal
liver, suggesting the migration of haematopoietic progenitors (Medvinsky et al.,
1993). Grafting P-Sp from E8.5-9 embryos under the kidney capsule of adult
immunodeficient SCID mice resulted in the donor derived B-cell progenitors in the
host, showing lymphoid potential of the P-Sp (Godin et al., 1993). Transplantation
of AGM region cells from late E10 embryos into irradiated adult recipients gave rise
to long term reconstitution of all haematopoietic lineages in serial recipients,
demonstrating a full HSC potential. LTR-HSC activity was found in the AGM
region before the appearance of stem cell activity in the yolk sac and foetal liver
(Muller et al., 1994).
While these experiments suggested that the AGM region was the most potent
site of definitive HSC activity prior to the foetal liver, they did not identify the
primary source of HSCs due to the possibility of cell migration. Since intricate
grafting experiments, as those performed in the non-mammalian vertebrates, were
not possible in mammalian embryos, Medvinsky and colleagues (Medvinsky and
Dzierzak, 1996) developed an in vitro organ culture approach to isolate yolk sac,
AGM region and foetal liver thus preventing cell migration. The study showed that
at E10 only the AGM region was able to initiate and expand LTR-HSC activity. By
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Ell some HSC activity was detected in cultured yolk sac, but at a much lower
frequency than cultured in AGM region. This finding is in strong support of
autonomous de novo generation and expansion of HSCs in the intraembryonic AGM
region, which subsequently colonise the foetal liver. Furthermore, Cumano and
others (Cumano et al., 1996) showed that cultured E7.5 P-Sp isolated prior to
circulation had both lymphoid and myeloid potential in vitro, while cultured yolk sac
at the same gestational stage had a reduced myeloid and no lymphoid capacity.
While no in vivo reconstitution by pre-circulation P-Sp cells had previously
been achieved (Cumano et al., 1996; Muller et al., 1994), LTR-HSC activity was
found more recently in cultured pre-circulation P-Sp when transplanted into adult
Rag2yc+ (NK cell deficient) mice, but only short term erythromyeloid reconstitution
was achieved from cultured yolk sac (Cumano et al., 2001). Mice lacking NK
activity were used as recipients based on the rationale that levels of MHC class I
expression are low on embryonic cells from before El0.5 and are therefore killed by
NK cells (Ozato et al., 1985). These data provide further evidence for the P-
Sp/AGM region as the first site of definitive LTR-HSC emergence because the
tissues were explanted before circulation is established and before reconstituting
activity is detected in these tissues in vivo. Of course the possibility that the P-Sp is
more suitable for this type of organ culture compared to the yolk sac cannot be ruled
out.
In morphological studies clusters of haematopoietic cells have been found
along the ventral wall of the dorsal aorta in mouse (Garcia-Porrero et al., 1995;
Wood et al., 1997) and human embryos (Tavian et al., 1999) supporting the data
provided by transplantation experiments that HSCs emerge at this site.
HSC and progenitor activity peaks in the AGM region at El 1-12 (Godin et
al., 1999; Kumaravelu et al., 2002; Muller et al., 1994) and then decreases as HSC
activity increases in the foetal liver (Ema and Nakauchi, 2000; Kumaravelu et al.,
2002). It has often been postulated that HSCs colonise the liver rudiment via the
circulation but adult repopulating HSC activity had never been detected in
embryonic blood until recently (Kumaravelu et al., 2002). HSC activity in the foetal
liver peaks at E16 (Ema and Nakauchi, 2000). HSC seed the spleen at E15 (Godin et
al., 1999) and finally the bone marrow around birth.
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1.3.3 HSCs in the embryo
The surface phenotype of the HSCs that emerge during ontogeny has been
extensively characterised in an attempt to gain an insight into their developmental
origin. There are some significant differences in the markers used to discriminate
LTR-HSCs in the adult bone marrow (see section 1.2.2) compared to the those
expressed by repopulating cells in the embryo. They perhaps relate to or reflect the
contrasts between embryonic HSCs and their adult counterparts in properties such as
cycling status.
As in the adult bone marrow, all LTR-HSCs in the AGM region and foetal
liver express c-kit, but there are also c-kit+ cells (pre-HSCs) in early E10 AGM
region that do not yet have the capacity to repopulate (Sanchez et al., 1996). The
majority of c-kit+ HSCs from the AGM region and foetal liver are also express CD34
(Sanchez et al., 1996) in contrast to adult bone marrow, which are CD34 (Osawa et
al., 1996). The authors do not quantify the numbers of CD34+c-kit+ HSCs but base
their conclusion on the fact that high numbers of CD34 cells from AGM region and
foetal liver did reconstitute a small number of recipients, but also suggest this could
be due to the purity of the sort. In addition, E9 yolk sac and P-Sp cells that can
repopulate newborn but not adult recipients express CD34 (and c-kit), while the
CD34 population did not have that ability (CD34 P-Sp cells were not tested) (Yoder
et al., 1997a). Nevertheless, this difference in CD34 expression by AGM region,
foetal liver and bone marrow HSCs might be related to the cell cycle status in
embryonic and adult HSCs. While repopulating cells in the embryo are
predominantly in cycle, their adult bone marrow counterparts are mostly quiescent.
CD34 expression on bone marrow HSCs has been associated with proliferation (Sato
et al., 1999). Recent work has found that bone marrow HSCs in the mouse are
CD34+ until 7-10 weeks, after which the numbers are dramatically reduced (Ito et al.,
2000).
Sca-1, another marker used to purify HSCs from adult bone marrow is also
found on repopulating cells from the foetal liver (Jordan et al., 1995). HSCs from
the AGM region, on the other hand, are contained within both the positive and
negative cell populations sorted on their surface antigen expression of Sca-1 (de
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Bruijn et al., 2002). However, in transgenic mice generated to express a GFP
reporter under the control of regulatory elements of the Ly-6A gene (which encodes
Sca-1), only GFP+ cells gave rise to long term repopulating activity from the AGM
region (de Bruijn et al., 2002). The authors say this indicates that the Sca-1 antigen
is expressed at low levels on HSCs from the AGM region since there were eight
copies of the GFP transgene compared to the usual two alleles of the Ly-6A/E gene.
However, it may also reflect the additional post translational modifications for
surface membrane expression (Sca-1) compared to a cytoplasmic protein (GFP), or
the loss of specific enhancers or repressors in the transgene. No GFP+ cells were
observed in the yolk sacs of the transgenic embryos (de Bruijn et al., 2002) and in
vivo reconstituting cells from the yolk sac have not been found to express significant
levels of Sca-1 surface antigen (Huang and Auerbach, 1993).
Foetal liver LTR-HSCs are highly enriched in the AA4.1+ fraction (Jordan et
al., 1995; Jordan et al., 1990). AA4.1 expression can be used to enrich for yolk sac
HSCs (Huang and Auerbach, 1993) and has been detected on multipotent progenitors
in P-Sp (Godin et al., 1995). In contrast, while AA4.1 is detected on adult bone
marrow cells, it is not a marker of the stem cell population in this tissue (Rebel et al.,
1996; Trevisan and Iscove, 1995).
Interestingly a macrophage lineage marker used to deplete bone marrow of
mature cells, Mac-1, is expressed on all the LTR-HSCs in foetal liver (Morrison et
al., 1995). Mac-1 is also detected on cells from the AGM region, but both positive
and negative populations contained long term repopulating activity at similar
frequencies (Sanchez et al., 1996).
Dye efflux properties differ on embryonic HSCs compared to those in the
adult. Foetal liver HSCs appear to retain Rhodamine-123 and are Sca-1+Mac-
l+Rhobnght (Rebel et al., 1996). SP cells have been isolated from yolk sac and embryo
proper from E7.5, but before circulation is established they show no haematopoietic
activity in vitro and express endothelial markers (VE-cadherin and Flk-1). From
E9.5 some SP cells had begun to express c-kit and acquired haematopoietic potential.
SP cells from the yolk sac and embryo proper, especially, had low sensitivity to
verapamil compared to bone marrow SP cells, indicative of a difference in the efflux
pumps used by the two cell populations and again highlighting the differences
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between embryonic and adult HSCs (Nadin et al., 2003). These experiments have
not been performed on dissected AGM regions (Dr Karen Hirschi, personal
communication).
1.3.4 Model of the origins ofhaematopoiesis in the embryo
In summary, the experimental evidence to date supports a complex model of
haematopoiesis in the embryo. The yolk sac supplies all the early primitive
erythrocytes from E7 and then also early definitive erythroid and myeloid
progenitors from E8.5. There are no haematopoietic precursors detected in the
embryo proper before this time. The progenitors enter the embryo proper via the
circulation, which has been established by E8.5. Since little haematopoietic
maturation occurs in the yolk sac and precursors are present in the circulation and
increasingly in the developing liver rudiment, it seemed likely that cells were being
produced in the yolk sac for export to other sites. Therefore the yolk sac provides
the developing embryo with primitive functional erythrocytes and definitive
progenitors.
The first adult repopulating HSCs emerge in the intraembryonic AGM region
between ElO and 12, where they proliferate before colonising the foetal liver, which
takes over as the main site of haematopoiesis. HSCs are present in the yolk sac
immediately after appearing in the AGM region and there is ongoing controversy as
to whether they arise here de novo at this stage or are seeded from the AGM region.
The main reason for this controversy is that the assay for HSCs is the full
reconstitution of haematopoiesis in irradiated adult animals, which relies on the
homing of HSCs to the bone marrow. It has been argued that it is perhaps
unreasonable to expect embryonic cells to be able to home to a place that does not
yet exist in its embryonic origin. This is supported by the engraftment of early yolk
sac or P-Sp cells in foetal and newborn environments or in NK cells deficient hosts
but not in adult bone marrow. However it appears that HSCs can expand (and are
perhaps generated) in yolk sac and colonise the foetal liver between Ell and 13.
Expansion and maturation of the HSCs then takes place in the foetai iiver before
migrating to the spleen and bone marrow around birth.
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1.4 Emergence of HSCs in the embryo and the adult stem cell niche
1.4.1 Haematopoietic clusters in the embryonic vessels
Transplantation of subdissected AGM regions lead to the conclusion that
LTR-HSCs first emerge in the dorsal aorta and surrounding mesenchyme as well as
the vitelline and umbilical arteries of the El l mouse embryo (de Bruijn et al., 2000).
The LTR-HSC activity coincides with the appearance of clusters of presumptive
haematopoietic progenitors on the ventral wall of these arteries (Garcia-Porrero et
al., 1995), which also appear in other species including humans (Tavian et al., 1999).
These clusters express surface antigens and transcription factors that have been
shown to be associated with HSCs, such as c-kit (Bernex et al., 1996; North et al.,
2002), AA4.1, CD45, Lmo2 (Manaia et al., 2000), CD34 (Garcia-Porrero et al.,
1998; Wood et al., 1997), Amll/Runxl (North et al., 2002), endomucin
(Brachtendorf et al., 2001) and Tie2/TEK (Takakura et al., 1998) (see section 1.3.3
and below).
These presumptive haematopoietic clusters have been documented since early
last century in various species and the idea that they arise from the endothelium of
the vessels has contributed to the speculation about the existence of a haemangioblast
or a haematogenic endothelium. Lineage tracing analyses in chick embryos
suggested that the haematopoietic clusters are derived from endothelial cells
(Jaffredo et al., 1998) and in mice that circulating haematopoietic cells are generated
from endothelial cells in the E10 embryo (Sugiyama et al., 2003). Similarly,
candidate cells from the AGM region sorted by flow cytometry for expression of
endothelial markers, for example VE-cadherin (Nishikawa et al., 1998a) or
Tie2/TEK (Hamaguchi et al., 1999) can generate haematopoietic progeny in vitro. In
the latter study, single Tie2/TEK+ cells could, very infrequently, give rise to both
haematopoietic and endothelial colonies, which the authors point out supports the
haemangioblast hypothesis in the AGM region. However the possibility that the
HSCs develop from a multipotent mesodermal precursor cannot be ruled out.
More recently, mesodermal precursors have been identified in the
mesenchyme beneath the floor of the dorsal aorta. Before E8.5 the tissue underlying
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the ventral aorta is endoderm, but as the mesodermal cells accumulate and the
splanchopleura becomes the P-Sp/AGM region, GATA-3 is expressed. At E10 a few
of the cells beneath the aortic clusters express GATA-3 more strongly, and by Ell
the transcript is exclusively detected there. These regions have been defined as the
"sub-aortic patches" and are present for the duration of HSC emergence,
disappearing when production ceases (Manaia et al., 2000). The precise
developmental relationship between the HSCs and the sub-artic patches has not been
determined, but it is likely that HSCs are generated from mesodermal precursors,
which migrate through the vessels, proliferate and enter the circulation.
1.4.2 Molecular determinants of HSC induction in the embryo
Several transcription factors were discovered to have important roles in
haematopoiesis by their identification in chromosomal translocations found in
leukaemias. Transgenic mouse models with targeted deletions of these genes have
enabled some analyses of their function in haematopoietic commitment. Some of the
genes are involved in primitive and definitive haematopoiesis (e.g. SCL/tal, Lmo2),
while others are only involved in definitive haematopoiesis (e.g. AML-l/Runxl, c-
Myb), highlighting both the similarities and differences in their development. Here,
the focus is on genes involved in the initial development of adult-type HSCs.
The disruption of SCL, a basic helix-loop-helix transcription factor, in
embryos was found to result in failure of yolk sac erythropoiesis, although the
endothelium appeared to form normally, resulting in embryonic death at E9-10.5
(Robb et al., 1995; Shivdasani et al., 1995). To circumvent the embryonic lethality
and assess the function of SCL later in development, chimeric mice were made using
Set1' ES cells and no contribution to haematopoietic lineages was found (Porcher et
al., 1996). Furthermore, long term repopulation from transplanted bone marrow cells
where Scl was conditionally deleted demonstrated that SCL is not required for self-
renewal or differentiation (except erythroid and megakaryocyte lineages) of HSCs
but is necessary for their initial specification (Mikkola et al., 2003).
Similarly, the LIM finger protein LM02, is essential for yoik sac
erythropoiesis and null mutant mice die at about E9-10 (Warren et al., 1994). As
was found with SCL, LMQ2' ES cells did not contribute to any haematopoietic
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lineages in chimeras (Yamada et al., 1998). Expression of LM02 is maintained in P-
Sp/AGM region during the whole phase of HSC generation and has been postulated
to play a part in the early specification of mesodermal precursors to HSCs (Manaia et
al., 2000). LM02 protein directly interacts with SCL in erythroid cells as part of a
complex and has been proposed as a bridging molecule, which brings together DNA
binding proteins.
AMLl/Runxl, which encodes the DNA binding subunit of a core-binding
factor (CBF), is required for the establishment of definitive but not primitive
haematopoiesis. Runxl'1' embryos develop normal blood islands, which generate
primitive progenitors that seed the foetal liver rudiment, but die at El 1-12.5.
Haemorrhage and necrosis of the CNS suggests additional vascular defects (Okuda et
al., 1996; Wang et al., 1996a). AMLl/Runxl is expressed in the endothelial cells of
the ventral wall of the dorsal aorta before the emergence of the haematopoietic
clusters, in cells of the para-aortic mesenchyme and later in CD45+ intra-aortic
clusters, which are absent in AMLl/Runxl deficient embryos (North et al., 1999;
North et al., 2002), suggesting a role in specification of HSCs from the endothelium.
In vitro culture of wild type P-Sp/AGM region generates both endothelial and
haematopoietic cells, but AML1 /Runxl'1' P-Sp gave rise to only endothelial cells in
support of this. Interestingly, haematopoietic potential was rescued by introduction
of a retroviral vector containing AMLl/Runxl cDNA but only in cultures of early
(E9.5) P-Sp, (Mukouyama et al., 2000), suggesting that haematogenic precursors are
specified independently of AMLl/Runxl at E9.5 but it is required for their
maintenance and haematopoietic commitment.
The proto-oncogene, c-Myb, encodes a transcription factor required for
definitive haematopoiesis, since lack of c-Myb causes death in mice around E15
purportedly from severe haematopoietic defects in the foetal liver (Mucenski et al.,
1991), although cultures of c-Myb'1' P-Sp/AGM regions were devoid of
haematopoietic progenitors, implicating an earlier defect in HSC generation
(Mukouyama et al., 1999).
Other transcription factors, such as and GATA-2 are involved in the




Studies in Xenopus embryos have shown that LM02, SCL, GATA-2 and
possibly Xaml (the orthologue of AMLl/Runxl) are inducible by BMP-4 (Sadlon et
al., 2004). In mammals there is no direct evidence for such induction, but BMP-4 is
thought to act as a downstream mediator of Indian hedgehog signalling cascade,
which has been shown by in vitro explant co-culture assays to be the diffusible factor
secreted by visceral endoderm necessary for the development of primitive
haematopoiesis in extraembryonic mesoderm (Belaoussoff et al., 1998; Dyer et al.,
2001). There is also evidence suggestive of a definitive haematopoiesis-inducing
role in the AGM region. In human embryos, when the haematopoietic clusters of the
dorsal aorta are forming, BMP-4 is expressed in the underlying mesenchyme (sub¬
aortic patches) consistent with an anterior-posterior developmental progression
(Marshall et al., 2000). Once the clusters disappear, the strong BMP-4 expression is
gone. Furthermore, BMP-4 is present in a highly polarised gradient along the dorsal-
ventral axis of the AGM region mesoderm, with highest levels in the ventral side,
beneath the aortic clusters.
1.4.3 The HSC niche in adult bone marrow
The niche in which HSCs reside has remained relatively uncharacterised
compared to those of other adult somatic tissues such as the gut and skin (Alonso and
Fuchs, 2003; Marshman et al., 2002). The self-renewal and differentiation of the
stem cell is regulated through the interaction with its microenvironment. For the
HSC, the microenvironment that provides the structural scaffolding for
haematopoiesis is the stromal component of the bone marrow. The non-random
spatial distribution of primitive haematopoietic cells and progenitors in the bone
marrow has been defined, with the primitive cells (CFU-S) found in the endosteal
marrow and more mature cells found approaching the central longitudinal axis of the
bone (Gong, 1978); (Lord, 1990). It was postulated that the most primitive HSC was
essentially a "fixed tissue cell" because it remained in such close association with
other cells (Schofield, 1978). A more recent study has shown that after intravenous
injection bone marrow subpopulations localise within the bone marrow according to
their phenotype, with the HSC-enriched fractions lodging in the endosteal region, in
contrast to the lineage committed fractions, which were found in the central marrow
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region. This redistribution occurred within 5-15 hours after transplant (Nilsson et al.,
2001).
The close association of and the interactions between HSCs and the cells that
line the endosteal surfaces (osteoblasts) has lead to speculations about their role in
haematopoiesis (Taichman and Emerson, 1998). Recently, two groups have
demonstrated that osteoblasts are a regulatory component of the HSC niche (Calvi et
al., 2003; Zhang et al., 2003). Both studies found that by using genetic strategies to
increase the number of osteoblasts an increased number of HSCs resulted. One study
found evidence to suggest that this increase occurred through Notch activation (Calvi
et al., 2003), while the other found evidence that BMP signalling regulated the
number of HSCs indirectly by controlling the niche size in terms of the number of
supporting osteoblasts (spindle-shaped N-cadherin+CD45) or SNO cells, which
possibly interact through N-cadherin and (3-catenin (Zhang et al., 2003). An increase
in bone marrow HSCs is observed after conditional deletion of c-myc, which has also
been postulated may be due to increased adherence to SNO cells via N-cadherin
(Anne Wilson, personal communication). Notchl activation has been previously
found to enhance HSC self-renewal and expand the stem cell pool (Stier et al., 2002).
Wnt signalling via (3-catenin has been shown to have a similar role in promoting
stem cell proliferation and may act upstream of Notch. Activated (3-catenin or
exogenous Wnt3a resulted in expansion of HSCs in vitro (Reya et al., 2003; Willert
et al., 2003). Interestingly, inducible inactivation of /3-catenin in bone marrow had
no adverse effect on HSC self-renewal or multilineage reconstitution (Cobas et al.,
2004), which suggests functional redundancy. Transduction of primary bone marrow
cells with HoxB4 resulted in ex vivo expansion of transplantable HSCs (Antonchuk et
al., 2002) and enhanced repopulating activity in vivo (Thorsteinsdottir et al., 1999).
Wnt signalling may also regulate expression of HoxB4 (Reya et al., 2003).
There have now been several reports on the role played by bone marrow
osteoblasts on HSC function. Membrane bound SCF (tm-SCF) may also have a role
in the adherence of HSC to osteoblasts. Few donor cells were evident in the
endosteal region of Sl/Sld recipients (lacking tm-SCF) compared to Sld,+ mice
following transplant of Sld/+ HSCs. Homing to the bone marrow was not thought to
be impaired because equivalent numbers of transplanted HSCs were found in the
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central femoral section of the bone marrow up to 15 hours post transplant of cells to
Sld,+ or Sl/Sld mice. These findings were mimicked by neutralising antibodies to c-
kit, the receptor for SCF (Driessen et al., 2003). Another study demonstrated that
Tie2+ HSCs adhere to osteoblasts by interaction with Angiopoietin-1. It was
suggested that Tie2/Ang-1 signalling acted to maintain the repopulating activity of
HSCs by inhibiting cell division (Arai et al., 2004).
All the data discussed so far highlight the important role the
microenvironment plays in the control of HSC development and function, from the
first induction during embryogenesis to haematopoiesis in the foetus and adult
animal.
1.5 Generating haematopoiesis from embryonic stem cells
Embryonic stem (ES) cell differentiation has been used as an in vitro model
of haematopoiesis to, for example, identify novel haematopoietic genes (Baird et al.,
2001; Stanford et al., 1998).
Since the derivation of human embryonic stem (ES) cells several years ago
(Thomson et al., 1998) and their subsequent differentiation in vitro down various
lineages including haematopoietic cells (Kaufman et al., 2001), much speculation has
surrounded the possibility of obtaining transplantable HSCs from differentiating ES
cells as an alternative source to bone marrow. The transplantation of HSCs is used to
treat certain haematological disorders including leukaemias, anaemias and
autoimmune disease. Unfortunately it is often difficult to find suitable donors
because of the high level of tissue matching required for a successful transplant.
Furthermore although advances have been made in the identification and molecular
characterisation of HSCs, it has so far proven difficult to reliably maintain and
expand these stem cells in culture for prolonged periods. For these reasons a source
of HSCs other than donor bone marrow would be useful. Although there are still
limitations and technical and ethical hurdles to overcome, ES-derived HSCs
theoretically have several advantages over bone marrow HSCs. ES cells can be
expanded indefinitely in vitro, so they are potentially an unlimited supply of cells.
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Embryonic HSCs are more competitive in repopulating than their adult counterparts
(Harrison et al., 1997; Jordan et al., 1995; Rebel et al., 1996) improving engraftment
efficiency. ES-derived HSCs would be "younger" than donor bone marrow and aged
bone marrow accumulates mutations (Sudo et al., 2000) and is associated with
decreased patient survival and increased graft versus host disease (Kollman et al.,
2001). Although it is unknown whether these problems would also arise if the ES
cells were derived from "reprogrammed" blastocysts generated by nuclear transfer
using a mature donor cell.
However, arguably the more interesting reason for acquiring long term
repopulating (LTR) HSCs from ES derived cells is for studying the development of
mammalian HSCs in an accessible system. For the differentiation of ES cells in vitro
to be a representative tool to investigate the factors controlling HSC induction,
proliferation and differentiation, it is important that HSCs can be produced
efficiently and reproducibly and that they can be identified and isolated.
1.5.1 Embryonic stem (ES) cells
Embryonic stem cells were first isolated over twenty years ago from the inner
cell mass (ICM) of preimplantation E3.5 mouse blastocysts (Evans and Kaufman,
1981; Martin, 1981). Cells of the ICM are pluripotent with the capacity to form all
the cells of the embryo proper and although this pluripotency is only transient in
vivo, ES cell lines can be maintained indefinitely in an undifferentiated state while
retaining pluripotency when cultured on a feeder layer of murine embryonic
fibroblasts (MEFs) and/or in the presence of leukaemia inhibitory factor (LIF)
(Smith et al., 1988; Williams et al., 1988).
Pluripotency is demonstrated by their ability to contribute to all the lineages
of the embryo proper in vivo, including the germ line, when introduced into the early
embryo by either injection into blastocysts (Hogan et al., 1994) or aggregation to
morulae (Nagy et al., 1990) forming chimaeras with the host cells. Indeed
completely ES cell derived embryos can be produced by aggregation with tetraploid
4-cell stage embryos, because the ES cells form the embryo proper and the tetraploid
cells contribute to the extraembryonic tissues (Nagy et al., 1990; Nagy et al., 1993).
21
Chapter One: Introduction
Since the developmental capacities of the diploid and tetraploid components
complement each other the process is known as tetraploid complementation.
Differentiation of ES cells into various cell lineages occurs spontaneously in
vitro by the withdrawal of LIF. Derivatives of all three germ layers (ectoderm,
mesoderm and endoderm) of the embryo develop when teratoma-like structures of
semi-organised tissues called embryoid bodies (EBs) are allowed to form
(Doetschman et al., 1985). There are several methods used to generate EBs: culture
of ES cells either in suspension at high density (Doetschman et al., 1985), in
semisolid media containing methylcellulose (Wiles and Keller, 1991) or in "hanging
drops" of medium to form more uniform aggregates of cells (Wobus et al., 1991)
(see Chapter 2: Materials and Methods, section 2.2.1.3.1). By such methods many
cell types have been obtained from differentiating ES cells in vitro, including muscle,
cardiomyocytes, neuronal, adipocytes, chondrocytes, osteoblasts, endothelial, lung,
hepatocytes, pancreatic islet (Rippon and Bishop, 2004) and cells of the
haematopoietic lineages (see section below).
1.5.2 Haematopoietic differentiation ofES cells in vitro
It is well established that most mature haematopoietic cells can be obtained
from populations of differentiating ES cells, including of the erythroid (Wiles and
Keller, 1991), myeloid (Burkert et al., 1991; Fujimoto et al., 2003; Wiles and Keller,
1991) and lymphoid (Nakano et al., 1994; Nakayama et al., 1998; Potocnik et al.,
1994) lineages. Haematopoietic development is initiated spontaneously within EBs
without the addition of exogenous growth factors or cytokines, except for those
present in the FCS (Hole et al., 1996; Keller et al., 1993), most likely because
differentiating ES cells express many cytokines and their receptors endogenously
(Croizat and Bouhassira, 1999; Hole et al., 1996; Keller et al., 1993; Schmitt et al.,
1991).
However, changing the culture conditions, adding specific cytokines or
culture on stromal cell lines, can enhance or skew in vitro haematopoietic
differentiation of ES cells down certain lineages. For example, the addition of SCF,
11-3 and M-CSF to increases the yield of macrophages (Lieschke and Dunn, 1995),
reduced oxygen conditions increase and prolong erythroid development (Potocnik et
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al., 1994) enhance mesoderm and early haematopoietic/endothelial commitment
(Ramirez-Bergeron et al., 2004) and increase the number of early myeloid
progenitors (A.K. and H.T., unpublished) in EBs. Perhaps most dramatically is a
stromal cell (OP9) based co-culture system that reproducibly induces the
differentiation of ES cells (without the prior formation of EBs) through a defined
mesoderm stage to first primitive and then more mature haematopoietic lineages
including lymphoid cells, which are not frequently observed in EBs (Nakano et al.,
1994). The crucial element to this induction system is the use of the OP9 cell line,
which was derived from the bone marrow stroma of newborn osteoporotic mice
lacking functional M-CSF, because ES cells have a tendency for preferential
differentiation into the macrophage lineage. It is generally believed that in the
absence of exogenous stromal cells, EB formation is required for significant
haematopoietic development during ES cell differentiation in vitro.
In a detailed time course analysis of ES cell differentiation, the appearance of
haematopoietic lineages within differentiating EBs, as determined by colony assays,
responsiveness to cytokines and gene expression, was found to be similar to that
observed in the yolk sac (see section 1.3.1) indicating that the early stages of
haematopoietic commitment in the EB parallels that found in the embryo (Keller et
al., 1993) making a suitable in vitro model system of haematopoietic development.
In this study no haematopoietic progenitors were detected before day 3 of
differentiation. Primitive erythroid progenitors (EryP) appeared transiently from day
3.5 EBs, increased in numbers dramatically and were undetected by day 10.
Definitive precursors emerge shortly after primitive precursors in the EBs, starting
with erythroid progenitors (EryD) from day 5, macrophage precursors from day 6
and mast cell progenitors from day 10. Bipotential (GM-CFC) and multipotential
(CFC-mix) were also detected within differentiating EBs. It is unclear whether EryP
and EryD in the embryo are derived from a common precursor (Wong et al., 1986a;
Wong et al., 1986b), but studies using OP9 induction show ES derived EryP and
EryD appear in two distinct waves and that they have different growth factor
requirements. These data taken together wiih limiting dilution analysis provide




The model system provided by ES cell differentiation has also been used to
investigate the development of pre-haematopoietic precursors. In vitro colony assays
in combination with gene targeting studies have lead to a possible model of early
haematopoietic commitment.
A common bipotential precursor to the haematopoietic and endothelial
lineages (the haemangioblast) has been identified during ES cell differentiation by
Gordon Keller and his colleagues (Choi et al., 1998; Kennedy et al., 1997). Blast-
colony forming cells (BL-CFC), which give rise to blast colonies in response to
VEGF when replated in methylcellulose cultures, emerge from EBs before the
appearance of haematopoietic progenitors. The blast cells within the colonies
expressed genes common to both haematopoietic and endothelial lineages, such as
Scl, CD34 and Flk-1. More importantly, they contain cells with both endothelial and
haematopoietic (primitive and definitive) progenitors as demonstrated by replating in
medium containing specific growth factors. These data suggest that the BL-CFC is
the in vitro equivalent to the putative haemangioblast and provide the strongest
evidence to date in support of such a bipotential precursor. Another study
demonstrated that EB derived Flk-1+ cells contained precursors with both
haematopoietic and endothelial potential (Nishikawa et al., 1998b). BL-CFC have
since been shown to be Flk-1+ (Faloon et al., 2000), which is not surprising since
they have been shown to grow in response to VEGF (Kennedy et al., 1997), although
not all Flk-1+ cells are BL-CFC (Faloon et al., 2000). It is likely that the progenitors
identified by Nishikawa et al, and the BL-CFC are identical on the basis of their in
vitro potential and the expression of Flk-1.
Two studies investigating the genetic regulation of BL-CFC commitment by
Flk-1 and Scl during EB differentiation identified a more primitive cell type
emerging one day before BL-CFCs, which gave rise to so-called "transitional"
(Robertson et al., 2000) or "blast-like" (Faloon et al., 2000) colonies. The co-
expression of the early mesodermal marker, Brachyury, and markers for
haematopoietic and endothelial lineages in these "transitional" colonies, and the
generation of blast colonies on replating, suggested that the "transitional" colony
forming cell (Trans-CFC) represents an earlier mesodermal developmental stage than
the BL-CFC (Robertson et al., 2000).
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The role of SCL in haematopoiesis during mouse development has to some
extent been determined by targeted deletion (see section 1.4), but due to its early
embryonic lethal phenotype, the in vitro model for haematopoiesis provided by ES
cells has provided further insight into its function. SCL is required for the formation
of haematopoietic lineages in vitro and in chimeras (Porcher et al., 1996; Robb et al.,
1995). Scl'1' EBs do not express haematopoietic-specific genes, but do express genes
that are associated with mesoderm or co-expressed by haematopoietic and
endothelial lineages (Elefanty et al., 1997). In addition SCL-deficient EBs do not
contain BL-CFC, but can generate "transitional" colonies (Faloon et al., 2000;
Robertson et al., 2000). Taken together, these data provide support for a model in
which SCL is essential for haematopoietic commitment at the putative
haemangioblast stage.
Flk-1, a receptor for VEGF, is involved in haematopoietic and endothelial
development during embryogenesis. Mice deficient in Flkl do not develop blood
vessels or yolk sac blood islands (Shalaby et al., 1995), which is also illustrated by
the failure of Flk-1 deficient ES cells to contribute to vessels or haematopoiesis in
chimeras (Shalaby et al., 1997). In vitro Flk-1'1' EBs show a significant reduction in
the frequency of BL-CFC (Schuh et al., 1999) but are able to differentiate into
haematopoietic and endothelial progenitors (Hidaka et al., 1999; Schuh et al., 1999).
This supports the hypothesis that haematopoietic and endothelial progenitors can
arise independently of Flk-1, and the phenotype of Flk-1 deficient mice is due to
defective expansion and migration of those progenitors.
These and other studies using ES cells (Chung et al., 2002) have contributed
to a model of early haematopoietic development whereby Flk-1+SCL cells are
mesodermal precursors (Trans-CFC) to the putative haemangioblast, which
coexpress Flk-1 and SCL. As haematopoietic and endothelial commitment proceeds,
Flk-1+SCL+ cells eventually become positive for either SCL or Flk-1, respectively.
Since Flk-1+ endothelial cells emerge in the absence of SCL some endothelial cells
are thought to develop directly from Flk-1+ mesoderm bypassing the haemangioblast
stage.
Runxl is required for definitive haematopoiesis in vivo (see section 1.4) and a
similar block in definitive haematopoietic potential has also been observed in mutant
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Runxl' EBs (Miller et al., 2001; Okuda et al., 1996). More recently, by ES cell
differentiation in vitro a role in early definitive haematopoietic commitment at the
haemangioblast level was defined (Lacaud et al., 2002). This study showed that
Runxl is expressed by EB-derived BL-CFC but not by Trans-CFC. Furthermore,
Runxl deficient EBs showed a dramatic reduction in BL-CFC, which on replating
only gave rise to a endothelial cells and a few colonies of primitive erythroid cells
but no definitive lineages, demonstrating that Runxl is essential for definitive
haematopoiesis acting at the putative haemangioblast stage. Interestingly Runxl
haploinsufficiency results in accelerated commitment to mesodermal,
haemangioblast and haematopoietic development in ES cells (Lacaud et al., 2004) as
observed in the AGM region in vivo (Cai et al., 2000).
BMP-4 is essential for haematopoietic differentiation of ES cells in
chemically defined serum free medium (Johansson and Wiles, 1995) and has more
recently been found to be essential for ES cell self-renewal (Ying et al., 2003).
Interestingly, the self-renewal capacity of early haematopoietic progenitors (CFU)
derived from human ES cells was supported by BMP-4, independently of cytokines,
as quantified by the number of secondary colonies generated after replating the
primary CFC colonies (Chadwick et al., 2003).
Some of the factors implicated to have a role in HSC self-renewal in the bone
marrow niche have been found to effect the haematopoietic differentiation of EBs.
Transfection of ES cells with retroviral vectors expressing Wnt3 and Wnt5a resulted
in a 2-fold increase in the proportion of EBs commited to a haematopoietic fate
(Lako et al., 2001). Retroviral overexpression of HoxB4 resulted in an increase in
definitive, but not primitive (as determined by colony assays and gene expression)
haematopoietic differentiation of ES cells in vivo (Helgason et al., 1996).
Overexpression of HoxB4 has since been shown to have a much more dramatic
effect on the development of HSCs in EBs (see section 1.5.3).
1.5.3 Deriving transplantable HSCs from ES cells
ES cells have the capacity to differentiate into all haematopoietic lineages in
vivo, as demonstrated by their contribution to these tissues in chimaeras. ES cells
must also be able to produce all the cells of the haematopoietic niche which support
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HSC development, since foetal liver HSCs isolated from embryos derived entirely
from ES cells generated by tetraploid complementation can reconstitute lethally
irradiated recipients (Forrester et al., 1991). Interestingly, uneven contribution to
haematopoietic development in chimeras by donor ES cells has been reported
(Berger et al., 1995). This study showed a bias towards ES-derived B-lymphocytes,
while ES-derived T-lymphocytes in the spleen were underrepresented, indicating that
haematopoietic commitment of differentiated ES cells may be different from host
ICM cells. Nevertheless progeny of ES cells show LTR-HSC potential in chimeric
mice after differentiation in vivo.
Unfortunately there has been limited success in long term haematopoietic
reconstitution by ES-derived cells after differentiation in vitro. Direct injection of
undifferentiated ES cells leads to the formation of tumours (Muller and Dzierzak,
1993), so prior in vitro differentiation is essential. Most transplantation studies
report low levels of engraftment and contribution restricted to certain lineages. The
following section outlines most of the reported data on the long term repopulating
ability of in vitro differentiated ES cell progeny.
Muller and Dzierzak (Muller and Dzierzak, 1993) injected cells intravenously
(i.v.) from differentiated EBs (0.8xl05-3.6xl06 Percoll fractionated or unfractionated
cells per animal) into newborn immunodeficient SCID or Wv/ Wv anaemic, mast cell
deficient mice. They found 0.1-4% of the nucleated cells in the peripheral blood to
be donor ES-derived after 6.5 months, but only of the lymphoid lineages. B-cells
were demonstrated to be functional by the presence of circulating antibodies in the
peripheral blood of SCID recipients. Macrophages and mast cells were reportedly
absent. All days of EBs (between 5 and 22 days of differentiation) produced
repopulating activity, but the greatest proportion of mice repopulated with EB cells
were those given day 11-13 EBs, a later time point than perhaps expected from
previous in vitro data (see section 1.5.2). No short term reconstitution (CFU-SI0)
was achieved in this study. However, it is interesting to note that a small increase in
CFU-S compared to the irradiation controls was observed, but the colonies were not
donor ES derived.
Guterrez-Ramos and Palacios (Gutierrez-Ramos and Palacios, 1992) also
reported B- and T-lymphoid repopulation 10-16 weeks after injection of
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differentiated ES cells (2xl05-lxl06 mononuclear cells per mouse) i.v., or directly
into the liver, spleen or peritoneal cavity of sublethally irradiated SCID or normal
mice. The ES cells were differentiated for 25 days on a bone marrow stromal cell
line (RP.0.10) in the presence of cytokines (IL-3, 6 and 7) and were found to include
cells that expressed early lymphoid markers but only a few with myeloid markers.
Palacios and colleagues (Palacios et al., 1995) subsequently reported ES derived
myeloid, erythroid and lymphoid progenitors in the bone marrow of sublethally
irradiated recipient SCID mice 12-18 weeks after transplantation of 4-6xl04 sorted
PgP-l(CD44)+Lin ES-derived cells. Haematopoieitc reconstitution was also
achieved when bone marrow from primary recipients was transplanted into
secondary SCID recipients to demonstrate the presence of long term repopulating
activity. This study showed a promising result with high donor contribution. A
similar differentiation regime to their previous study was used here, with the
exception of a replating step onto fresh stromal cells after 21 days for a further 6-8
days and the addition of supernatant from a foetal liver stromal cell line (FLS4.1)
containing FLT3 ligand, steel factor and purportedly a mystery cytokine which
supports the proliferation of HSCs.
Another group injected 104 sorted AA4.1+B220+ or AA4.1+B220 cells from
day 15 EBs i.v. into sublethally irradiated Rag-1 recipients (Potocnik et al., 1997).
Transplantation of AA4.1+B220+ EB cells resulted in a single transient wave of B
cells and no T cells. On the other hand, AA4.1+B220~ cells gave rise to both B-and
T-lymphocytes for at least 24 weeks, but the level of donor contribution decreased
over time, indicating limited self-renewal capacity of the transplanted cells. The
repopulation efficiency of the AA4. EB220 EB cells was also much lower than the
equivalent population isolated from E14.5 foetal liver.
The only study to assess the long term repopulating activity of cells derived
from EBs at earlier time points during in vitro differentiation was by Hole and
colleagues (Hole et al., 1996). lxlO6 unsorted cells from day 4 EBs were injected
i.v. into lethally irradiated adult mice along with a limiting dose (5xl05) of
autologous spleen carrier ceils. Haematopoietic progenitors with short term
reconstituting activity, as measured by the CFU-A assay (see section 1.2.3 and
1.6.4.1) appear from day 5 of EB differentiation, therefore cells from day 4 EBs were
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transplanted to potentially coincide with the emergence of LTR-HSCs. Analysis of
peripheral blood 12 week after transplantation detected donor EB-derived
granulocytes and lymphocytes, demonstrating that cells with long term repopulating
activity were present in EBs at day 4.
More recently, Flk-1+ cells from day 4 EBs generated leukocytes
(granulocytes and lymphocytes) and thrombocytes after injection into sublethally
irradiated SCID recipients. (Miyagi et al., 2002). However, recipient animals were
only analysed up to 30 days post transplant, so long term reconstituting activity was
not assessed. Interestingly but not surprisingly, given the reported presence of a
bipotential cell from differentiating ES cells, neoangiogenesis by donor cells was
observed in the host spleens.
A variety of methods have been used in an attempt to optimise the in vitro
differentiation of ES cells to obtain haematopoietic progenitors with repopulating
ability, but no specific population of cells within EBs has yet been identified as LTR-
HSCs. It is possible that ES-HSCs are not produced in sufficient numbers or are too
similar to early yolk sac progenitors without long term repopulating ability. Much of
the in vitro data described above (see section 1.5.2) would point to this scenario. In
addition, the transplantation studies described above have not formally addressed the
efficiency with which the progenitors derived from EBs or differentiated ES cells can
colonise the bone marrow and therefore whether defective homing explains, at least
in part, the low level of contribution observed in the peripheral blood of recipient
mice.
To address this question Burt and others (Burt et al., 2004) compared the
repopulation ability of haematopoietic progenitors from EBs injected either
intravenously or directly into the femoral bone marrow cavity (IBM). Enriched c-
kit+CD45+ cells from day 7 EBs (grown in the presence of SCF, 11-3 and 11-6) were
selected as the transplanted population based on their efficiency for haematopoietic
colony formation in vitro. The authors stated that unsorted day 7 EB cells injected
i.v. into lethally irradiated animals had lead to death within 8-13 days (also observed
previously with day 4-6 EBs by Hole et al, 1996) and injected iBM had resulted in
very low levels of haematopoietic contribution and in some cases teratomas formed
at the site of injection. However, when 105 sorted progenitors were injected IBM,
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donor chimerism of peripheral blood mononuclear cells (including T- and B-
lymphocytes, monocytes and granulocytes) at 20 weeks was found to range from
45.7-91% compared to 7.9-18.6% after i.v. injection of 106 cells, strongly suggesting
that homing to the bone marrow via the i.v. route of administration is inefficient and
a reason for the low levels of contribution seen previously. However, creating
"space" in the bone marrow was essential for engraftment since a sublethal dose of
irradiation prior to IBM transplantation (compared to a lethal dose) resulted in lower
levels of haematopoietic contribution. The c-kit+CD45+ cells were enriched for cells
expressing Sca-1 and lacking lineage markers (lin ), and thus immunophenotypically
resemble KTLS cells (see section 1.2.2). The authors also reported that although
donor and recipients were MHC mismatched, the was no clinical or histological
evidence for graft-versus-host disease and no in vitro mixed lymphocyte response
(MLR) of chimeric mice to donor or recipient antigen despite an intact response to a
third party antigen and normal production of INF-y. The data reported in this study
are promising when considering the future possibility of using human ES cells for
cell therapy in the clinic.
Using a different approach, ectopic expression of the homeobox gene HoxB4
was shown to endow differentiated ES cells with LTR-HSC activity (Kyba et al.,
2002). ES cells with a doxycycline inducible HoxB4 transgene were differentiated as
EBs for six days, which were then dissociated for further culture on OP9 stromal
cells. Doxycycline was added between EB days 4 and 6 to induce HoxB4 expression
and maintained during OP9 co-culture. 2xl06 EB cells were injected i.v. into lethally
irradiated adult mice, resulting in full, normal, multilineage reconstitution in primary
and secondary recipients. This method was also used to partially repair the immune
function of Rag2 ' immunodeficient mice (Rideout et al., 2002). A Rag2~' ES cell
line was generated by nuclear transfer/therapeutic cloning, one allele was repaired by
homologous recombination resulting in Rag2+I~ ntES cells, which were retrovirally
transduced with HoxB4, differentiated as above and transplanted into the Rag2'~
immunodeficient mice, reconstituting their haematopoietic system and partially
restoring their immune function. These experiments provide a "proof-of-principie"
for the combined use of nuclear transfer and ES cell differentiation technology in the





There are still limitations in the ES cell differentiation system.
Haematopoietic progenitors are generated in very low numbers within EBs. At day 6
of differentiation 0.5-1% of EB cells are CFCs (Keller et al., 1993), whereas only
0.002% are HPP-CFCs (Palis et al., 1999) and 0.1% are CFU-A (see Figure 3.5),
which is approximately one cell per EB (Hole et al., 1996); Figure 5.2). These data
are from differentiation in the absence of exogenous growth factors (apart from those
in FCS) and advances are being made in identifying the cytokines and growth factors
which can increase the number of haematopoietic cells generated from EBs (see
section 1.5.2). The OP9 stromal cell differentiation system, although importantly
lymphoid lineages can readily be obtained by this method, the frequency of early
haematopoietic progenitors is low. When the system is working efficiently, 90% of
colonies after the first 5 days of co-culture are mesodermal and by a further five days
after replating onto fresh OP9 cells, between 1/500 and 1/1000 (0.1-0.2%) cells give
rise to CFC-mix (Kitajima et al., 2003). A direct comparison between differentiation
in EBs and in the OP9 system found that haematopoietic cells (Scl+) developed more
efficiently in EBs, while endothelial cell (VE-cadherin+) maturation was better
supported by OP9 cells (Zhang et al, Blood, in press).
Reliably and efficiently achieving long term multilineage repopulation by EB
cells is limited. There are several possible explanations for this problem. ES-HSCs
may be inefficient at homing to the bone marrow or developmentally too immature
to function in an adult environment. It may also reflect the low numbers of
progenitors generated or perhaps HSCs are generated but have a tendency for





These limitations may partly be attributed to a sub-optimal microenvironment
for full haematopoietic development within ES/EBs differentiating in vitro.
Elegant co-culture experiments between yolk sac and foetal liver rudiments
demonstrate that diffusible factors from the foetal liver are able to induce
differentiation of primitive yolk sac erythrocytes towards a foetal/adult type of
erythropoiesis, and that in the absence of the yolk sac, foetal liver erythropoiesis is
not initiated (Cudennec et al., 1981). In this set of experiments, E9.5 yolk sac
cultured alone for seven days produced a single transient wave of primitive nucleated
erythrocytes, which expressed embryonic globins, while E9.5 foetal liver cultured
alone (before the emergence of haematopoietic cells) did not express any globins.
When these organ rudiments were co-cultured to allow cell migration, a second wave
of erythrocytes was observed in the yolk sac and both tissues expressed definitive,
adult-type globins. However, when filters were used to separate the yolk sac and
foetal liver such that cells could not pass between the organ rudiments, adult
erythrocytes were found in the yolk sac but none in the foetal liver. Intriguingly,
other parts of the embryo body had the same inductive effect on the yolk sac. These
experiments were set up to demonstrate that foetal liver erythropoiesis is only
initiated by colonising cells and that these cells are from the yolk sac, nevertheless
they also illustrate the potential of an appropriate inductive microenvironment even
in vitro. The optimal microenvironment, which provide the necessary signals for
HSC development is found in the haematopoietic organ rudiments of the embryo
during ontogeny. Therefore exposure of differentiating ES cells to haematopoietic
organ rudiments may potentially enhance their haematopoietic development.
1.6.3 Experimental system
The experiments in this thesis test the effect of co-culturing differentiating ES
cells in the presence of embryonic tissue that should provide a more appropriate
microenvironment for haematopoietic commitment. The AGM region was chosen as
the haematopoietic organ rudiment for the co-culture experiments for several
reasons. First, the AGM region is the earliest site in the developing embryo able to
generate definitive, adult type LTR-HSCs (see section 1.3.2) so it must be a potent
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source of inductive signals for HSC commitment. The induction of LTR-HSC
activity in E8.5 yolk sac after culture on a stromal cell line derived from the AGM
region (Matsuoka et ah, 2001) supports this idea. Second, the emerging HSC
population expands in the AGM region without significant haematopoiesis. In
addition to HSCs, primordial germ cells (PGCs) migrate through the AGM region
from about E8.5 and arrive in the genital ridge around E10-11, where they continue
to self-renew until El3.5 (Matsui et ah, 1992; McLaren, 2003). It is the only site in
the embryo where stem cell proliferation occurs in the absence of differentiation.
For these reasons it would be logical to presume that there should be a strong drive
promoting self-renewal in this environment. Third, LTR-HSC activity has been
found to increase within AGM region explant cultures (Medvinsky and Dzierzak,
1996), indicating that the elements of the supporting microenvironment for
expansion of definitive HSCs can be captured in vitro.
1.6.4 Readout for haematopoietic commitment
The differentiation of ES cells within EBs was quantitatively assessed by an
in vitro colony assay (CFU-A), which detects early haematopoietic progenitors. A
colony assay-based readout was chosen in favour of other methods, because it would
be difficult to choose the most appropriate and specific system for identification.
Colony assays have the additional advantage of measuring haematopoietic potential
or function. A good illustration of this is by Burt and others (Burt et al., 2004), who
achieved haematopoietic reconstitution with c-kit+CD45+ ES-derived cells injected
IBM. The authors reported 3% of the EB cells had this phenotype, yet only 0.3 % of
these cells had multilineage potential in vitro (4 CFU-mix colonies were produced
per 1200 c-kit+CD45+ cells plated in methylcellulose).
1.6.4.1 The CFU-A assay
The CFU-A assay was chosen as the readout for early haematopoietic
commitment in EBs in these experiments because this assay quantitatively measures
one of the most primitive haematopoietic progenitors measurable in vitro. In the
CFU-A assay, macroscopic multilineage colonies (see Figure 2.4) are generated
from normal mouse bone marrow at a frequency of approximately 150 in 105 cells in
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response to synergistic action by conditioned medium from a mouse lung fibroblast
cell line (L929), a source of CSF-1, and a rat fibroblast cell line transformed with the
malignant hystiocytosis sarcoma virus (AF1.19T), a source of GM-CSF (Pragnell et
al., 1988). The CFU-A has been shown to be the in vitro correlate to the CFU-S12
based on several shared functional characteristics from investigations with normal
and regenerating mouse bone marrow (Lorimore et ah, 1990). A high proportion of
both CFU-A and CFU-S12 are quiescent with only 10% of the clonogenic cells in S
phase, compared to more mature, lineage-restricted progenitors (GM-CFC) where
that figure was 30%. CFU-A displayed the same dose response to CFU-S12
proliferation regulators. The kinetics of CFU-A and CFU-S12 activity in recovering
bone marrow after 5-Fu treatment are comparable as is their response to ionising
radiation. CFU-A and CFU-S12 show similar radial distribution in bone marrow;
both progenitors are detected with increasing frequency at distances further from the
femoral axis and closer to the endosteal region.
With specific relevance here, the CFU-A detected in EBs has been shown to
be functionally indistinguishable from its bone marrow equivalent in terms of
sensitivity to the stem cell specific regulator SCI/MIPla. However replating
efficiency is lower in EB-CFU-A compared to those in bone marrow (Hole et ah,
1996; Pragnell et ah, 1988). Furthermore, a highly reproducible time course of
emergence has been established for the CFU-A in differentiating ES cells (Hole et
ah, 1996).
The precise relationship between the CFU-A and the various HPP-CFC is not
fully established, but it has been suggested that the CFU-A is more mature than the
most primitive HPP-CFC (type 1) (Ivanovic et ah, 1999; Pragnell et ah, 1994). Here
the CFU-A was compared to the HPP-CFC type 2 (McNiece and Briddell, 1994;




Chapter Two: Materials and Methods
2.1 Animals
Animals were bred and maintained at the Biomedical Research Facility
(BRF) of the University of Edinburgh or purchased from Harlan Olac, Ltd. Mice
were treated according to the provisions of the Animals (Scientific Procedures) Act
(UK) 1986. The daily care of the animals and plug checking was done by the staff at
the BRF.
C57B1/6 mice were donors for all wild type embryo material used. Female
129/Sv mice were recipients in transplantation experiments. Female mutant mice
heterozygous for the gene trap integration, GT411, into the endothelial cell
aminopeptidase gene (EcapG,4"For/+) (Wallis, Axton and Forrester, unpublished) on a
129/Sv background were the source of carrier spleen cells in transplantation
experiments (see section 2.9).
The mutant mice heterozygous for the gene trap integration, GT246, into the
ubiquitin conjugating enzyme 7 gene (Ubc7G'246For/+) were either on an outbred MF1
background or 129/Sv backcrossed onto a CBA/Ca background. (For a note on the
nomenclature of gene trap loci see section 2.10).
2.1.1 Embryo harvest
AGM regions were isolated from E10.5 and El 1.5 embryos. Foetal liver was
isolated from El3.5 embryos. Noon on the day the vaginal plug was found was
considered day 0.5 of gestation, based on the assumption that mating took place
around midnight. At the appropriate stage of gestation, female mice were killed by
cervical dislocation. All subsequent manipulations were performed under sterile
conditions in a horizontal laminar flow hood to facilitate embryonic organ rudiment
culture. The mice were sprayed with 70% ethanol and all instruments used had been
sterilised. Uteri from the pregnant mice were dissected as described in Hogan et al
(Hogan et al., 1994). The skin on the lower abdomen was pinched away from the
peritoneum and a small lateral nick made in the midline. The skin was pulled apart
towards the head and tail to expose the peritoneum while ensuring the fur was
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sufficiently out of the way to avoid contamination. A midline incision was made in
the peritoneum. The intestines were moved out of the way and the uterus was cut at
the level of the cervix. The two uterine horns containing the embryos were pulled
out of the mouse, cutting away any attached mesenteric tissue and severed at the
fallopian tubes.
The embryos were dissected out of the uterus in PBS in a 5cm bacteriological
grade petri dish using a dissection microscope. With forceps, the muscular wall of
the uterus was gently torn apart to release the embryos still attached to their placentas
within the extraembryonic membranes. At this stage they were transferred to a fresh
dish of PBS. The extraembryonic tissues were removed and the embryos were again
transferred to fresh PBS.
2.1.1.1 AGM region dissection
Tungsten needles were used for AGM region dissections, the preparation and
sharpening of which is described below. These dissections were carried out as
quickly as possible from the time of killing the pregnant female to maintain cell
viability for culture.
E10.5 or El 1.5 embryos were bisected at the forelimb buds between the heart
and liver. Using numerous small incisions, the somites were cut away as close to the
dorsal aorta as possible, starting at the forelimb buds extending past the hindlimb
buds. The remaining part of the embryo was turned dorsal side up with the limb
buds splayed out. Now the dorsal aorta, genital ridges and mesonephri are clearly
visible. The bilateral extraneous tissue was removed, followed by the gut and liver
so that only the AGM region remained (Figure 2.1).
2.1.1.2 Preparation of tungsten needles by electrolysis
Tungsten needles used for dissection of the AGM region from the embryo
were made and re-sharpened by exploiting an electrolysis reaction carried out in a
fume cabinet (Figure 2.2) (Hogan et al., 1994). Tungsten wire (99.95% pure, 0.5mm
diameter; Goodfellow) served as the anode, copper wire was the cathode and 1.0M
NaOH solution was used as the electrolyte. In these conditions the tungsten metal
was corroded into the electrolyte solution allowing a needle-like point to be shaped.
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Figure 2.1 Dissection of the embryonic AGM region, (a) Late E10.5 embryo, (b) Step
1. The embryo is bisected at the forelimb buds between the heart and liver, (c) Step 2.
Using numerous small incisions, the somites are cut away as close to the dorsal aorta as
possible, starting at the forelimb buds extending past the hindlimb buds, (d-e) Step 3. The
remaining part of the embryo is turned dorsal side up with the limb buds splayed out. Now
the dorsal aorta, genital ridges and mesonephri are clearly visible. The bilateral extraneous
tissue is removed, (f) Step 4. The remaining tissue is turned on its side and the liver and gut
are removed so that only the AGM region remains, (g) A dissected AGM region, ht = heart,
lb = limb bud, sm = somites, Iv = liver, da = dorsal aorta, agm = AGM region, gt = gut, gr =
genital ridge, m = mesonephros
solution
Figure 2.2 Preparation of tungsten needles for AGM region dissection
by electrolysis. Metal is eroded from the tungsten wire when connected to a
circuit with a piece of copper as the cathode and NaOH solution as the
electrolyte.
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The anode and cathode were connected by crocodile clips to wires leading to
a transformer using mains power giving an output of up to 15V. To make a new
needle, a suitable length of tungsten wire, with a piece of plasticine or BluTac™
attached to one end to act as a weight, was submerged in the NaOH electrolyte
solution. For a smooth point, the tungsten wire was continuously moved a few
millimetres up and down until the metal in the solution had been completely
corroded leaving a needle-point. Needles were also sharpened regularly using this
process.
2.2 Tissue culture
To avoid bacterial or fungal contamination, all cell and tissue culture
including reagent preparation was carried out in a specialised tissue culture facility
with Class II vertical laminar flow hoods, using sterile technique. The media were
not routinely supplemented with antibiotics.
The stock solutions used for tissue culture, including the preparation and
testing of supernatants containing cytokines (e.g. LIF) and batch testing of sera for
haematopoietic differentiation, were routinely done by Helen Taylor, Julie Buchanan
and Aileen Leask.
2.2.1 Embryonic stem (ES) cells
2.2.1.1 Maintenance of ES cells
The ES cell line GFP#7a (Gilchrist et al., 2003), which constitutively
expresses GFP was used in co-culture experiments. ES lines EFC-1 (Nichols et al.,
1990) and GFP#97a (Gilchrist et al., 2003) were also used in the initial optimisation
experiments. GFP clones #7a and 97a were derived from parental ES line E14tg2a.
ES ceils were maintained in an undifferentiated state by routine passage in
feeder-free conditions on gelatin-coated tissue culture grade flasks with specialised
medium (Glasgow Minimal Essential Medium containing 10% FCS, 0.25% sodium
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bicarbonate, 1% non-essential amino acids, 4mM L-glutamine, 2mM sodium
pyruvate and 0.1mM 2-mercaptoethanol) supplemented with lOOU/ml Leukaemia
Inhibitory Factor (LIF). LIF was obtained as culture supernatant from Cos-7 cells
transiently transfected with a murine LIF expression plasmid (pCAGGSLIF-418).
Serial dilutions of the supernatant were tested on CP1 ES cells (Bradley et al., 1984)
and lOOx the minimum concentration required to keep the cells undifferentiated was
generally used as the working concentration. 1U of LIF is defined as the minimum
concentration that keeps CP1 ES cells in a morphologically undifferentiated state.
ES cells were passaged when sub-confluent. This was usually every two
days when seeded at a density of 6xl04 cells/cm2 (1.5xl06 cells/10 ml in a 25cm2
flask) giving a typical yield of 5-9xl06 cells. Flasks were coated with 0.1% gelatin
in PBS for at least 5 minutes and removed before adding the cells. To passage, spent
medium was aspirated from the flasks and the cells were washed briefly in PBS to
remove any residual serum. To harvest cells, l-2ml trypsin solution (0.025% trypsin,
0.1% chicken serum and 1.3mM EDTA in PBS) was added to the cells and incubated
at 37°C for approximately two minutes before tapping the flask sharply in order to
detach the cells and achieve a single cell suspension. Four times the volume of
medium was added to neutralise the trypsin. The cell suspension was centrifuged at
100 x g for 5 minutes. The supernatant was aspirated off and the pellet resuspended
in fresh medium. The cells were counted using a haemocytometer (Improved
Nebauer) to seed the new flask at the appropriate density. Cells were cultured at
37°C in a humidified 5% C02 atmosphere.
2.2.1.2 Thawing and Freezing of ES cells
Vials of frozen ES cells were taken directly from storage at -140°C and
thawed quickly at 37°C in a waterbath. Cells were transferred to prewarmed ES
medium and immediately centrifuged at 120 x g for 3 minutes. The medium was
removed, the pellet resuspended with fresh ES medium and seeded in a gelatin-
coated 25cm2 flask. The medium was replaced after about 8 hours to remove any
dead cells and residual cryoprotectant.
To freeze, cells were harvested as during normal passage described above but
the pellet resuspended in cold freezing medium (10% dimethyl sulphoxide [DMSO]
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in ES medium) and aliquoted quickly into cryotubes. Cells were normally frozen in
2 x lml vials per confluent 25cm2 flask. Cryotubes were put immediately at -80°C
overnight to freeze slowly before being transferred to -140°C for long term storage.
Exposure of ES cells to DMSO is kept to a minimum due to its toxicity to cells and
its properties as an ES cell-differentiating agent.
2.2.1.3 Differentiation of ES cells
ES cells were differentiated as Embryoid Bodies (EBs) using the hanging
drop method to make undifferentiated ES cell aggregates of as uniform a size as
possible (Ansell and Hole, 2000).
2.2.1.3.1 The Hanging Drop method
ES cells were harvested as during normal passage described above. A
suspension of single ES cells (3 x 104 cells/ml, typically 6xl05 cells/20ml) in ES
medium with LIF (lOOU/ml) was prepared. The cells were aliquoted with a multi-
channelled pipette in 10pl drops (ca. 300 cells/drop) onto the underside of an
upturned square-shaped bacteriological grade petri dish. Lids were replaced onto the
dishes, which contained about 10ml of tissue culture grade water to humidify the
hanging drops of cell suspension. Cells were cultured in this way at 37°C in a
humidified 5% COz atmosphere for 48 hours. After 2 days the hanging drops were
harvested by tapping one side of the plate at an angle against the hood base allowing
the medium to collect in the edge. The newly formed ES cell aggregates (day 0 EBs)
were transferred to a universal tube and centrifuged at 80 x g for 3 minutes. The
medium was removed and replaced with fresh ES differentiation medium, made up
as ES medium without LIF and using a batch of FCS that had been tested for its
potency for haematopoietic differentiation. Batches of sera were tested for their
ability to promote haematopoietic differentiation in terms of the CFU-A assay (see
below) in a time-course dependent manner.
EBs were cultured in suspension in bacteriological grade petri dishes. For the
first 48 hours after harvest, peniciilin/streptomycin was added to the cultures, as they
are thought to be particularly vulnerable to bacterial contamination at this time.
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EBs cultured in suspension were farmed every two days; EBs and medium were
transferred to a universal tube where the EBs were allowed to settle with gravity to
the bottom before the supernatant was removed, the EBs resuspended in fresh ES
differentiation medium and moved to a new petri dish.
2.2.2 Stromal cell lines
Stromal cell lines derived from the AGM region (AM20.1B4 and UG26.1B6)
and foetal liver (EL08.1D2) as described previously (Oostendorp et al., 2002a;
Oostendorp et al., 2002b), were a kind gift from Prof. Elaine Dzierzak at the Erasmus
University, Rotterdam. Stromal cells were cultured in gelatin-coated tissue culture
flasks in specialised stroma medium (50% MyeloCult long-term culture medium
M5300 and 35% a-minimal essential medium containing 15% FCS, 4mM L-
glutamine and lOpM 2-mercaptoethanol supplemented with 10-20% 0.2pm-filtered
supernatant from the previous passage). Cells were passaged when sub-confluent,
which was normally every 2-3 days if split in a 1:3 ratio. All stromal cultures were
maintained at 33°C (due to the presence tsA58 transgene encoding the temperature
sensitive SV40 large T antigen, which immortalised the cell line) in a humid 5% C02
atmosphere.
Thawing and freezing of stromal cell lines was as described for ES cells with
the exception that the freezing medium consisted of 10% DMSO in FCS instead of
medium.
2.2.3 Organ culture of haematopoietic tissues
Haematopoietic organ rudiments dissected from embryos (AGM region and
foetal liver) were cultured in 5cm bacteriological grade petri dishes at the air-
medium interface on hydrophilic Durapore 0.56pm filter membranes supported by
stainless steel mesh stands in ES medium (Figure 2.3). The filters were washed and
sterilised in several changes of boiling tissue culture grade water before use in
culture experiments. The mesh stands were made from expanded stainless steel
minimesh (Expamet) which had been treated in concentrated nitric acid overnight,
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(a) Co-culture materials
(b) Stainless steel support
12mm
12mm 5mm
Figure 2.3 AGM region explant and EB co-culture materials, (a) Co-
cultures are set up at the interface between the medium and the air on
hydrophilic filter membranes supported by stainless steel grids, (b)
Dimensions of the stainless steel supports which are hand made.
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washed thoroughly several times in tissue culture grade water and autoclaved to
sterilise before use in culture experiments. The stands could be washed in 7X®PF
detergent, rinsed thoroughly in tissue culture grade water and autoclaved for re-use.
Tissues were cultured in ES differentiation medium (with or without
penicillin/streptomycin) at 37°C in a humid 5% C02 atmosphere.
2.2.4 Co-culture
2.2.4.1 Co-culture of ES cells and haematopoietic tissues
AGM region or foetal liver tissues and ES cells were co-cultured at the air-
medium interface as described above. Cultures were in ES differentiation medium
(see sections 2.2.1.3.1 and 2.2.1.1) without the addition of any cytokines. Day 0 or 1
EBs collected from the harvest of no more than 10ml hanging drops (giving rise to
up to 1000 EBs) were cultured with three intact AGM regions or 1mm3 pieces of
foetal liver. Co-culture took place over a time course lasting up to 6 days, at 37°C in
a humidified 5% C02 atmosphere before harvesting to assess haematopoietic
differentiation of the ES cells. Half the medium was replaced with fresh medium
once if deemed necessary by a fall in the pH indicated by a change in colour of the
medium from pink/orange to orange/yellow due to the presence of Phenol Red in lOx
GMEM. Control cultures of EBs alone were cultured in the same way.
2.2.4.2 Co-culture of ES cells on primary cultures of dissociated AGM region
derived cells
Dissected AGM regions were dissociated to a single cell suspension by
digestion with dispase solution for 45 minutes at 37°C followed by mechanical
disruption through a 23G syringe. Cells were plated onto gelatin-coated 24-well
plates at a density of approximately 0.5 embryo equivalents per well in stromal
medium (see section 2.2.2). Cells were allowed to grow for 7 days at 37°C in a
humidified 5% C02 atmosphere, changing the medium on day 2 and 6. On day 7 the
medium was exchanged for ES differentiation medium. Day 1 EBs were added 1 per
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well either directly onto the AGM cell monolayer or into transwell inserts. Control
EBs were cultured on gelatin.
2.2.4.3 Co-culture of ES cells and stromal cell lines
Stromal cell lines AM20.1B4, UG26.1B6 and EL08.1D2 were grown to
confluence in stromal medium on gelatin-coated tissue culture grade 24-well, 6-well
plates or 25cm2 flasks and irradiated with 30 Gy from a Cs source. After irradiation
cells were washed several times with PBS and fresh ES differentiation medium was
added. Three methods of co-culture were employed: (i) approximately 20 day 0 EBs
were cultured per well of a 6-well plate for up to 6 days on stromal cells and
harvested to assess haematopoietic differentiation, (ii) single day 1 EB was cultured
per well of a 24-well plate for up to 9 days on stromal cells and harvested to assess
haematopoietic differentiation and (iii) 1.5 x 106 ES cells were plated onto stromal
cells in 25cm2 flasks and were passaged every two days, as described above for ES
cells (see section 2.2.1.1) on gelatin, but seeded into fresh flasks of irradiated stroma.
Cells were collected after every passage for 10 days for assessment of ES self-
renewal potential. Control EBs or ES cells were cultured on gelatin-coated plastic.
2.2.4.4 Culture ofEBs in conditioned medium
Stromal cell lines AM20.1B4, UG26.1B6 and EL08.1D2 were grown to
confluence in stromal medium (see section 2.2.2). One day after reaching
confluence, the supernatant was collected, centrifuged at 100 x g for 5 minutes to
remove dead cells and debris, 0.2 pm filtered and stored at 4°C until needed. EBs
were cultured in ES differentiation medium containing 50% conditioned medium
from stromal cell lines. Control EBs were cultured in ES differentiation medium
containing 50% fresh stromal medium.
2.3 Harvest of ES derived celis to assess haematopoietic differentiation.
All EBs and tissues were enzymatically dissociated by amino-endo peptidase
treatment with dispase II (neutral protease) solution (1.2U/ml dispase containing
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70pl/ml DNase I, added to prevent the cells from clumping) in PBS at 37°C before
being pulled gently through a 23G syringe several time to achieve a single cell
suspension.
2.3.1 Organ rudiment explant co-cultures
Durapore filter membranes with adhering cultures were removed from the
metal stands with sterile forceps and transferred to a fresh, empty bacteriological
grade petri dish. 1-1.5ml dispase solution was added carefully onto the filter
membranes to cover its surface and incubated at 37°C for one hour. The dome-like
drop of dispase solution is held in place on the membrane by surface tension.
Cultures were not washed with PBS before adding dispase solution to minimise loss
of cells. Instead, some of the excess medium could be removed by dabbing the back
of the filter membrane on a sterile surface (e.g. the inside of the petri dish lid) before
transfer to the fresh dish. After an hour the dispase solution was taken up by a
syringe with a 23G needle and expelled over the culture to wash it off the membrane.
The EBs and AGM regions were then pulled through the needle until released into a
single cell suspension. The dispase was neutralised by transferring the cells back
into the medium remaining in the petri dish where the culturing had taken place.
This step was taken to avoid the loss of any single cells that may have floated off the
membrane into the medium during culture. The cells were centrifuged at 120 x g for
5 minutes, the medium removed and the pellet resuspended in an appropriate volume
(usually 10ml) of ES differentiation medium, counted with a haemocytometer and
assessed for haematopoietic differentiation/activity (see section 2.4).
2.3.2 Stromal cell line orAGM region monolayer co-cultures
EBs co-cultured on stromal cells were washed gently with PBS after
removing the medium. 1 ml/well dispase solution was added to the 6-well plates and
incubated for 1 hour at 37°C. After an hour a single ceil suspension was also
achieved here by pulling through a 23G needle. For EBs cultured in 24-well plates,
individual EBs were picked off the stromal cells using a yellow tip and transferred to
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separate wells of a 96-weII plate containing lOOpl/well dispase solution and
incubated for 45 minutes at 37°C. Single cell suspensions were obtained by gentle
pipetting with a yellow tip. The enzymes were neutralised with fresh medium.
2.3.3 Conditioned medium co-cultures
EBs cultured in suspension were harvested into universal tubes for
dissociation as described in section 2.2.1.3.1. Once the EBs had settled at the bottom
of the tubes, the medium was removed and the EBs were washed in PBS. 1ml
dispase solution was added and incubated in an orbital incubator (Gallenkamp) at 15-
20rev/min at 37°C. EBs cultured for more than 4 days were treated for 1 hour and
EBs less than 4 days were treated for 45 minutes. Single cell suspensions were
achieved by pulling through a 23G needle.
2.4 Harvest of embryonic tissues to assess haematopoietic
differentiation
Cultured embryonic organ rudiments were dissociated as described in section
2.3.1 above. Freshly dissected organ rudiments were dissociated as in section 2.3.3
above. Single cells obtained were resuspended in an appropriate volume of medium,
typically 0.5ml/organ rudiment (e.g. AGM).
2.5 Haematopoietic colony assays
Two agar based colony assays were used to quantify the primitive
haematopoietic progenitor activity within the differentiating EBs: the Colony
Forming Unit- Type A (CFU-A) and the High Proliferative Potential-Colony
Forming Cell (HPP-CFC) assays (see Chapter 1: Introduction, section 1.2.3 and
1.6.4.1).
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2.5.1 CFU-A assay
The CFU-A assay was set up as described previously (Pragnell et al., 1994;
Pragnell et al., 1988). A feeder layer consisting of 0.6% agar in a modified Eagle's
medium (25% a-MEM, 20% horse serum, 0.25% sodium bicarbonate and 4mM L-
glutamine) supplemented with 10% conditioned medium from each of two cell lines
(L929, a source of CSF-1 and AF1-19T, a source of GM-CSF) was poured into 3cm
diameter tissue culture grade dishes (1ml per dish). Cells to be analysed were
resuspended in 0.3% agar in Eagle's medium (as before) at a density of 3xl04
cells/ml and plated onto the set feeder layers in triplicate dishes. The dishes were
incubated for 11 days at 37°C in a 5%Oz and 10%CO2 humidified atmosphere.
Macroscopic colonies of neutrophils and macrophages formed after 11 days were
scored as CFU-A colonies (Figure 2.4). For experiments involving differentiation of
individual EBs in separate wells of a 24-well plate, dissociated EBs were not counted
but all the cells were added to the top agar layer.
2.5.2 HPP-CFC assay
The HPP-CFC (McNiece and Briddell, 1994) assay was set up as the CFU-A
assay, with the exception of the cytokines used. Conditioned medium from two cells
lines were the source of the cytokines (L929, a source of CSF-1 and Wehi 3b, a
source of !L3)(McNiece et al., 1986; McNiece et al., 1987).
2.6 ES cell self-renewal assay
5xl03 cells were plated per well onto gelatin-coated 6-well plates containing
standard ES medium supplemented with varying concentrations of LIF ranging from
0 to lOOU/ml in duplicate wells. Cells were grown at 37°C in a humidified
atmosphere of 5% COz for 6 days. The resulting colonies were stained for alkaline
phosphatase activity using the Leukocyte AP staining kit (Sigma Diagnostics)






Figure 2.4 CFU-A colony. Macroscopic colonies consisting of
macrophages and some neutrophils are generated by day 11 in
reduced oxygen conditions from seeded progenitors which respond to
M-CSF and GM-CSF. Colonies in the HPP-CFC assay look similar,
but not as dense.
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acetone-formaldehyde fixative (25ml citrate solution (18mM citric acid, 9mM
sodium citrate, 12mM sodium chloride with surfactant, buffered at pH 3.6), 65ml
acetone and 8ml 37% formaldehyde) for 30 seconds and washed gently in deionised
water for 45 seconds. Cells were stained immediately with 1.5ml/well alkaline dye
mixture (1ml 0.1M sodium nitrite solution added to 1ml FRV- Alkaline solution
(5mg/ml fast red violet LB base in 0.4M hydrochloric acid, with stabiliser) in 45ml
deionised water and 1ml Naphthol AS-BI Alkaline solution (4mg/ml naphthol AS-BI
phosphate, in 2M AMPD buffer, pH 9.5)) for 15 minutes in the dark. Cells were
washed thoroughly in tap water and air-dried. All incubations were carried out at
room temperature.
Cells were evaluated microscopically for the presence of undifferentiated
stem cell, mixed or differentiated colonies as shown (Figure 2.5).
Duplicate wells were counterstained with 0.2% trypan blue for a couple of
minutes to allow macroscopic visualisation of "white" differentiated colonies
negative for AP staining.
2.7 Cardiomyocyte assay
Day 1 EBs plated onto 24-well plates at one EB per well on the stromal cell
lines AM20.1B4, UG26.1B6, EL08.1D2, a mixture of AM20.1B4 and UG26.1B6
cells or on gelatin (as section 2.2.4.3). EBs were co-cultured for a further 9 day.
Medium was changed as necessary. At day 10 of differentiation, EBs were assessed
microscopically. An EB was scored as positive for cardiac differentiation if areas of
cells were observed to be twitching synchronously (Wobus et al., 1991).
Cardiomyocyte differentiation was presented as a percentage of positive EBs out of




Figure 2.5 Classification of the colonies in the ES cell self-renewal assay in
terms of morphology and alkaline phosphatase expression, (a) Stem cells
have high self-renewal potential giving rise to tight colonies expressing AP. (b) As
self-renewal potential decreases progenitors generate colonies with both AP
positive stem cells and AP negative differentiated progeny. A range of morphology
and AP expression is seen in the colonies, from mostly undifferentiated to mostly
differentiated, (c) Progenitors with no self-renewal capacity generate diffuse
colonies with cells which do not express AP.
2.8 Flow cytometry
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2.8.1 Determining the percentage of GFP expressing cells in the co-
cultures
Cells to be analysed were washed and resuspended in PBS (containing 0.1%
sodium azide and 0.1% BSA) at a concentration of approximately 2xl06 cells/ml.
Data for 40,000 live cells was acquired using a FACSCaliber equipped with a 488nm
laser (Becton Dickinson). A sample of GFP+ ES cells alone was used to define an
electronic gate on a histogram of Fluorescence 1 (GFP) to exclude AGM derived
GFP cells. Data was analysed with CellQuest software (Becton Dickinson) to
determine the percentage of GFP-expressing (EB-derived) cells. The percentage of
GFP+ EB cells typically obtained from co-cultures of 3 intact AGM regions and up to
1000 EBs (see above) was between 75 and 90%. A small population (<1%) of GFP
EB cells was found in the Ml gate of the GFP#7a EB cells cultured alone (Figure
2.6). Although most of the cells in this gate may be dead, the rare presence of GFP
CFU-A colonies derived from GFP#7a EB cells (when visualised by fluorescence
microscopy), and the detection of GFP cells reported in the original line (Gilchrist et
al, 2003) indicate that viable cells are present in this population.
2.8.1.1 Normalisation of CFU-A and FIPP-CFC scores to exclude AGM
region derived colonies
These experiments depend on the ability to compare the number of
haematopoietic progenitors, which arise spontaneously within populations of
differentiating ES cells to their frequency after co-culture with the AGM region (or
other tissues). The AGM region also contains cells, which form colonies when
plated in the conditions of the haematopoietic colony assays. Therefore to compare
only the haematopoietic activity within the EB-derived populations, the AGM
region- and EB-derived cells must be distinguishable. The ES cell line used
(GFP#7a) constitutively expressed the GFP reporter gene (Gilchrist et al., 2003).
Dissociated pure EB- or co-cultures were plated into the haematopoietic colony





(b) Day 6 EB control
Day 6 EB and E10.5 AGM
region co-culture





Figure 2.6 Flow cytometric analysis of day 6 GFP#7a EBs cultured alone or with
E10.5 AGM region, (a) Histogram showing GFP expression of GFP#7a EB cells
compared to EFC-1 EB cells. A sample of GFP+ cells was used to define an electronic
gate (R1) of Fluorescence 1 (GFP) to exclude GFP" cells, (b) Top panels show the
forward and side scatters. Lower panels show GFP expression in fluorescence
channel 1 of GFP#7a EB cells and co-cultures of GFP#7a EB cells and AGM regions.
The gates Ml and M2 denote GFP" and GFP+ popuiations respectiveiy. A population
of GFP" AGM region derived cells is clearly seen in the M1 gate of the co-cultured cells.
A small population (<1%) of GFP'EB cells is also found in the M1 gate of the GFP#7a
EB cells cultured alone as expected.
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for analysis by flow cytometry to determine the percentage of GFP expressing (ES-
derived) cells in the cultures (see section 2.7.1).
Haematopoietic colony assays were scored using a fluorescence microscope
with uv through eGFP filters to count the proportion of green GFP-expressing
colonies. Pure EB cultures produced haematopoietic colonies all of which were
green as expected (see section 2.8.1). Co-cultures produced colonies of which a
proportion was not green because they originated from the AGM region. The
number of green EB-derived colonies from the co-cultures was then normalised to
represent the number of colonies per 3xl04 GFP-expressing EB-derived cells, which
excludes the AGM region cells. The following formula was used
Normalised no. of EB-derived colonies = Number of green colonies counted
Proportion of GFP expressing cells
For example, if there were a total of 120 CFU-A colonies in a dish in which 3xl04
co-culture cells were plated and 114 of them were green by uv microscopy and 79%
of the cells plated express GFP by flow cytometry, then
The normalised no. of EB-derived colonies = 114 = 144
0.79
2.8.2 Surface phenotypic analysis of cells
2.8.2.1 Co-cultures
Co-cultures and EBs were dissociated (see section 2.3.1), washed in PBS
(containing 0.1% BSA and 0.1% sodium azide), counted and finally re-suspended at
2xl06 cells/ml for use. Aliquots containing 2xl05 cells were incubated for 40
minutes at 4°C with optimum concentrations of appropriate monoclonal antibody
(determined by titration), washed to remove unbound antibody and re-suspended in
PBS for acquisition. Where a primary biotinylated antibody was used, a secondary
avidin-phycoerythrin (PE) conjugate was used to detect binding and incubation
before washing steps were repeated as above. Data for 40,000 live cells was
acquired using a FACSCaliber equipped with a 488 nm laser (Becton Dickinson). A
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sample of GFP ES cells alone was used to define an electronic gate on a histogram
of Fluorescence 1 (GFP) to exclude AGM derived GFP cells and analysed with
CellQuest software (Becton Dickinson). Antibodies were all PE or tricolor (TC)
conjugated rat anti-mouse monoclonal antibodies (Caltag and BD). Controls
included were unstained cells and cells stained with avidin-PE alone. The antibodies
used and the cell types to which they adhere are outlined in Table 2.1.
2.8.2.2 Stromal cell lines
Confluent stromal cells were harvested, washed and stained with antibodies (Table
2.1) as described above.
2.9 Transplantation experiment
Female 129/Sv mice (8-12 weeks) were irradiated with 10.5 Gy gamma (y) rays
from a Cs source in a single dose at a rate of 21.6 rad/minute. The mice received
neomycin (500mg/l) in their drinking water for the first 10 days after transplantation
to prevent infections that may result because of haemorrhaging from the gut caused
by the high dose of irradiation. Co-cultures of AGM regions and EBs were
harvested and dissociated after 5 days in culture as described above. 20 recipient
mice were divided into four groups as listed below and cells were injected into the
tail vein.
• irradiation controls
• 2 x 105 carrier spleen cells only
• 1 x 106co-cultured EB and AGM region cells
• 1 x 106co-cultured EB and AGM region cells with 2 x 105carrier spleen cells
Carrier spleen cells were given as a source of short term repopulating HSCs to
protect the recipients from the effects of irradiation before engraftment of donor test
cells. The contribution of donor cells to the peripheral blood of surviving mice was
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antigen Conjugate Other name
CD29 FITC Integrin |3i chain
CD31 PE Pecam-1
CD34 PE Mucosialin
CD44 FITC Polymorphic glycoprotein 1
CD45 FITC Common leukocyte antigen
CD49e PE Integrin a5 chain
CD51 PE Integrin av chain







Table 2.1 of all antibodies and corresponding surface markers
FITC = Fluorescein, PE = Phycoerythrin, TC = TRI-COLOR® (PE-Cy5)
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assessed 2 and 7 months after transplantation. Blood for analysis was collected from
the tail vein of recipient animals at 2 months after injection. The animals were killed
7 months after injection to harvest the spleens and bone marrow along with
peripheral blood. The markers used to distinguish between recipient, donor EB or
AGM region cells and carrier spleen cells are outlined in Table 4.1.
Methods used to detect the various markers are described below. Briefly, the
GPI-1 alloenzyme was identified by protein electrophoresis; GFP expression was
detected by flow cytometry and fluorescence microscopy; Ly9.1 expression was
detected by flow cytometry and the presence of the YMT and LacZ genes by PCR.
2.9.1 Analysis of haematopoietic tissues from surviving recipient mice
transplanted with co-cultured AGM region and EB cells.
2.9.1.1 Glucose phosphate isomerase (GPI) electrophoresis of blood
The structural locus of the GPI-l complex (Gpil) which codes for the
alloenzymes has four alleles (A, B, C and D). The expression of these alleles is
found to vary among inbred mouse strains. Two of the alleles, A and B, are useful
strain specific markers because the expression level and alloenzyme activities are
similar allowing quantitative comparison and can be distinguished
electrophoretically with a sensitivity that allows the detection of less than 1%
contribution in small pieces of tissue. Electrophoretic separation of GPI alloenzymes
was carried out using the Helena electrophoresis system (Helena Laboratories,
Texas, USA) as described (Micklem et al., 1987).
Contribution of donor derived C57B1/6 AGM region cells was assessed based
on the presence of the GPI alloenzyme B in the 129/Sv host, which is A. One drop
of blood from each animal was added to 50pJ sample buffer (50mM triethanolamine
hydrochloride pH 7.6 containing 0.3mg/ml dithioerythritol, 0.5mg/ml BSA, 2mg/ml
digitonin) and stored at -80°C. Samples were thawed, vortexed and centrifuged in a
microfuge to pellet cells. Using Super Z applicator tips I -2(0,1 of the supernatant of
each sample was loaded onto Titan III cellulose acetate electrophoresis membranes
that had been soaked in Supre heme electrophoresis buffer (Helena Laboratories) for
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20 minutes and gently blotted dry. Cold Supra heme buffer was added to the anodal
and cathodal chambers of the electrophoresis tank. Paper wicks soaked in the buffer
were applied over the sides of the bridges. The membranes (2/tank) were placed,
sample side down, onto the bridges of the tank. A small weight (5-10g e.g. a coin)
was placed on each membrane to ensure maximum contact between the cellulose
acetate and the wicks. Gels were run at 320V at 4°C for about 1 1/2 hours (or until
the haemoglobin band reached the bottom). Gels were then stained with staining
buffer (400pl 0.5M Tris-HCL pH 8.0, 1ml assay stock (1ml 1.0M Tris-HCL pH 8.0
containing 0.3mg NADP and 6.5mg fructose 6-phosphate), 15pl G6PD (300U/ml),
1.5ml MgCl2:glycerol mix (50% 0.2% MgCl2 and 50% glycerol) 500pl MTT
(lOmg/ml) and 500pl PMS (2.5mg/ml)) in the dark until bands appeared. When
developed, gels were rinsed with water, fixed in 5% acetic acid for 5 minutes,
washed in water for 15 minutes, dried and stored in the dark.
2.9.1.2 PCR analysis of genomic DNA from peripheral blood
2.9.1.2.1 Isolation of genomic DNA from blood
5-6 drops of blood were collected from each animal and stored at -20°C.
Frozen samples were thawed and washed twice in 1ml SSC (8.8g/l NaCl and 4.4g/l
sodium citrate in H20, pH 7.0), vortexed to mix and centrifuged for one minute at
12,000rpm in a microfuge to pellet cells discarding all the supernatant after the
second wash. To digest the cells, 375pl 0.2M NaOAC was added to each pellet and
vortexed briefly, followed by 25pl 10% SDS and 5pl proteinase K (20mg/ml H20), a
brief vortex and incubated at 55°C for 1 hour. 120pl phenol:chloroform:isoamyl
alcohol (phenokchloroform 1:1 with isoamyl alcohol 25:1) was added to extract the
DNA, the tubes inverted, vortexed for 30 seconds and centrifuged at 12,000rpm for
30 seconds. The aqueous layer was removed into a fresh 1.5ml tube and the DNA
was precipitated with 1ml cold 100% EtOH incubated at -20°C for 15 minutes.
Samples were centrifuged at 12,000rpm for 2 minutes, the supernatant decanted and
the pellet air-dried. The DNA was resuspended in 50pl sterile distilled H20 and
stored at-20°C. This method yielded approximately lOOng/pl.
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2.9.1.2.2 Polymerase chain reaction
PCR was used to determine the contribution of either donor ES or AGM
region cells by the presence of the Y-chromosomal specific YMT gene or carrier
spleen cells by the presence of the LacZ reporter gene from the gene trap vector.
500ng genomic DNA isolated from peripheral blood (see above) was used in







Myogenin was amplified in combination with YMT and as the internal PCR control.
Primers for the amplification of LacZ were specific for the integration into Ecap by
the gene trap vector. The reaction for YMT/myogenin was initial heating at 95°C for
5mins, followed by 30 cycles of 94°C for 10s, 60°C for 30s, 72°C for 35s and a final
single cycle at 37°C for lOmins, producing amplicons for YMT at 342bp and
myogenin at 245bp (Medvinsky and Dzierzak, 1996). The reaction for LacZ was
initial heating at 94°C for 2mins, followed by 35 cycles of 94°C for 15s, 65°C for
30s, 72°C for 2mins producing an amplicon of approximately 1200bp. Since all the
animals that received spleen cells died before blood samples were taken, the PCR
reaction for the LacZ reporter was never performed. The products were separated on
2% agarose containing ethidium bromide.
2.9.1.3 Flow cytometric analysis ofperipheral blood, spleen and bone
marrow
Peripheral blood, spleens and femurs were harvested from killed recipient
mice. Spleens were homogenised to obtain single cell suspensions. Bone marrow
was flushed from the femurs with PBS using a 25G needle. The cells were washed
with PBS counted and an aiiquot of each was resuspended in PBS (containing 0.1%
BSA and 0.1% sodium azide) at a concentration of about 2xl06 cells/ml. Half of
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each sample was stained with FITC labelled antibody against Ly9.1. Cells were
analysed by flow cytometry for GFP and FITC expression (see section 2.7.2).
2.9.1.4 Detection of GFP expression in CFU-A colonies derived from
recipient spleen and bone marrow
CFU-A assays with bone marrow and spleen cells harvested from recipient
mice were set up as described in section 2.5.1. Colonies were analysed with a
fluorescence microscope to detect any GFP expressing cells.
2.10 Genotyping of UbcT0'246^ mice and embryos
The loci of gene trap integrations, once characterized as potentially unique,
can be named and symbolised as members of a series, using the prefix Gt (for gene
trap), followed by a vector designation in parentheses, a serial number assigned by
the laboratory characterizing the locus, and the laboratory ILAR code
(http://www.informatics.jax.Org/mgihome/nomen/gene.shtml#gtl). Therefore, the
246th ES clone generated, which had trapped a gene by the pGTO, 1 or 2 vector in
the laboratory of Lesley Forrester (For) is symbolized as Gt(pGT0,l,2)246For. A
gene trap designation becomes an allele of the gene into which it was inserted, once
that gene is identified. Therefore, Gt(pGT0,l,2)246For is known to disrupt the
ubiquitin conjugating enzyme 7 (Ubc7) gene; thus the full allele designation for this
gene trap mutation is ubc7Gt(pGmi'2)246For and its abbreviated form is Ubc7G,246For.
The mutant mouse line Ubc7G,246For was generated by gene trapping using a
vector containing a LacZ reporter gene (see section 6.2.1.2). Since the trapped gene
is ubiquitously expressed (Tgalactosidase activity detected by X-gal staining of
tissues was used to determine the genotype (Ubc7+/+, uiJCyG'246Forl+ or
Uf?cyG'246For/Gl246For) 0f the mice. Ear punches were taken for genotyping adult mice
and yolk sac or head was used for embryos.
Ear punches, yolk sacs or embryonic heads were washed in PBS and fixed at
room temperature with 0.2% gluteraldehyde, 5mM EGTA (pH7.3), 2mM MgCl2 in
0.1M sodium phosphate for 5 minutes (yolk sac or head) or 15 minutes (ear
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punches). The samples were then washed at room temperature in wash buffer
(20mM MgCI2, 0.01% deoxycholate, 0.02% Nonidet in 0.1 M sodium phosphate (pH
7.3)) three times for 5 minutes (yolk sac or head) or 15 minutes (ear punches).
Samples were stained at room temperature (yolk sac or head) or 37°C (ear punches)
using X-gal stain (lmg/ml X-gal, 250mM potassium ferrocyanide, 250mM
potassium ferricyanide in wash buffer) from 4 hours to overnight. After staining,
samples were stored in wash buffer at 4°C. X-gal stain was collected, filtered and
frozen for re-use.
After staining with X-gal tissues were examined either by eye or light
microscopy. The tissues that stayed clear/yellow were wildtype, heterozygous
tissues turned blue and homozygous tissues turned a deep turquoise colour.
2.11 Wholemount in situ hybridisation of embryos
2.11.1 Probe synthesis
The murine cDNA (from Hogan E8.5 library) for the 3'UTR and C-terminus
of Wnt8B was used as a template for generating riboprobes for in situ hybridisation.
The 720kb cDNA template cloned into pBSII KS- (R129) was a kind gift from Dr
John Mason.
lpg DNA plasmid each were linearised by restriction digest with Xbal (for
transcription with T3 RNA polymerase to generate the antisense probe) and with
Xhol (for transcription with T7 to generate the negative control sense probe).
For synthesis of digoxygenin (DIG)-labelled RNA probe, transcription
reactions were set up at room temperature to generate antisense and sense probes
using the DIG RNA labelling kit from Roche as per manufacturer's instructions.
I3pl dH20, 2pl lOx transcription buffer (400mM Tris HCl pH8.25, 60mM Mgcl2 and
20mM spermidine), lpl 0.2M DTT, 2pl nucleotide mix (lOmM GTP, lOmM ATP,
lOmM CTP, 6.5mM UTP and 3.5mM digoxigenin-UTP), I pi (lpg/pl) iinearised
plasmid template cDNA, 0.5pl (lOOU/pl) placental ribonuclease inhibitor and lpl
(lOU/pl) T3 or T7 RNA polymerase were mixed and incubated at 37°C for 2 hrs. A
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lpl aliquot was removed and run on a 1% agarose gel containing ethidium bromide.
An RNA band ca. 10 fold more intense than the plasmid band was used as an
indicator the ca. 10pg probe had been synthesised. 2pl DNase I (RNase free) was
added to the remaining transcription reaction and incubated at 37°C for 15 mins.
To precipitate the synthesised probe, lOOpl TE (50mM Tris HC1, ImM
EDTA pH8.0), 10pl LiCl and 300pl EtOH were mixed, incubated at -20°C for
30mins, spun in a microfuge at 4°C for 10 mins washes twice in 70% EtOH and air-
dried. The probed were then dissolved in TE at ca. 0. lpg/pl and stored at -80°C.
lOpl/ml hybridisation mix was used in the hybridisation stage (see section 2.11.3)
2.11.2 In situ hybridisation
2.11.2.1 Pre-hybridisation treatment
Dissected E10.5 mUbcT'+ and m Ubc ■yG'246For/Gt246For embryos (see section
2.1.1) were fixed in 10ml 4% paraformaldehyde in PBS at 4°C o/n. Unless
otherwise stated all incubations were carried out at room temperature and solutions
were made up in PBT (0.1% Tween 20 in PBS).
Fixed embryos were washed twice in PBT and dehydrated by taking through
a MetOH series (25%, 50% and 75% MetOH) incubated for 5 mins each. Embryos
were finally washed twice in 100% MetOH (and were stored at -20°C for several
days). Rehydration was in the reverse series to before (75%, 50% and 25% MetOH)
and with rinsing (twice) in PBT also for 5 mins each.
Embryos were bleached with 6% hydrogen peroxide for 1 hr and washed with
PBT three times for 5 mins each. Treatment with Proteinase K (lOpg/ml) was
carried out to allow the RNA probe to penetrate the cells of the embryo. Incubation
was for exactly 15 mins after which the embryos were washed immediately with
fresh glycine (2mg/ml) to inhibit the action of Proteinase K, followed by two washes
with PBT, before refixing with 0.2% glutaraldehyde/4% paraformaldehyde (40pl
25% gluteraldehyde in 5ml 4% paraformaldehyde) in PBS and two washes in PBT
for 5 mins each.
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2.11.2.2 Hybridisation
Unless otherwise stated, all solutions are made up in dH20. Embryos were
rinsed and incubated at 70°C for lhr in prehybridisation solution (50% formamide,
5x SSC pH4.5 and 1% SDS). During this incubation, the probes were denatured at
80°C for 10 mins and cooled on ice and added to hybridisation solution (50%
formamide, 5x SSC pH4.5, 1% SDS, 50pg/ml yeast RNA and 50pg/ml heparin) at
ca. lpg/ml. Embryos were rinsed in hybridisation solution and then incubated in
hybridisation with probe at 70°C o/n on a rotating platform in a hybe oven.
2.11.2.3 Post hybridisation treatment and staining with antibody against
digoxygenin
After hybridisation with probe, embryos were washed twice at 70°C for 30
mins each in pre-warmed post-hybridisation solution I (50% formamide, 5x SSC
pH4.5 and 1% SDS as prehybridisation), followed by a 10 min wash at 70°C with a
1:1 mixture of solution I and II (0.5M NaCl, 0.1M Tris pH7.5 and 0.1% Tween 20)
and 3 washes with solution II at room temperature for 5 mins. To remove unbound
probe, embryos were incubated twice with lOOpg/ml RNase A in solution II at 37°C
for 15 mins each and rinsed in solution II for 5 mins. A final two posthybridisation
washes were performed with solution III (50% formamide and 5% SSC pH4.5) at
65°C for 30 mins each.
Embryos were then washed three times in TBST (0.4M NaCl, 2.7mM KC1,
25mM Tris HC1 pH 7.5 and 0.1% Tween 20) and preblocked with 10% sheep serum
(endogenous alkaline phosphatases were inactivated by heating serum at 65°C for 30
mins) in TBST for 2.5 hrs at room temperature. Incubation with anti-DIG antibody
conjugated to alkaline phosphatase (AP) (lpl anti-DIG-AP in 2ml 1% sheep serum
in TBST) was carried o/n at 4°C on a rocker.
After staining with antibody, samples were washed thoroughly in 5ml TBST
at room temperature, first for three washes of 5 mins each followed by a further five
washes for 1 hr each.
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2.11.2.4 Staining for alkaline phosphatase activity
All incubations, unless otherwise stated, were carried out at room
temperature. Embryos were washed three times in freshly made up NTMT (0. lM
NaCl, 0.1M Tris pH9.5, 0.05M MgCl2 and 0.1% Tween 20) before staining with
NBT (6.75pl in 2ml NTMT) and BCIP (5.25pl in 2ml NTMT) substrate mix.
Samples were stained at 4°C in the dark o/n.
When the reaction was complete, the embryos were washed twice in NTMT
for 10 minutes and in PBT for a further 10 mins. The embryos were post fixed in 4%
paraformaldehyde and 0.1% gluteraldehyde in PBS for 1 hr, washed twice with PBT
and stored at 4°C.
For photography, embryos were washed in 50% and then 80% glycerol in
PBT.
2.12 Microscopy and Photography
Cells were examined with a Leitz Labovert light or Zeiss Axiovert 25
fluorescence microscope. eGFP was visualised with uv light through Zeiss filter
#44. Embryo dissections were performed using a Zeiss Stemi 2000-C dissecting
microscope.
Cells and embryos were photographed with an AxioCam digital camera using
AxisVision 3.1 software. For images of the self-renewal assay, 6-well plates were
digitally scanned on an Epson Perfection 2480 Photo flatbed scanner.
2.13 Statistical analysis
Statistical analysis was performed using the Mann-Whitney U and Student's t
Tests to assess significance of the non-parametric data sets.
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Chapter Three: Establishing conditions for co-culture
3.1 Aim
To develop a method for the co-culture of differentiating ES cells with the
AGM region.
3.2 Introduction
Methods for the in vitro differentiation of ES cells down haematopoietic
lineages are well established as reviewed in Chapter E A method for culturing the
embryonic AGM region, while maintaining its haematopoietic activity, has also been
described (Medvinsky and Dzierzak, 1996). However, these culture conditions are
very different. Differentiation of ES cells usually involves the formation of
embryoid bodies cultured in suspension, with or without the addition of growth
factors or on particular stromal feeder cells. In contrast, AGM regions are cultured
on membranes at the interface between the air and the medium to maintain their
haematopoietic activity. Both have defined culture media requirements. Thus the
first aim was to find a method that allowed the co-culture of the differentiating ES
cells and the embryonic AGM region, which was optimal for either partner.
3.3 Experimental approach
• Determine the haematopoietic activity of the AGM region in culture using the
CFU-A assay for comparison with published data using other assays.
• Identify a genetically marked ES cell line, which would allow the ES cells to be
distinguished from the AGM region cells after co-culture and investigate its
haematopoietic differentiation capacity in standard conditions.
• Assess whether the organ rudiment explant culture conditions were conducive to
ES cell differentiation as there are no reports published on the effect of culturing
EBs at the interface between the air and the medium.
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3.4.1 CFU-A activity in haematopoietic tissues
Although the haematopoietic activity has been analysed in the AGM region
using other assays (e.g. CFU-S8and n) (Medvinsky and Dzierzak, 1996; Medvinsky
et al., 1993), there are no reports of the use of the CFU-A assay in this regard. The
baseline level of CFU-A activity in haematopoietic tissues was therefore determined.
The number of CFU-A colonies per 3xl04 cells in uncultured AGM region increased
from 3 ± 1.4 to 25 ± 23.6 between day 10.5 and 11.5 post coitus (p.c.). This is
similar to the emergence of CFU-S,, previously reported, which increase from 0.94 ±
0.42 to 5.98 ± 0.87 per tissue (approximately 2xl04 cells) between day 10 and 11 of
gestation (Medvinsky et al., 1993). CFU-A activity in the liver at El3.5 was 30 ±
10. 5 colonies per 3xl04 cells, adult spleen had 44 ± 10.0 and bone marrow had 88 ±
8.2 colonies (Figure 3.1).
Medvinsky and colleagues (Medvinsky and Dzierzak, 1996) have shown that
the numbers of CFU-S,, expand in organ culture. Hence the capacity of
haematopoietic activity, as measured by the CFU-A assay, to expand in culture was
tested (Figure 3.1). The explant culture system used by Medvinsky and others, in
which the embryonic organ rudiment is cultured at the interface between the air and
the medium, was used. However, because the system was being optimised for co-
culture with ES cells, standard ES cell differentiation medium (see Chapter 2:
Materials and Methods section, 2.2.1.3) was used instead of the specialised medium
for haematopoietic progenitors (MyeloCult M5300 from Stem Cell technologies).
The AGM region from the E10.5 embryo shows the greatest expansion of
progenitors in culture (to 91.7 ± 55.3 per 3xl04 cells).
The variability in CFU-A activity in El0.5 AGM region after culture is very
high. To examine this in more detail, AGM regions from E10.5 C57B1/6 littermates
were cultured individually and their CFU-A activity compared. Even within inbred
littermates, the variation in the number of CFU-A colonies after culture was very
high, ranging from 17.3 to 160 colonies per 3xl04 cells (approximately 0.3-1 embryo
equivalents; e.e.) (Figure 3.2). This could be due to a variation in the developmental
































Figure 3.1 CFU-A activity in haematopoietic tissues. The number of CFU-A
colonies in the haematopoietic tissues from foetal and adult mice, immediately after
dissection (B) and when cultured for 6 days P). Coloured bars show the number of
colonies/3x104 cells. Results for fresh tissues are taken from two independent
experiments set up in triplicate. Numbers of experiments for cultured tissues are

























Figure 3.2 Variability of CFU-A activity in E10.5 AGM regions among inbred
littermates after organ culture.. Each data point represents the number of
CFU-A colonies/3x104 cells (typically 0.3-1 e.e.) from the AGM region of individual
C57BI/6 littermates at E10.5 after 6 days of culture. The numbers of colonies are
means of triplicate plates.
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Given that an increase was observed after six days in culture a more detailed
study was carried out to assess the timing of expansion of CFU-A progenitors. A
time-course was set up to further compare the AGM region from El0.5 and El 1.5
embryos (Figure 3.3). In this experiment, the number of CFU-A progenitors in
E10.5 AGM increased dramatically between days two and four (26 ± 2.0 to 165 ±
31.7) after which, no further expansion is seen, while only a doubling was observed
over the same period in El 1.5 AGM region (27 ± 1.7 to 43 ± 7.2). This is in contrast
to the published data for cultured AGM region using the CFU-S,, assay, where
greater expansion is seen in El 1.5 embryos. However, as seen here using the CFU-
A assay, it has been demonstrated that HSC activity of the AGM region increases
dramatically in the first 2-3 days in organ culture after which it is maintained for at
least one week, and in addition the HSC activity was reportedly more extensive in
E10.5 AGM explant cultures compared to El 1.5 (de Bruijn et al., 2001).
Thus in summary, the baseline CFU-A activity found in the AGM region was
comparable to the published CFU-S activity and there was expansion of the CFU-A
progenitors in culture, demonstrating that the organ culture system was reproducible
in the lab and could be useful for co-culture experiments.
3.4.2 CFU-A activity in differentiating ES cells
A marked ES cell line was needed for the co-culture experiments because
haematopoietic progenitors in the AGM region can be maintained and expanded in
organ culture as shown in the previous section and by others (Medvinsky and
Dzierzak, 1996). Therefore, ES cell and AGM region derived cells needed to be
distinguishable for two reasons. First, to determine by flow cytometry the
contribution of AGM region and ES cells to the co-cultures at the time of harvest for
setting up the CFU-A assay. Second, to distinguish by fluorescence microscopy the
colonies derived from the ES cells from the endogenous AGM region-derived
colonies when scoring the assay. The enhanced Green Fluorescent Protein (eGFP)
reporter was chosen because it is detectable in viable cells in contrast to, for example
































Figure 3.3 CFU-A activity in AGM regions after organ culture. Numbers of
CFU-A colonies/3x104 cells in pooled AGM regions from E10.5{<*~) and E11.5 (♦-)
mouse embryos over 6 days in culture. Error bars represent standard deviations of
the mean for triplicate plates.
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Two GFP-marked ES cell lines (GFP#7a and GFP#97a) (Gilchrist et al.,
2003) were chosen, which were previously generated from the parental line E14tg2a
by Dr Derek Gilchrist (in the lab of Dr Alexander Medvinsky). The cell lines were
made in order to generate a reporter mouse, which would express eGFP in the
majority of cells in all tissues, particularly those of the haematopoietic lineages,
which are prone to silencing transgenes. The eGFP reporter Cre-inducible ES cells
were electroporated with a "silent" eGFP construct in which the PGK promoter and
eGFP sequences are separated by puromycin resistance gene and stop cassette
flanked by loxP sites. Upon Cre-mediated excision of the puromycin resistance gene
and stop cassette (by electroporation of a Cre-expressing plasmid when testing the
ES cells in vitro) the eGFP was "activated" (Figure A.l in Appendix). Several lines,
including #7a, showed high eGFP expression in all haematopoietic cells after in vitro
differentiation in methylcellulose. Furthermore, after germline transmission and
activation in ovo (by crossing with mice where Cre is expressed exclusively in the
growing oocyte prior to the completion of the first meiotic division), eGFP was
expressed ubiquitously including in 90% of lymphoid and myeloid cells for at least
10 months. The #97a ES cells contained the eGFP-F reporter, which contains a
farnesylation signal fused to the c-terminus of eGFP. This signal directs eGFP-F to
the inner face of the plasma membrane where it remains bound in both living and
fixed cells (Derek Gilchrist, personal communication and Clontech technical
information).
Here GFP#7a and #97a ES cells were examined to i) confirm the level of
their GFP expression by both fluorescence microscopy and flow cytometry and ii)
test their ability to form CFU-A colonies upon differentiation. The GFP expressed
by GFP#7a cells was readily detectable by eye with a fluorescence microscope and
by flow cytometric analysis the shift in the fluorescence peak is substantial compared
to wild type cells. GFP#97a ES cells were not as easily visualised by microscopy
probably because the eGFP was confined to the plasma membrane. When analysed
by flow cytometry, a substantial GFP population was detected, which was not
observed in GFP#7a ES cells (Figure 3.4). Haematopoietic differentiation was
compared to the wild-type EFC-1 (Nichols et al., 1990) ES cells routinely used in the
73
(a) GFP#7a (b) GFP#97a
Figure 3.4 GFP expression in #7a and #97a ES cell lines, (a) GFP#7a ES cells
with eGFP and (b) GFP#97a ES cells with the membrane bound form of eGFP-F.
Top panels show flow cytometric analysis of FSC and SSC and GFP expression in
fluorescence channel 1. #7a ES cells are brighter and 100% GFP+ as shown by
the peak along the FL1 -H axis and the M2 gate, respectively. Bottom panels show
microscopic analysis of the GFP#7a and #97a ES cells with light and fluorescence
microscopy. Flow cytometric analysis was performed by Kay Samuel.
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lab. ES cell lines can vary in their ability to form CFU-A colonies, so it was
essential that this comparison be made. The percentage of EBs, which gave rise to
CFU-A colonies after 6 days in suspension culture was similar in all three lines
(EFC-1, 42±3.6; GFP#97a, 22±12.3; GFP#7a, 28±7.4; Figure 3.5a). However, due
to the high level of GFP expression in the GFP#7a cell line, it was chosen for
analysis of CFU-A emergence over a time-course of differentiation. The GFP#7a
line was equivalent to the EFC-1 line in terms of (i) the percentage of EBs which
gave rise to CFU-A colonies, (ii) the timing with which these cells emerge (Figure
3.5b) and (iii) the frequency with which CFU-A progenitors are found in dissociated
EBs (Figure 3.5c).
3.4.3 Culture ofEBs: suspension versus air-medium interface
Organ rudiments are often cultured at the interface between the air and the
medium (Cudennec et al., 1981), presumably due to oxygen tension. This has also
been found to be the best way to culture the embryonic AGM region to allow
induction, maintenance and proliferation of HSCs (Medvinsky and Dzierzak, 1996).
It was surmised that to fully exploit the capture of this microenvironment in vitro for
co-culture experiments, it was useful to establish whether EBs could also be cultured
as organ rudiments at the air-medium interface and retain the ability to differentiate.
The haematopoietic differentiation of GFP#7a EBs was compared when cultured in
suspension or at the air-medium interface for up to six days (Figure 3.6a).
Differentiation was not affected by the method of culture; 34 ± 4.6 and 38 ± 2.5
CFU-A colonies per 3xl04 cells plated were found after six days of suspension or
interface culture respectively (Figure 3.6b). Although there is a 10-fold difference
in the CFU-A activity at four days, this did not warrant further consideration because
both values are very low and within the expected range for ES cell lines in the lab.
The purpose of this experiment was to determine whether haematopoietic
differentiation of EBs was at all possible when cultured at the air-medium interface;
the data show that it is. Cultures of EBs alone would be set up alongside all co-
culture experiments to control for the inter-experimental variability often observed
during ES cell differentiation. In comparison, the low level of inter-experimental
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variation in the CFU-A activity of adult bone marrow (Figure 3.1) indicates that the
CFU-A assay itself is not the source of the variability in these experiments but rather
the differentiation of the ES cells.
It should be noted that it is not possible to retrieve individual intact EBs from
the membranes of the interface cultures so all EBs were dissociated enzymatically to
achieve a single cell suspension for plating in the CFU-A assay (see Chapter 2:
Materials and Methods, section 2.3.1).
3.5 Discussion
There were two issues to be dealt with when establishing a method for co-
culturing ES cells and AGM region. First, the two co-culture components normally
require very different culture conditions, so a method that would be conducive to ES
cell differentiation while not detrimental to the haematopoietic supporting
microenvironment of the AGM region and vice versa had to be found. An
embryonic organ rudiment culture system, which importantly preserves the structure
and function of the AGM region, was chosen as the basis for the co-culture
experiments. Since the co-culture system was being optimised for ES cells, standard
ES cell differentiation medium was used. The AGM region appeared to respond well
to this medium as shown by the expansion of CFU-A progenitors in culture. The
question of whether the explant culture system is conducive to ES cell differentiation
remained, because there are no reports in the literature on the effect of culturing EBs
at the interface between the air and the medium. The data show that interface
cultures do not inhibit the haematopoietic differentiation of ES cells, at least as
measured by the CFU-A assay.
The second issue was the ability to distinguish between the ES cells and the
AGM region, since both contain CFU-A progenitors. Indeed, the simplest strategy to
eliminate the colony forming potential of the AGM regions would be by irradiation
before co-culture. However, the ability to capture the AGM region
microenvironment, including its ability to produce HSCs, was considered an



















Figure 3.5 CFU-A activity in differentiating unmarked and GFP-marked ES cells, (a)
Percentage of EBs giving rise to CFU-A colonies from EFC-1 (■), GFP#97a ( ) and
GFr#7a (S) ES ceils after 6 days of differentiation, (b-c) CFU-A activity in EBs from EFC-
1 and GFP#7a (•} ES cells over a time course from 0 to 10 days of differentiation
showing the percentage of EBs giving rise to CFU-A colonies (b) and the number of CFU-
A colonies/3x104 cells after dissociation (c). Error bars represent standard deviations of








Figure 3.6 Comparing culture of embryoid bodies in suspension and at the air-
medium interface, (a) Diagram showing culture of EBs i) in suspension and ii) at the
interface between the air and the medium, (b) The number of CFU-A colonies/3x104
cells over a time-course for EBs in suspension-(•-) or at the air-medium interface ( ).
Error bars represent standard deviations of the means of triplicate plates.
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Therefore, a highly expressing GFP-marked ES cell line was identified, which
produced colonies in the CFU-A assay that were visible by fluorescence microscopy.
Furthermore, the GFP-marked cells were easily distinguished from wild type cells by
flow cytometry, which was useful for determining the level of contamination by the
AGM region cells in the co-cultures. That information made it possible to compare
the numbers of CFU-A colonies derived from equivalent numbers of EB cells in co-
cultures and control cultures.
The co-culture method established as a result of these experiments is
described in Chapter 4.
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Chapter Four: ES cell and AGM region co-culture
4.1 Aim
To examine the effect of the AGM region on the haematopoietic
differentiation of ES cells.
4.2 Introduction
4.2.1 The method for AGM region and ES cell co-culture
The co-culture method established as a result of the experiments described in
Chapter 3 is illustrated in Figure 4.1 (see Chapter 2: Materials and Methods for a
detailed description of all the procedures outlined).
In brief, EBs were made by the hanging drop method from GFP#7a ES cells
and cultured at the interface between the air and the medium with the AGM regions
dissected from E10.5 or 11.5 embryos. The controls were EBs cultured alone. No
cytokines were added to the cultures to assess only the effect of the AGM region on
the differentiating EBs. Cultures were harvested, dissociated and plated into the
CFU-A (or other haematopoietic colony) assay. Samples of the cells were analysed
by flow cytometry to determine the percentage of GFP* ES-derived cells. The
percentage of GFP+ EB cells typically obtained from co-cultures comprising of three
intact AGM regions and up to 1000 EBs was between 75 and 90% (e.g. FACS
histogram in Figure 4.1 and Figure 2.6). CFU-A assays were scored by light and
fluorescence microscopy to count the total number of colonies and the green GFP+
colonies respectively. Using the percentage of GFP+ ES-derived cells determined by
flow cytometry, the number of CFU-A colonies per 3xl04 EB cells was calculated to
allow the comparison to control cultures containing only EB cells.
A comparison to foetal liver co-culture was also made.
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AGM and EB co-culture
10' 10 10" 10n
FL1-H
e
Sample of cells analysed
by flow cytometry to
determine the percentage
of GFP ES derived cells.
R1 gate on the histogram
denotes GFP expression
Figure 4.1 Flow diagram illustrating the co-culture set up and subsequent
haematopoietic analysis. A detailed description of all the procedures depicted
can be found in Chapter 2: Materials and Methods.
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4.3 Experimental approach
• Set up a preliminary study to rapidly assess the AGM region co-culture strategy
as a method for enhancing haematopoietic differentiation of ES cells and to
investigate the inter-experimental variability of the system.
• Compare the effect of the E10.5 and 11.5 AGM region and another
haematopoietic tissue, the E13.5 foetal liver, on the haematopoietic
differentiation of ES cells.
• Investigate the inductive capacity of the El0.5 AGM region over a more
extensive time-course of ES cell differentiation.
• Compare the CFU-A assay with the more widely used HPP-CFC assay, which
also detects primitive haematopoietic progenitors over a time-course of
differentiation.
• Assess the ability of progenitors from co-cultured EBs to engraft in vivo after
transplantation into lethally irradiated recipients.
4.4 Results
4.4.1 Preliminary co-cultures to assess the feasibility and variability of
the experimental system
The initial co-culture experiments were performed to assess first, whether the
AGM region had any effect on the haematopoietic differentiation of ES cells and
second, the reproducibility of the system. In three independent experiments EBs
were co-cultured with AGM regions from late E10.5 and early El 1.5 embryos. All
experiments resulted in a greater number of haematopoietic colonies from the co-
cultured EBs compared to those cultured alone. The range of increase in CFU-A
activity after co-culture was from 1.5- to 4-fold (39 to 151, 69 to 166 and 79 to 120
colonies per 3xl04 cells, Figure 4.2). P < 0.01 as determined by the t Test. These
preliminary data provide strong evidence to support the hypothesis that exposure of
embryonic AGM region to differentiating ES cells enhances haematopoietic

























Figure 4.2 Variability of CFU-A activity in differentiating embryoid bodies
co-cultured with AGM region. Numbers of CFU-A colonies/3x104 cells in EBs
cultured alone^ ) and co-cultured with E10.5 -11.5 AGM region (•) for 6 days.
Each data point represents the mean number of colonies in triplicate plates from
independent experiments. The shapes correspond to individual matched
experiments. Circles P) represent E11.5 AGM regions. Diamonds and squares
f ,■) represent E10.5 AGM regions. Bars (-) show overall means. P < 0.01, as
determined by the t Test.
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differentiation is prone to inter-experimental variation as was also found in the level
of haematopoietic activity in the spontaneously differentiating EBs cultured alone.
Interestingly, there was some correlation between the level of induction and the
developmental stage of the embryos from which the AGM regions were dissected.
The smallest increase in CFU-A activity came from El 1.5 AGM region (indicated by
circles in Figure 4.2).
Importantly, the co-culture differentiation system is a multi-step process,
which inherently introduces variables, increasing the potential for error. Possible
sources of error include: (i) the precise gestational age of the embryos from which
AGM regions are dissected, (ii) the quality of the dissection and how long it takes,
(iii) the number of EBs in contact with the inductive factors from the AGM regions
and (iv) the membrane filters being exactly at the air-medium interface; neither too
far above the medium nor too submerged.
4.4.2 The effect of the embryonic AGM region and foetal liver on the
haematopoietic differentiation of ES cells
The CFU-A activity of EBs after co-culture with AGM regions from El0.5
and El 1.5 embryos or foetal liver from E13.5 was compared. The time-points (four
and six days of differentiation) were chosen based on the emergence of CFU-A
activity in differentiating EBs (Chapter 1: Introduction, section 1.6.4.1; Figure 3.6
and Hole et al., 1996). The El0.5 AGM region had the most potent effect on
haematopoietic differentiation. After six days in co-culture, the number of CFU-A
colonies per 3xl04 cells plated was 9-fold greater than in EBs cultured alone (15 ±
5.9 to 142 ± 12.7, Figure 4.3a). Co-culture with El 1.5 AGM resulted in only a 2-
fold increase (62 ± 11.4 to 137 ± 34.1 colonies per 3xl04 cells, Figure 4.3b). In



























































Figure 4.3 CFU-A activity in embryoid bodies after cc-cuiture with AGM
region and foetal liver. Numbers of CFU-A colonies/3x104 cells in EBs
cultured alone (g) and co-cultured (g) for either 4 or 6 days with (a) E10.5 AGM
region, (b) E11.5 AGM region or (c) E13.5 foetal liver. Error bars represent the
standard deviations of the mean of triplicate plates.
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4.4.3 Time-course of haematopoietic differentiation of ES cells by AGM
region co-culture
In order to analyse the effect of AGM region on differentiating ES cells in
more detail, a more extensive time-course was performed and the CFU-A assay was
compared to the HPP-CFC.
4.4.3.1 CFU-A assay
Haematopoietic progenitors emerge in a time-course dependent manner with
a peak at six days of differentiation. CFU-A activity was increased approximately
20-fold by co-culture (186 ± 27.5 colonies per 3xl04 cells) compared to the control
EBs cultured alone (10 ± 5.5 per 3xl04 cells, Figure 4.4).
Interestingly, there was a decrease in haematopoietic activity in EBs at seven
days. A likely explanation for this observation is that the progenitors had
differentiated into more mature cell types, which are not detected by this assay. An
alternative hypothesis was that extended culture of EBs at the air-medium interface
may result in cell death. However, there was no evidence for this when cells were
stained with propidium iodide (PI) and annexin V and analysed by flow cytometry
(data not shown).
4.4.3.2 HPP-CFC assay
The HPP-CFC (High Proliferative Potential-Colony Forming Cell) assay was
set up in parallel to the CFU-A assay, as a second, more widely used measure of
primitive haematopoietic progenitors.
The emergence of HPP-CFC progenitors in the time-course followed the
CFU-A with a peak at six days, although HPP-CFC colony numbers were lower in
both control and co-cultured EBs (Figure 4.5). The number of colonies in the
control EBs cultured alone was as found previously by others using this assay (Palis
et al., 2001). There was a 50-fold increase in HPP-CFC activity after co-culture with
the AGM region, with the number of colonies per 3xl04 cells plated rising from 0.3 ±

























Figure 4.4 Time course of CFU-A activity in embryoid bodies after co-
culture with AGM region. Numbers of CFU-A colonies/3x104 cells in EBs
cultured alone (•) and co-cultured (•) with E10.5 AGM region for up to 7 days.
Error bars represent the standard deviations of the mean of triplicate plates.
Figure 4.5 Time course of HPP-CFC activity in embryoid bodies after co-
culture with AGM region. Numbers of HPP-CFC colonies/3x104 cells in EBs
cultured alone (•) and co-cultured (•) with E10.5 AGM region for up to 7 days.
Error bars represent the standard deviations of the mean of triplicate plates.
Chapter Four: ES cell and AGM region co-culture
4.4.4 Transplantation of co-cultured EB and AGM region cells into adult
recipients
To determine whether co-cultured EBs contained LTR-HSCs, the cells were
transplanted into adult mice and the contribution to haematopoiesis measured (see
Chapter 2: Materials and Methods section 2.8 and Figure 4.6). For transplantation
experiments the co-cultures were harvested after only five days of differentiation
assuming that cells detected by the CFU-A and HPP-CFC assays are derived from
FTR-HSCs. Fethally irradiated adult mice were each injected with lxlO6 co-cultured
cells. It must be noted that the cells harvested from the co-cultures were not sorted
prior to injection and therefore approximately 10% were AGM region derived (as
measured by flow cytometry, data not shown). One group received 2xl05 carrier
spleen cells in addition to the experimental cells from the co-cultures. Control
animals received either irradiation only or were irradiated and injected with 2xl05
carrier spleen cells. Historical controls for EBs cultured alone were used (Hole et al.,
1996) in combination with a concurrent transplantation experiment carried out by
Helen Taylor, Julie Buchanan and Kay Samuel, to repeat the previous findings by
this lab (Hole et ah, 1996). The contribution of donor cells to haematopoiesis in the
surviving recipients was assessed two and seven months after transplantation.
A marker system was devised to analyse the contribution of donor cells to the
haematopoietic compartment. Cells from up to four different sources (host, EB cell,
AGM region and carrier spleen) had to be distinguishable, thus a combination of
markers was used to recognise them (Table 4.1). ES-derived cells were identified by
GFP expression. Host animals were female; although the GFP#7a ES cell line is
male, the Y-chromosome specific YMT gene was not unique to the EB-derived cells
because half of the AGM regions in the co-cultures would also be male. However,
the AGM regions were dissected from C57B1/6 embryos, which harbour a different
allele of the GPI-1 gene (/*) from the mouse strainl29/Sv (/"), the strain of the
recipients, carrier spleen cells and ES cells. In addition C57B1/6 cells do not express
the Ly9.1 antigen, which is found on the surface of most 129/Sv cells. Finally, the
spleen cells used as carriers were harvested from a female 129/Sv mouse carrying the
gene trap integration, GT411 with the LacZ reporter (Wallis, Axton and Forrester,
unpublished).
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Figure 4.6 Flow diagram illustrating procedure for transplantation experiment.
Co-cultured EBs and AGM region were dissociated and 1x106 cells were injected
into lethally irradiated female 129 recipient mice (n=5). (See Table 4.1 and 4.2 for
cell markers and information on control mice respectively). 2 months after injection
blood was taken from surviving mice and analysed for the presence of EB or AGM-
derived cells. After a further 5 months the mice were killed, the blood, spleens and
bone marrow were harvested for further analysis. See also Chapter 2: Materials and
Methods, section 2.9
GPI-1 GFP Ly9.1 YMT LacZ
Recipient mice
129/Sv female
A - + - -
ES cells (GFP#7A)
129/Sv male









Table 4.1 Markers used to distinguish donor and host cells after transplantation
GPI-1 alloenzymes were distinguished by electrophoretic separation. GFP and Ly9.1
expression was detected by flow cytometry. The presence YMT and LacZ sequences









1 - - 10-12 days (5/5)
2 + - ~1 month (5/5)
3 - + 10-12 days (2/5)
~7 months* (3/5)
4 + + 10-12 days (5/5)
Table 4.2 Survival data. All recipient mice were irradiated wth 10.5 Gy y-rays
before being injected with cells as indicated, "these mice were healthy by were
killed for analysis of donor EB-cell contribution to haematopoietic tissues
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Survival of the control mice was as expected; the non-injected irradiation
controls died after 10-12 days and the mice injected only with carrier spleen cells
survived approximately one month. Three out of the five mice given co-cultured
cells survived for the duration of the experiment and were killed seven months after
transplantation for analysis. All the mice injected with co-cultured cells
accompanied by spleen carriers died unexpectedly after only 10-12 days. It is most
likely that these animals developed graft-versus-host (GVH) disease, or more
accurately a "graft-versus-graft" response. Mature T cells from the carrier spleen
cells would have recognised the AGM region cells as foreign. It is perhaps
surprising that this did not merely result in a failure of the AGM region cells to
engraft, but apparent systemic immune disease killing the animals. In vitro
immunologic assays (such as testing for T-cell cytotoxicity by a mixed lymphocyte
reaction) could be set up to test this hypothesis. In future experiments this could also
be avoided by depleting the T cells from the carrier spleen by irradiation, which
would also rule out the possibility of long term engraftment by stem cells in the
spleen. In the concurrent but independent transplantation experiment none of the
animals injected with lxlO6 day 5 EB cells survived. Two out of the five mice, who
received carrier spleen cells in addition to EB cells, survived over 7 months as
previously reported (Hole et al., 1996) and (data not shown). The survival data for
the present study are shown in Table 4.2.
Eight weeks after transplantation, peripheral blood was taken from the three
surviving mice. The blood was analysed (i) by flow cytometry for any GFP
expressing cells and for the presence of Ly9.1, (ii) for the GPI isoenzyme assay and
(iii) genomic DNA was extracted for PCR analysis and (see Chapter 2: Materials and
Methods, section 2.8.1). No GFP+ cells were detected in any of the animals by flow
cytometry (Figure 4.7). From PCR amplification of the genomic DNA with primers
specific for the YMT gene, it was apparent that all three mice had been repopulated
with male cells (Figure 4.8a). Due to the absence of any GFP, differentiated ES
cells could not be responsible. However, the small number of cells expressing Ly9.1
(Figure 4.7) suggested that most of the peripheral blood was not host derived. GPI
analysis demonstrated that the peripheral blood consisted of GPI-b cells, confirming
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Figure 4.7 Peripheral blood shows no haematopoietic repopulation from ES-
derived cells. Flow cytometric analysis of peripheral blood taken from recipient mice 2
months after being injected with 1x106 co-cultured AGM and ES cells. Histograms
show data from one representative animal (AK3). (a) FSC and SSC profiles of PB.
The R1 gate (• ,62.84% total) denotes lymphocytic cells. The R2 gate (•,31.50%
totai) denotes granulocytic ceiis. The ceiis were gated for anaiysis because the
granulocytes have higher levels of autofluorescence, which interferes with the
detection of GFP and surface antigen expression, (b) PB unstained and stained with
antibodies against CD45 and Ly9.1 is shown as gated in (a). Unstained samples show
no GFP+ cells in the FL1 channel. A small population of CD45+ haematopoietic cells,
both lymphocytes (7.32%) and granulocytes (2.16%), express Ly9.1 indicating that
they are host derived. Flow cytometric analysis was done by Kay Samuel.
female male AK1 AK2 AK3*(a)
YMT ►
myoD ►
(b) 129 C57 AK1 AK2 AK3* 129 C57
GPI A ►
GPI B ►
Figure 4.8 Surviving recipient mice are repopulated by AGM region-derived cells. PCR
and GPI analysis of peripheral blood taken from female irradiated 129 mice 2 months after
being injected with 1x106 co-cultured AGM and ES cells, (a) PCR for Y-chromosome specific
YMT gene shows all three recipient mice are repopulated with male cells. The amplification of
the MyoD gene was used as an internal control for the reaction (b) GPI analysis shows all
three recipient mice are repopulated with GPI B cells, in this case from the C57BI/6 mouse
strain, donor of the AGM regions. * indicates the recipient animal shown in Figure 4.7
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the haematopoiesis (Figure 4.8b). In the concurrent control experiment, no GFP+
cells or YMT expression was detected in the two surviving animals that received EB
cells with carrier spleen. Interestingly, expression of the LacZ reporter gene was
detected by PCR suggesting engraftment of the carrier spleen cells (data not shown).
To investigate the possibility of long-term engraftment of EB-derived cells
from the co-cultures, the three surviving animals were killed 7 months after
transplantation and their haematopoietic tissues (peripheral blood, spleen and bone
marrow) were analysed. Again, no GFP+ cells were detected by flow cytometry
(data not shown, as in Figure 4.7). It was concluded from these data that the survival
was due to engraftment of AGM region-derived cells and confirmed by the small
percentage of cells expressing Ly9.1. The remaining spleen and bone marrow cells
were used to set up CFU-A assays in an effort to expand any ES-derived cells that
might have been present but were not sufficiently abundant for detection by flow
cytometry. The CFU-A colonies were scrutinised by fluorescence microscopy, but
none of the progeny were visibly GFP1 (data not shown).
Again, there was persistent haematopoietic contribution by carrier spleen
cells in the animals in the concurrent control experiment (data not shown).
A summary of the results described in this section is shown in Table 4.3.
4.5 Discussion
The data demonstrate that the differentiation of ES cells into early
haematopoietic progenitors in vitro is enhanced by co-culture with the embryonic
AGM region. The gestational age of the embryo from which the tissue was dissected
is important. As shown in Figures 4.2 and 4.3, E10.5 AGM region has a more
potent effect on haematopoietic differentiation than one day later in development. In
vivo HSCs emerge from the AGM region after E10 and by El 1.5 their numbers have
peaked. One could hypothesise that the E10.5 AGM region is an inductive
microenvironment for HSCs whereas the El 1.5 AGM may be more expansive, and
this activity is reflected on ES cell differentiation. However, there is no direct
evidence for this and it is purely speculative to draw such conclusions at this stage
from only these data. To test such a hypothesis one would have to be able to
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2 months 7 months
PB PB Spl BM
1 2 3 1 2 3 1 2 3 1 2 3
GFP1 -
Ly9.1
YMT + + + + + + + + + + + +
GPI B B B nd nd nd nd nd nd nd nd nd
GFP" nd nd nd nd nd nd -
Table 4.3 Summary of the analysis of the transplantation experiment. The
numbers (1, 2 and 3) represent the three surviving mice AK1, AK2 and AK3. GFP1
stands for analysis by flow cytometry. GFP2 denotes visual examination of CFU-A
colonies, nd = not determined.
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compare the proportion of EBs in culture which show CFU-A activity and the
number of CFU-A progenitors within each EB after co-culture with AGM region
from embryos of various stages and control EBs alone. This is not possible using the
co-culture system because individual EBs cannot be harvested intact from the
cultures.
The possibility that AGM region cells were promoting the formation of
colonies within the CFU-A assay itself was ruled out by plating mixtures of cells
from AGM regions and EBs that were cultured separately. No increase in EB-
derived CFU-A activity was found (data not shown).
Co-culture of EBs with foetal liver did not result in an increase in
haematopoietic activity. There are several possible explanations for this result.
First, the foetal liver may not be an inductive environment. Second, the organ
rudiment explant culture conditions may not be suitable for culturing pieces of foetal
liver. Third, the foetal liver was taken from E13.5 embryos because it is at this stage
during development when the haematopoietic activity in the organ has peaked in
terms of number of LTR-HSCs. It could be reasoned however, that since HSC
activity is present in the foetal liver from day 11 of gestation, earlier stages could
have been effective.
Another experiment, which could be suggested, is to co-culture EBs with
yolk sac, which has repopulating activity from El 1. More significantly, definitive,
adult-type HSCs have recently been found to expand in organ culture at E12.5, and
may perhaps even be generated in this tissue (Kumaravelu et al., 2002).
Nevertheless, the AGM region is the only tissue tested here that increases
haematopoietic differentiation from ES cells; control experiments using limb buds,
somitic tissue and foetal head also had to effect (data not shown).
The CFU-A assay is not widely used despite being established in the
literature (see Chapter 1: Introduction). Therefore, the emergence of CFU-A over a
time-course of EB differentiation was compared to a more widely used assay, the
HPP-CFC. These data are shown in Figure 4.5. The CFU-A and HPP-CFC assays
detect equivalent progenitors in the haematopoietic hierarchy, though the CFU-A are
reported to be more mature than the most primitive HPP-CFC (see Chapter 1:
Introduction). This may explain why overall there were fewer HPP-CFC colonies
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than CFU-A colonies. HPP-CFC activity in differentiating EBs cultured alone was
as previously demonstrated by others (Palis et al., 2001), as was the CFU-A activity
(H.T., unpublished). A direct comparison of ES cell differentiation using both
haematopoietic colony assays has not been reported previously. Co-culture with the
E10.5 AGM region resulted in a substantial rise in the number of progenitors
detected by both assays peaking at six days of differentiation; where there was a 20-
fold increase in CFU-A activity, the increase in HPP-CFC activity was more than 50-
fold. No published differentiation protocol has resulted in such a substantial increase
in haematopoietic progenitors from ES ceils.
Since haematopoietic progenitors arise within spontaneously differentiating
EBs it is not possible to determine from these data whether the increase in CFU-A
and HPP-CFC after AGM region co-culture is due to de novo induction from
precursors or proliferation of progenitors. When EBs were allowed to differentiate
for three days prior to co-culture with the AGM region, there was no significant
increase in haematopoietic activity (Figure A.2 in Appendix). This is unexpected if
the expansion of existing precursors was solely responsible for the increase observed
and would support the hypothesis of an inductive role for the AGM region.
However, to test such a hypothesis, as stated above, one would need to determine the
proportion of EBs in co-culture and alone which exhibit CFU-A activity and the
number of CFU-A progenitors within each EB. Furthermore, since CFU-A have
self-renewal potential as determined by their ability to form secondary (2°) CFU-A
colonies on replating, it would be interesting to examine the effect of AGM region
co-culture on this proliferative potential both in terms of the proportion of original
CFU-A colonies that can generate 2° CFU-A colonies and their frequency within the
original CFU-A.
The CFU-A and HPP-CFC assays are not a measure of engraftable HSCs
capable of persistent reconstitution of the adult haematopoietic system. That was
assessed by transplantation into haemato-compromised animals and the subsequent
long-term analysis of haematopoiesis for contribution from the donor cells.
Unfortunately no evidence of engraftment by co-cultured ES-derived cells was found
and the survival of the experimental animals was due to repopulation by HSCs from
the AGM region, which were present because the cells from the co-cultures were not
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sorted prior to injection. A previous study based on a similar time-course of ES
differentiation (Hole et al., 1996) reported the survival of lethally irradiated mice
injected with EB cells but only when accompanied by carrier spleen cells. However,
the level of engraftment by the EBs was so low they could only be detected by PCR
amplification of the Y chromosome specific sequence after hybridisation. In that
study, the carrier spleen cells were not distinguishable from the host animals so their
potential long term engraftability could not be determined. Control mice receiving
only spleen cells were rescued over the short term, which is the function of carrier
spleen cells. These experiments were repeated concurrently with the present
transplantation study, but using spleens from genetically marked animals as carriers
to enable their detection. The apparent long term reconstitution of the
haematopoietic system by spleen cells when co-injected with differentiated ES cells
was unexpected. This observation leads to speculation that the EB cells produce a
factor or factors, which facilitate engraftment by spleen derived cells. In support of
this hypothesis, conditioned media from ES cells and differentiating EBs have been
shown to increase the number of initiating cells (IC) in long term cultures (LTC) of
primitive human progenitors (Croizat and Bouhassira, 1999) and CFU-S colonies
were generated (at a higher frequency than the irradiation controls) after injection of
EB derived cells, but no evidence of donor cell contribution was found (Muller and
Dzierzak, 1993). Also, in EB and AGM region co-cultures, the increase in
haematopoietic activity was not confined to the EB cells but the CFU-A activity of
the AGM regions was also increased (data not shown). However more experiments
are needed to substantiate this because of the high variation in haematopoietic
activity in cultured AGM regions (Figures 3.1 and 3.3). Indeed, in support of a
facilitative role for differentiating ES cells, the level of stable engraftment by the
AGM region cells after co-culture with EBs in the three surviving mice was very
high. Unfortunately no control animals were injected only with AGM region cells
(due to lack of material) to verify such a possibility.
The possibility of very low level engraftment cannot be ruled out for the
transplantation experiment described above, but it is unlikely because bone marrow
and spleen cells harvested from transplanted mice were plated into the CFU-A assay
and no GFF^ colonies were found on examination using fluorescence microscopy.
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Any EB derived HSCs would probably have been out-competed by HSCs from the
AGM region. In future experiments, co-cultured EB cells should be sorted from
AGM region cells prior to injection.
A CFU-A assay was set up at day 6 of differentiation (one day after
transplantation) with cells co-cultured in parallel to the transplanted cells. In this
particular experiment very low numbers of CFU-A colonies were generated by both
co-cultured and control EBs (data not shown). This was not a good indicator of cell
differentiation and/or quality.
There could be several additional reasons for the failed engraftment of EB
cells. Cells expressing low levels of MHC Class I are recognised and cleared by the
animal's NK cells. MHC I is not highly expressed by early gestation embryos before
the development of the immune system (Ozato et al., 1985) and was similarly not
found on the surface of ES cells (K.S., unpublished). However, when a chromium
release assay was set up to measure the killing of ES cells by NK cells in vitro, no
such activity was found (Figure A.3 in Appendix). A criticism of this experiment
however, is that the assay should also have been performed with cells from
differentiated EBs to recapitulate the transplanted population. The expression of
MHC I on differentiated mouse ES cells is unknown, but undifferentiated human ES
cells have been found to express very low levels of MHC I, which is slightly elevated
upon differentiation. Furthermore, only limited cytotoxic NK cell activity against
both undifferentiated and differentiated cells was observed in this study (Drukker et
al., 2002).
Although reconstitution is possible with a single HSC, perhaps lxlO6 EB
cells does not contain a sufficient number of HSCs. If AGM region co-culture can
give rise to 200 CFU-A colonies per 3xl04 cells, this still only represents 0.7% of the
total EB cell population (0.2% in the case of HPP-CFC) and the number of HSCs
from which they descended is presumably even smaller. A possibility would be to
sort the EB cells on the basis of surface markers associated with HSCs (e.g. KTLS;
see section 1.2.2). Preliminary flow cytometric analysis showed an increase in the
number of cells from EBs expressing c-kit and CD34 after AGM region co-culture
(Figure A.4 in Appendix). However, Sca-1 is not detected at significant levels in
differentiating ES cells. The Ly-6 gene locus encoding Sca-1 shows strain-dependent
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allelic variation. The 129 mouse, from which ES cells are most frequently derived,
is a Ly-6 strain which only expressed Sca-1 in on about 25% of HSCs in the bone
marrow (Spangrude and Brooks, 1993) and might partly attribute to the low levels of
Sca-1 detected on differentiated ES cells and may therefore not be a useful marker
for ES-HSC.
The significant increase in repopulation of ES-derived HSCs after intra bone
marrow injection (Kurt and see Chapter 1: Introduction, section 1.5.3) indicates that
homing to the bone marrow is defective. Therefore it would be interesting to
determine whether AGM region co-culture enhances the surface expression of
antigens, associated with homing to and entry into the bone marrow, such as the
chemokine receptor CXCR4 (Peled et al., 1999) or adhesion molecules, for example
VLA-4/VCAM-1 (Chan and Watt, 2001). In addition, since the ectopic expression
of HoxB4 has recently been found to confer ES derived cell with LTR-HSC activity
and postulated to be a molecular "switch" for definitive haematopoiesis (Kyba et ah,
2002); see section 1.5.3), it would be interesting to see if AGM region co-culture
induces expression of this gene.
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Chapter Five: Stromal cell co-culture
5.1 Aim
To examine the effect of stromal cell lines derived from the haematopoietic
tissues (AGM region and foetal liver) of the midgestation mouse embryo on the
differentiation of ES cells.
5.2 Introduction
The experiments in Chapter 4 demonstrate that co-culture with the AGM
region, using an explant culture system, significantly increases the haematopoietic
differentiation of ES cells in vitro. However, the biological mechanisms involved in
this process are unknown. In an attempt to gain a mechanistic insight, co-culture
experiments using stromal cell lines derived from the embryonic AGM region and
liver were set up. These experiments were designed to address three important
questions, which may be useful in the identification of the haematopoietic promoting
factor(s). (i) What is the phenotype of the cell or cells within the AGM region which
support the haematopoietic differentiation of ES cells, (ii) are the haematopoietic
promoting factors dependent on cell-cell contact or are they secreted and (iii) is the
increased haematopoietic activity a result of de novo induction or proliferation of
committed progenitors.
5.2.1 Stromal cell lines
The most extensive and well characterised panel of stromal cell lines derived
from tissues of the midgestation embryo was generated by members of Elaine
Dzierzak's laboratory (Oostendorp et al., 2002a; Oostendorp et al., 2002b).
Mice transgenic for the temperature-sensitive form (tsA58) of the SV40 Tag
immortalising gene under the control of the (3-actin or PGK promoters were
generated for the purpose of establishing the cell lines. Control BLlb mice, which
express the LacZ reporter gene under the control of Ly6E, since Sca-1 is reportedly
expressed on most stromal lines (Montecino-Rodriguez et ai., 1994), were also used.
Stromal cell lines were derived from all three transgenic lines, but with much greater
efficiency from those harbouring the immortalising tag gene. More than 100 clonal
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cell lines were established from the liver, gastrointestinal region and subdissected
AGM region of E10 and El 1 transgenic embryos. Most of these lines were tested for
their ability to maintain haematopoietic progenitors and HSCs (Oostendorp et al.,
2002a; Oostendorp et ah, 2002b).
In the present study, three of the cells lines found by Oostendorp and others
to be most supportive of HSCs, UG26.1B6, EL08.1D2 and AM20.1B4 (a kind gift
from Prof. Dzierzak) were tested for their effect on differentiating ES cells. The
AM20.1B4 line was derived from the dorsal aorta and surrounding mesenchyme of
the AGM region dissected from an E10 tag expressing embryo. UG26.1B6 was
derived from the urogenital ridge of the AGM region from a tag expressing embryo
at Ell. EL08.1D2 was derived from the liver of an Ell control BLbl embryo
(Figure 5.1).
5.3 Experimental approach
• Measure the CFU-A activity in EBs after co-culture on primary cultures of
adherent cells derived from disassociated AGM regions as an alternative co-
culture strategy to the explant method, which could generate preliminary data on
the effect of contact compared to non-contact culture.
• Compare the expression of a selected panel of surface markers on the three
candidate stromal cell lines by flow cytometric analyses.
• Determine the effect of co-culture with the three candidate stromal cell lines on
the haematopoietic differentiation of ES cells as measured by the CFU-A assay.
• Examine the effect of conditioned medium from the stromal cell lines on the
haematopoietic differentiation of ES cells to determine if cell-cell contact is
required.
• Measure the CFU-A activity in individual EBs cultured on the candidate stromal
cell lines to investigate whether any increase in haematopoietic differentiation
was a result of de novo induction or proliferation of committed progenitors. A
hypothesis is that de novo induction of haematopoietic ceils wouid result in an
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Figure 5.1 Anatomical origin of the stromal cell lines, (a) Diagram illustrating
the midgestation AGM region, liver and gut from the ventral side, to highlight the
subrcgicns from which the stromal cell lines AM20.1B4, UG2S.1D8 and EL08.1D2
were derived. Adapted from Oostendorp et al, 2002. (b) Photographs of the
corresponding region dissected from an E11 embryo, taken from a dorsal and a
lateral view respectively.
Chapter Five: Stromal cell co-culture
increase in the number of colonies generated from each EB would indicate the
proliferation of progenitors.
• Investigate the capacity of the stromal cell lines for supporting ES cell self-
renewal.
• Assess the effect of stromal cell line co-culture on the differentiation of ES cells
into cardiomyocytes.
5.4 Results
5.4.1 CFU-A activity in EBs after co-culture on primary adherent AGM
region cells.
AGM regions from E10.5 embryos were dissociated to obtain a single cell
suspension, which was then seeded onto gelatin coated 24-well plates. The adherent
cells formed confluent monolayers within a week in culture onto which, day l EBs
produced in hanging drops were plated at a frequency of one EB per well. In
addition, half of the EBs were cultured in transwell inserts, which inhibit direct
contact between the AGM region cells and the differentiating ES cells but allow
secreted molecules to pass freely (Figure 5.2a and Chapter 2: Materials and
Methods, section 2.2.4.2). This co-culture experiment was set up to determine (i) if
the haematopoietic activity of differentiating ES cells is also increased by culture on
primary cells from dissociated AGM regions (with a view to using the stromal cells
lines) and (ii) whether direct cell-cell contact is required.
50% of the EBs plated onto gelatin contained CFU-A progenitors after six
days of differentiation (5 days in co-culture) (Figure 5.2b), which was as expected
(Hole et al., 1996; Lako et al., 2001), see section 3.4.2 and Figure 3.5a and b). The
number of CFU-A colonies derived from these individual EBs cultured on gelatin
ranged from 0 to 3, with a mean of 0.92 colonies per EB including those with no
CFU-A activity (Figure 5.2c). Similar observations have been made previously
(Hole et ah, 1996). 70% of the EBs cultured directly on AGM region derived cell
monolayers gave rise to colonies in the CFU-A assay and each contained an average





































Figure 5.2 CFU-A activity in individual embryoid bodies after co-culture on
AGM region derived cells, (a) Diagram illustrating the co-culture of EBs on AGM
region derived cells either i) on gelatin with no AGM cells, ii) in direct contact and iii)
in non-contact cultures using transwell inserts. Single EBs were cultured per well in
a 24-well plate for 6 days, (b) The proportion of EBs (%) that produced CFU-A
colonies, (c) The number of CFU-A colonies per EB after culture on gelatin (•), in
direct contact with AGM region cells and in non-contact cultures (^. Each data
point represents the number of colonies from an individual EB. Bars (J indicate the
mean number of colonies. Numbers of individual EBs analysed are shown.
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transwell inserts over the AGM region derived cells only 30% showed CFU-A
activity. The number of colonies ranged from 0 to 10, but the mean was only 1.3
colonies per EB, because although one EB generated 10 colonies, the majority (70%)
displayed no activity in this assay. The primary cultures of adherent AGM region
cells alone did not give rise to any colonies in the CFU-A assay (data not shown).
These data support the use of primary cultures of dissociated AGM region
derived cells to provide an effective environment for enhancing the haematopoietic
differentiation of ES cells with approximately 10 fold increase in CFU-A activity.
(Flowever, the data are not significant with >95% confidence in a non-parametric
test, p < 0.138 for contact cultures compared to control EBs cultured on gelatin as
determined by the Mann-Whitney U Test.) These data also suggest that direct cell-
cell contact is important.
It was next investigated whether the haematopoietic-enhancing capacity
could be maintained in clonal cells lines derived from subdissected AGM regions
(Figure 5.1).
5.4.2 Expression of surface antigens on the stromal cell lines
AM20.1B4, UG26.1B6 and EL08.1D2
The stromal cell lines AM20.1B4, UG26.1B6 and EL08.1D2 were examined
by flow cytometry for the expression of a small panel of cell surface antigens. These
included markers associated with haematopoietic cells (e.g. CD45, c-kit and Sca-l),
endothelial cells (e.g. CD31 and Flk-l) or stromal cells (e.g. CD29, CD44, CD49e,
CD106 and Sca-l). Sca-l is a known marker of LTR-HSCs, but also associated with
stromal cells and is found on several other tissues (see Chapter 1: Introduction,
section 1.2.2). A complete list is provided in Table 5.1.
Markers for haematopoietic (except Sca-l) and endothelial lineages were not
detected on any of the three cell lines. In contrast they were found to express surface
antigens associated with stromal cells (Table 5.1 and Figure 5.3). In this analysis
CD49e (a5 integrin) expression was higher on the AM20.1B4 stromal cell line and
Sca-l expression was lower on UG26.1B6 cells compared to the other cell lines.
Ill
UG26.1B6 AM20.1B4 EL08.1D2
CD29 Integrin 0i chain + + +
CD31 Pecam-1 - - -
CD44 Polymorphic glycoprotein 1 + + +
CD45 Common leukocyte antigen - - -
CD49e Integrin a5 chain + ++ +
CD51 Integrin av chain +/- +/- +/-
CD61 Integrin 03 chain - - -
CD106 VCAM-1 + + +
CD117 c-kit - - -
Sca-1 Ly6A/E - +/- +/-
Flk-1 VEGF-R2 - - -
Table 5.1 Relative expression levels of surface antigens on stromal cell





















Figure 5.3 Surface antigen expression on stromal cell lines derived from
the embryonic AGM region and liver by flow cytometry. Top paneis show
unstained cells in fluorescence channels 1, 2 and 3. Detection of antibodies
against CD29, CD31, CD44, CD45, CD49e, CD51, CD61, CD106, c-kit, Sca-1
and Flk-1 are shown on AM20.1B4 «, UG26.1B6 ( ) and EL08.1D2 *).
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Apart from these subtle differences, there was no marked difference between the
three cell lines in terms of surface marker expression.
5.4.3 Haematopoietic differentiation of ES cells after co-culture on
stromal cell lines AM20.1B4, UG26.1B6 and EL08.1D2
The CFU-A activity of EBs after co-culture on stromal cell lines AM20.1B4,
UG26.1B6 and EL08.1D2 was compared after six days of differentiation (see
Chapter 2: Materials and Methods, section 2.2.4.3). Only co-culture with the stromal
cell line derived from the dorsal aorta and surrounding mesenchyme of the AGM
region (AM20.1B4, see Figure 5.1) resulted in an increase in CFU-A activity (145.2
± 15.3 colonies/3xl04 cells) compared to EBs cultured on gelatin (39.7 ± 4.95
colonies/3xl04 cells); a 3.5 fold rise. In contrast, a reduction in the number of CFU-
A colonies was observed in EBs co-cultured with the other cell lines, UG26.1B6
(10.3 ± 0.8 colonies/3xl04 cells) and EL08.1D2 (8.7 ± 1.1 colonies/3xl04 cells) by
approximately 4 fold in both cases (Figure 5.4).
5.4.4 The effect of conditioned medium from the stromal cell lines
AM20.1B4, UG26.1B6 and EL08.1D2 on the haematopoietic
differentiation of ES cells
The CFU-A activity of EBs cultured for six days in ES differentiation
medium containing 50% conditioned medium from the stromal cell lines AM20.1B4,
UG26.1B6 or EL08.1D2 was compared. Control EBs were cultured in ES
differentiation medium containing 50% fresh stromal medium to rule out any effect
from the medium (see Chapter 2: Materials and Methods, section 2.2.4.4). CFU-A
activity was assessed both in terms of the number of colonies per 3xl04 cells derived
from a population of dissociated EBs and the proportion of EBs which gave rise to
the colonies determined by plating intact EBs into the assay.
Conditioned medium had no consistent effect on the haematopoietic
differentiation of ES cells (Figure 5.5). The data shown are compiled from two
independent experiments. In one experiment, culture of EBs in conditioned medium
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Figure 5.4 CFU-A activity in embryoid bodies after co-culture on stromal
cell lines derived from the embryonic AGM region and liver. Numbers of
CFU-A colonies/3x104 cells in EBs cultured for 6 days on gelatin ( 4, AM20.1B4
(UG26.1B6 ( ) and EL08.1D2 (4 cells. Error bars represent the standard











































































Figure 5.5 CFU-A activity in embryoid bodies after culture in conditioned
medium from stromal cell lines derived from the embryonic AGM region
and liver, (a) Numbers of CFU-A colonies/3x104 cells and (b) percentage of
EBs which gave rise to CFU-A colonies after culture for 6 days in "standard"
medium (50% ES differentiation medium/50% stromal medium, ■) or ES
differentiation medium containing 50% conditioned medium from AM20.1B4 (^,
UG26.1B6 ( ) and EL08.1D2 (^ cells. Error bars represent the standard
deviation of the mean of two independent experiments.
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from all three stromal cells lines resulted in a significant reduction in CFU-A activity
per 3xl04 cells derived from a population of dissociated EBs compared with control
EBs (data not shown). However this was not observed in the second experiment,
which explains the high variability. Furthermore, there was an increase in the
proportion of EBs harbouring CFU-A activity after culture in conditioned medium
from AM20.1B4 cells in one experiment (data not shown); again this observation
was not repeated. Thus, the possibility that conditioned medium has some effect on
the haematopoietic differentiation of ES cells cannot be ruled out, but this effect is
not consistent. Therefore the data support a cell-cell contact dependent mechanism,
but do not rule out a high concentration of a short-range secreted factor.
5.4.5 CFU-A activity in single EBs after co-culture on stromal cell lines
AM20.1B4, UG26.1B6 and EL08.1D2
The experiments so far have demonstrated that co-culture of EBs with the
stromal cell line AM20.1B4 enhances their haematopoietic activity after six days of
differentiation and that direct cell-cell contact is likely to be an important factor.
However, the co-culture experiments do not discriminate between an increase in
haematopoietic activity from de novo induction of precursors to a haematopoietic
fate or proliferation of committed progenitors. To address this issue, single EBs
were co-cultured on the stromal cell lines and the CFU-A activity was measured for
each EB individually (see Chapter 2: Materials and Methods, section 2.3.2).
Furthermore, CFU-A activity was assessed at six and ten days of differentiation to
determine the effect of prolonged co-culture.
16.7% of control EBs allowed to differentiate for six days in the absence of
any stromal cells generated colonies when dissociated and plated in the CFU-A assay
(Table 5.2). Similarly, 16.7% of EBs cultured on AM20.1B4 cells showed CFU-A
activity. However, the mean number of colonies per EB (including EBs with no
activity) was 0.6 (0 - 12) in controls and 2 colonies (0 - 24) after co-culture on
AM20.1B4 stromal ceils, a 3.3 foid increase confirming previous experiments see
section 5.4.3 and Figure 5.4). Only 4.2% of EBs produced CFU-A colonies after co-
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culture on UG26.1B6 or EL08.1D2 cells, and the overall mean number of colonies
was 0.04 (0-1) and 0.13 (0 - 3) respectively (Figure 5.6 and Table 5.2).
After ten days of differentiation, 87.5% of control EBs contained CFU-A
activity as compared to 91.7% after co-culture on AM20.1B4 cells. The mean
numbers of colonies per EB were 9.9 (0 - 62) and 47.5 (0 - 158) respectively.
Therefore co-culture on AM20.1B4 cells resulted in a 4.8 fold rise after 10 days.
Interestingly, after ten days of differentiation, there was a dramatic rise in the CFU-A
activity in EBs co-cultured on UG26.1B6 stromal cells. 95.8% contained CFU-A
progenitors and the mean number of colonies per EB was 50.7 (0 - 105). CFU-A
activity in EBs co-cultured on the EL08.1D2 cells remained very low (4.2% of EBs
with the mean from of 0.9 colonies per EB). This stromal cell line does not support
ES cell derived haematopoiesis and the data even suggest a negative effect on
haematopoietic differentiation (Figure 5.6 and Table 5.2). These data demonstrate
that AM20.1B4 and UG26.1B6 stromal cells support the proliferation of early
haematopoietic progenitors in differentiating EBs. These data also show that their
respective timings of action during EB differentiation are distinct, indicating that
there is a difference in the mechanism by which co-culture with AM20.1B4 and
UG26.1B6 cells results in an increase in CFU-A activity.
To further examine the action of the AM20.1B4 and UG26.1B6 stromal cells
on the haematopoietic differentiation of ES cells, these two cell lines were mixed
prior to co-culture. It was hypothesised that perhaps this would have an additive
effect. In this particular experiment, the overall level of CFU-A activity was lower
than previously (Figure 5.7 and Table 5.2). After six days control EBs had
differentiated well with 37.5% containing CFU-A activity and a mean of 1.2 (0 - 7)
colonies per EB. However, after ten days only 41.7% of control EBs generated
CFU-A colonies and each EB had fewer CFU-A progenitors (an overall mean of 0.9
colonies, ranging from 0 to 6, were produced per EB). Nevertheless the stromal cell
line AM20.1B4 supported the haematopoietic differentiation of ES cells with 50% of
EBs with CFU-A activity at day six and 95.8% at day ten, with 2.5 (0 - 11) and 21.3
(0 - 50) colonies per EB respectively. These data suggest that AM20.1B4 cells may
have an inductive role on the haematopoietic differentiation of ES cells because the
proportion of EBs that generated colonies in the CFU-A assay increased, but
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Expt none AM20.1B4 UG26.1B6 EL08.1D2 AM20.1B4
UG26.1B6
d 6 d 10 d 6 d 10 d 6 d 10 d 6 d 10 d 6 d 10
1 16.7 87.5 16.7 91.7 4.2 95.8 4.2 4.2 nd nd
2 37.5 41.7 50 95.8 12.5 41.7 nd nd 20.8 100
Table 5.2 Percentage of EBs co-cultured on stromal cell lines derived from
the embryonic AGM region and foetal liver that gave rise to CFU-A
























































Figure 5.6 CFU-A activity in individual embryoid bodies after co-culture
on stromal cell lines derived from the embryonic AGM region and liver.
Numbers of CFU-A colonies per EB cultured in individual wells of a 24-well
plate for 6 and 10 days on gelatin (^, AM20.1B4 (■), UG26.1B6 ( ) and
EL08.1D2 (4 cells. Bars (J indicate the mean number of colonies per EB
from one experiment. Inset shows the data at 6 days of differentiation. P
values are shown as compared to control EBs by the Mann-Whitney U Test.
Data at day 6 of differentiation were not significant with >95% confidence by a






















































Figure 5.7 CFU-A activity in individual embryoid bodies after co-
culture on stromal cell lines derived from the embryonic AGM region.
Numbers of CFU-A colonies per EB cultured in individual wells of a 24-well
plate for 6 and 10 days on gelatin (^, AM20.1B4 (■), UG26.1B6 ( ) and a
mixture of AM20.1B4 and UG26.1B6 p) cells. Bars U) indicate the mean
number of colonies per EB from one experiment. Inset shows data at six
days of differentiation. P values are shown as compared to control EBs.
Data at day S of differentiation were not significant with >85% confidence as
determined by a non-parametric test (Mann-Whitney U).
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combined with the previous experiment (Table 5.2 and Figure 5.6) the data are not
statistically significant with a 95% confidence limit as determined by the two-sample
t-test. Co-culture on the UG26.1B6 stromal cells again resulted in decreased
haematopoietic activity after six days of differentiation compared to control EBs,
12.5% EBs with CFU-A activity and an overall mean of 0.5 colonies (0 - 7) per EB.
Again at day ten, co-culture of EBs with UG26.1B6 cells resulted in an increase in
haematopoietic activity. The percentage of co-cultured EBs which gave rise to CFU-
A colonies was equal to control EBs (41.7%), but the overall mean number of
colonies per EB was higher at 2.6, ranging from 0 to 21 (compared to 0.9 colonies),
supporting a proliferative role.
When EBs were cultured on mixtures of the stromal cell lines AM20.1B4 and
UG26.1B6, 20.8% of EBs gave rise to CFU-A colonies at day six and there was an
average of 2.0 colonies (0 - 23) per EB. This level of CFU-A activity is between the
levels after co-culture on the stromal cell lines separately and does not support a
combined effect. However, after ten days of differentiation, 100% of EBs displayed
CFU-A activity with a mean of 26.1 colonies (1 - 78) in each EB, which indicates a
combined effect but only at later time points.
5.4.6 The self-renewal capacity of ES cells afterpassage on stromal cell
lines AM20.1B4, UG26.1B6 and EL08.1D2
The decrease in CFU-A activity observed in EBs co-cultured with UG26.1B6
(for the first six days of differentiation) and EL08.1D2 lead to the possibility that
these stromal cell lines might be inhibiting or delaying the differentiation of ES cells.
To test this, the self-renewal capacity of ES cells after passage on the stromal cell
lines was assessed. ES cells were serially passaged on all three irradiated stromal
cell lines in the absence of LIF for up to six passages. Control cultures of ES cells
on gelatin both in the presence and absence of LIF were set up as standards for
routine maintenance in LIF and for the rate of decline in self-renewal in the absence
of LIF. ES cells were harvested at each passage and samples were plated at iow
density in varying concentrations of LIF (0, 1, 10 lOOU/ml), allowed to grow for six
days and then stained for alkaline phosphatase expression as a marker of
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undifferentiated ES cells. After six days the relative numbers of colonies containing
AP expressing cells were compared for a gross assessment of the extent of their
differentiation and thus the self-renewal capacity of the clonogenic cell (see Chapter
2: Materials and Methods, section 2.6 and Figure 2.5). The experiment described in
this section was set up as a crude measure of the support of undifferentiated ES cells,
however the following observations from two independent experiments clearly show
how a detailed quantitative analysis would be beneficial.
As expected, ES cells cultured on gelatin in the presence of LIF maintained a
relatively stable self-renewal potential. ES cells cultured on gelatin in the absence of
LIF gradually lost their capacity to self-renew, as indicated by a decline in the
number of colonies expressing AP. It must be noted that within four passages, ES
cells cultured without LIF appeared to regain self-renewal capacity. This result was
unexpected but could possibly have occurred because the experimental conditions
enriched for cells with increased self-renewal/decreased differentiation potential.
Serial passage on AM20.1B4 cells resulted in an initial fall in the ability to give rise
to colonies expressing AP when replated in LIF, but appeared to become stable after
3-4 passages. Passage on EL08.1D2 cells resulted in the gradual decline in AP
expressing colonies. ES cells cultured on UG26.1B6 lost their self-renewal capacity
very rapidly, after two passages only one or two colonies stained for AP on replating
(Figure 5.8). Interestingly, ES cells cultured on either of the three stromal cell lines
did not regain their ability to generate AP expressing colonies in contrast to control
ES cells passaged on gelatin without LIF. Although 1.5xl06 cells were seeded at
each passage, the overall cell numbers followed the pattern of AP expression/self-
renewal potential (data not shown). The other intriguing observation was the
persistence and size of differentiated AP colonies after culture on either stromal cell
line, but particularly on UG26.1B6 cells compared to ES cells passaged on gelatin in
the absence of LIF. Colonies were counterstained with trypan blue in an attempt to
make this more visible (Figure 5.8, for enlargement of bottom panel see Figure A.5
in Appendix).
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Figure 5.8 Self-renewal of ES cells passaged on stromal cell lines derived
from embryonic AGM region and foetal liver, (a) The frequency of colonies
containing ES cells expressing alkaline phosphatase (AP) that arise after plating
1000 cells in LIF, after serial passage for up to 8 days on AM20.1B4, UG26.1B6
or EL08.1D2 stromal cells compared to control ES cells passaged on gelatin
either in the presence or absence of LIF. (b) Counterstaining of colonies from
passage 4 with trypan blue, (see Appendix: Supplementary data Figure A.5 for
enlargement of (b). Pictures are representative of duplicate weiis from two
independent experiments.
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5.4.7 Cardiac differentiation of ES cells after co-culture on stromal cell
lines AM20.1B4, UG26.1B6 and EL08.1D2
It was also interesting to determine if the differentiation of ES cells enhanced
by the stromal cell lines was specific to the haematopoietic lineage or occurs at the
level of commitment to a mesodermal fate. Therefore, the effect of the stromal cell
lines AM20.1B4, UG26.1B6, EL08.1D2 and a mixture of AM20.1B4 and UG26.1B6
on the differentiation of ES cells into cardiomyocytes was assessed by scoring the
percentage of "beating" EBs at day ten of differentiation in the co-culture
experiments described above. The level of cardiac differentiation in control EBs was
low with 4.2% recorded as "beating". The UG26.1B6 stromal line was highly
supportive of differentiation to a cardiac fate with 77.1% ± 14.7 EBs "beating"
compared to 4.2% ± 0 in control EBs; an 18 fold rise. The number of "beating" EBs
co-cultured on AM20.1B4 cells was highly variable between experiments with a
mean of 16.7% ± 26.6; a four fold increase relative to control EBs. Co-culture on a
mixture of these two stromal cell lines resulted in 70.8% of EBs containing
cardiomyocytes. EL08.1D2 cells did not effect the cardiac differentiation of ES
cells, the percentage of "beating" EBs was equal to the control cultures at 4.2%
(Figure 5.9). Since the number of "beating" EBs was scored prior to their
dissociation for plating in the CFU-A assay, it was possible to determine whether
commitment to cardiomyocytes was mutually inclusive or exclusive of
haematopoietic commitment. There was no correlation between CFU-A activity and
cardiomyocyte differentiation of individual EBs in these experiments (data not
shown).
5.5 Discussion
Overall, explant cultures of intact AGM regions provide the best
microenvironment for the haematopoietic differentiation of ES cells; after six days of
differentiation CFU-A activity is increased 20 fold compared to control EBs cultured
alone (Figure 4.4). Primary cultures of dissociated AGM region cells provided good






Figure 5.9 Cardiac differentiation of embryoid bodies co-cultured on
stromal cell lines derived from embryonic AGM region and liver. The
percentage of EBs which were "beating" after 10 days on gelatin ( 4,
AM20.1B4 (■), UG26.1B6 ( ), EL08.1D2 (■) and a mixture of AM20.1B4 and
UG26.1 B6 (■) cells. The numbers are from 24 EBs cultured individually per
well of a 24-well plate. Error bars represent the standard deviation of the
means from two independent experiments. Where there are no error bars
the data shown is from one experiment.
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compared to control EBs cultured alone (Figure 5.2). At six days of differentiation
the CFU-A activity was only 3.5 times that of control EBs when co-cultured on the
most supportive stromal cell line AM20.1B4 (Figure 5.4). There are several
possible explanations for these observations. There is evidence that in explant
cultures the AGM region develops as in vivo, and thus the appropriate factors for the
development of haematopoietic progenitors are likely to be present at the appropriate
times. Primary cultures of dissociated AGM regions might be more supportive than
stromal cell lines for two reasons. First, primary cultures contain more than one cell
type and second, the effect of irradiation on the stromal cells (the primary cultures
were unirradiated) is unknown. However, when differentiation is extended to ten
days, a 20-fold rise in CFU-A activity was achieved by co-culture on AM20.1B4
cells (Figure 5.6 and 5.7). Here the cell lines may have an advantage over the
explant cultures, where a decrease in haematopoietic activity was seen after seven
days of differentiation (Figure 4.4 and 4.5), because the cell lines provide a constant
source of the inductive signals. Perhaps then explant co-cultures could be improved
further by adding fresh AGM regions to the co-cultures every few days.
In the Introduction to this chapter, it was proposed that the experiments
described above were set up to gain an insight into first, the phenotypes of cells from
the AGM region that supports the haematopoietic differentiation of ES cells; second,
whether cell-cell contact is required and third, if the increased haematopoietic
activity is due to the induction of precursors de novo or proliferation of committed
progenitors.
5.5.1 How do the effects of the stromal cell lines on the haematopoietic
differentiation of ES cells compare with previous findings by others
using these cell lines?
In this study, by six days of differentiation, only the stromal cell line
AM20.1B4 enhances the haematopoietic differentiation of ES cells and the stromal
lines UG26.1B6 and EL08.1D2 appear to have a negative effect (Figure 5.4, 5.6 and
5.7). This is in contrast with previous findings in other studies where, of these three
cell lines AM20.1B4 was by far the least supportive of bone marrow derived
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haematopoietic progenitors in long term cultures as measured by the LTC-CFC
assay, while UG26.1B6 were most supportive (Oostendorp et al., 2002a). Here,
UG26.1B6 stromal cells do support and enhance haematopoietic activity of EBs
when co-culture was extended up to day ten of differentiation and AM20.1B4 cells
continue to enhance the haematopoietic activity of EBs at this time point (Figure 5,6
and 5.7). However, EL08.1D2 cells continue to have a markedly inhibitory effect
(Figure 5.6) in contrast to their ability to support bone marrow derived progenitors
(Oostendorp et al., 2002a). AM20.1B4 stromal cells are more effective at
maintaining LTR-HSCs from El 1 dorsal aorta compared with the UG26.1B6 line
(Prof. Elaine Dzierzak, personal communication). Taken together, these data
highlight a biological difference in maintaining embryonic-derived (from the AGM
region or EBs) compared to adult-derived HSCs (from bone marrow).
5.5.2 Is the increase in haematopoietic activity in the EBs after co-
culture a result of the de novo induction ofprecursors or the
proliferation of committed progenitors?
In the embryonic AGM region both de novo induction and proliferation of
HSCs occurs. It is assumed therefore that the AGM region is a source of signals for
both. Although the data are preliminary, co-culture of EBs on primary AGM region
cells supports this, since both the proportion of EBs with CFU-A activity and the
number of colonies generated from each EB is increased by co-culture. As for the
stromal lines, the data show that UG26.1B6 cells provide a proliferative effect
because co-culture on this cell line does not result in a large increase in the
percentage of EBs that contain CFU-A progenitors (Table 5.2). The increased
haematopoietic activity is also dependent on the "baseline" CFU-A activity in control
EBs and occurs only after an extended period of differentiation (Figure 5.6 and 5.7).
Oostendorp and others (Oostendorp et al., 2002a) have reported that adult bone
marrow derived HSCs maintain their ability to repopulate irradiated recipients even
after four weeks in co-culture with UG26.1B6 stromal ceils and that this cell line was
the most supportive clone tested. However, co-culture with this stromal line did not
induce LTR-HSC activity in a candidate pre-HSC population of CD34+c-kit+ cells
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from early E10 yolk sac and AGM region tissues, at a time before HSC activity is
detected.
The most convincing evidence that the stromal cell line AM20.1B4 has an
inductive effect on the haematopoietic differentiation of ES cells is that co-culture
can result in an increase in the proportion of EBs which give rise to colonies in the
CFU-A assay (Table 5.2). The effects of co-culture on pre-HSCs from yolk sac and
AGM region, as described above, would be interesting and could confirm an
inductive role for AM20.1B4 cells, but this experiment has not yet been performed
using this clone (Prof. Elaine Dzierzak, personal communication).
Combining the AM20.1B4 and UG26.1B6 cells could, in theory, have
exploited the inductive effect of the AM20.1B4 line and the proliferative effect of the
UG26.1B6 cells resulting in greater CFU-A activity in the EBs than from either cell
line used alone. Although 100% of the EBs contained haematopoietic progenitors,
the mean number of CFU-A colonies per EB was not as high as had been
hypothesised. A possible explanation is that the negative effect UG26.1B6 cells
have on the haematopoietic differentiation during the first days of co-culture might
have quenched the inductive effect of the AM20.1B4 cells. This may have been
exacerbated by a larger proportion of UG26.1B6 cells within the cultures because
that cell line grows more quickly than the AM20.1B4 line and equal numbers of cells
from both lines were seeded and then grown to confluence over two days prior to
irradiation and co-culture. It would be useful to fully establish the time course of
activity by the stromal cells during EB differentiation. Then a two-step co-culture
strategy could be employed that might exploit the respective inductive and
proliferative properties of the cells lines more fully and might also reflect more
accurately the development of HSCs in vivo.
The apparently inhibitory effect on the haematopoietic activity of EBs co-
cultured on UG26.1B6 cells during the first days of differentiation and on EL08.1D2
cells throughout is interesting. Both cell lines are unable to induce repopulating
activity in pre-HSCs from the yolk sac and AGM region (Oostendorp et al., 2002a).
Such inductive activity has been previously reported using the AGM region derived
stromal cell line AGM-S3 (Matsuoka et al., 2001). The foetal liver at El 1-12 is not
yet a highly supportive microenvironment for HSCs, as shown by organ culture
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experiments (Medvinsky and Dzierzak, 1996) and by the small number of supportive
stromal cell lines generated from this tissue in the panel by Oostendorp (Oostendorp
et al., 2002b). The primary haematopoietic function of the El 1-12 liver may be to
generate mature cells from HSCs migrating from the AGM region and yolk sac
(Kumaravelu et al., 2002). Perhaps EL08.1D2 cells might have a differentiating
effect on ES derived haematopoietic progenitors, which could be measured using an
assay that detects more mature cells such as the methylcellulose assay. Oostendorp
and his colleagues (Oostendorp et al., 2002b) tested the stromal cell line supernatants
for CFC-promoting activity on adult bone marrow cells in methylcellulose cultures
by using conditioned medium from the stromal cell lines in place of the pokeweed
mitogen-stimulated spleen cell-conditioned medium (PWM-SCM). They found that
all cell lines produced supernatants that were able to support the differentiated
growth of the CFCs. Supernatant from the primary line EL08 from which the clone
EL08.1D2 was derived, was one of the most efficient, supporting a differentiative
role of the EL08.1D2 cells. Interestingly, EL08.1D2 cells were found to be by far
the most supportive (several hundred fold), as compared to other stromal cell lines
including the other two in this study, of human cord blood CD34+ cells in long term
culture as measured by the CAFC assay. In fact their long term repopulating ability
was also maintained by co-culture on this clone and UG26.1B6 cells (Kusadasi et al.,
2002). The UG26.1B6 and EL08.1D2 cell lines might also be involved in regulating
the de novo induction of haematopoietic progenitors.
The assessment of self-renewal capacity of ES cells after serial passage of ES
cells on the stromal cell lines provided further insight into the inductive and
proliferative properties of these stromal cell lines (Figure 5.8). The experiment was
originally set up to examine whether any of the stromal cell lines could support
undifferentiated ES cells, because of the decreased CFU-A activity in EBs after co-
culture on UB26.1B6 and EL08.1D2 cells.
The AM20.1B4 line was the only line to provide any support for
undifferentiated ES cells. This was unexpected since CFU-A activity in EBs was
enhanced. After two passages (four days) the number of colonies expressing AP
appeared to have stabilised, indicative of the intriguing possibility that a balance
between self-renewal and differentiation had been established. An indicator of self-
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renewal and differentiation potential of the clonogenic cells is the presence of
colonies with both AP+ ES cells and AP differentiated cells ("mixed" colonies see
Figure 2.5). The three types of colonies (ES cell, mixed and differentiated) were not
quantified in this experiment due to the number of cells plated, but it will be
interesting to determine whether an increased number or proportion of "mixed"
colonies are a consequence of culture on AM20.1B4 (or other) stromal cell lines.
UG26.1B6 cells promoted the differentiation of ES cells very rapidly (within 2-3
passages), with no support of undifferentiated self-renewing ES cells. Co-culture of
EBs on EL08.1D2 cells resulted in almost no differentiation into cardiomyocytes or
haematopoietic progenitors, raising the possibility that this cell line might be
inhibiting or delaying the differentiation of ES cells, but EL08.1D2 cells did not
maintain undifferentiated ES cells. Taken together, these data suggest that
EL08.1D2 stromal cells promote differentiation into lineages not measured by the
assays used in this study. In addition, when an ES cell line expressing GFP targeted
to the mesodermal specific brachyury gene (Fehling et al., 2003); a kind gift from
Prof. Gordon Keller) were cultured on EL08.1D2 cells, no GFP* cells were detected
by fluorescence microscopy at the time point (up to 5 days) when control brachyury-
GFP ES cells cultured on control OP9 cells were mostly GFP* (>90%) (A.K.,
unpublished). GFP+ colonies were also generated after co-culture with AM20.1B4
cells and UG26.1B6, but these were not quantified (A.K., unpublished). These data
are indicative of a signal from EL08.1D2 stromal cells that blocks or delays the
commitment to mesodermal fates.
Two additional and potentially significant observations were made. First,
although the control ES cells cultured on gelatin without LIF regained their self-
renewal capacity after three passages (six days), ES cells cultured on either of the
stromal cell lines did not. In the case of UG26.1B6 and EL08.1D2 cells this suggests
a strong drive towards differentiation, but for AM20.1B4 cells that have a limited
capacity to support undifferentiated ES cells it is surprising. A possible explanation
could be that a balance self-renewal and differentiation has been established, but
again, quantification of the colonies is necessary to explore this possibility.
Second. ES cells cultured on the stromal cell lines had an increased tendency
to generate large differentiated AP colonies compared to control ES cells cultured on
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gelatin in the absence of L1F. To highlight this, duplicate wells were counterstained
with trypan blue (Figure A.5 in Appendix). Large, differentiated colonies are not
usually generated by ES cells that have been cultured without LIF, probably because
of a decrease in seeding efficiency and proliferation in differentiated ES cells, or
because of cell death on differentiation, which has previously been detected by DNA
laddering (Mehlen et al., 1997) and the TUNNEL assay (A.K., unpublished). These
data are in support of a production of factors by the stromal cell lines, especially
UG26.1B6, that promote cloning efficiency, cell proliferation or cell survival.
5.5.3 Are the factors that increase the haematopoietic activity of
differentiating EBs dependent on direct cell-cell contact or secreted
molecules?
Data from two experiments support a contact dependent mechanism. First,
when using primary cultures of adherent AGM region derived cells as "feeders" the
CFU-A activity in co-cultured EBs was only increased (compared to the control EBs
cultured alone) when there was direct contact; no increase was observed when EBs
were cultured in transwell inserts suspended over the AGM region cells (Figure 5.1).
Second, there was no significant effect on the CFU-A activity, either in the
proportion of EBs containing progenitors or the total number of colonies produced
from dissociated EBs, when cultured in conditioned medium from the stromal cell
lines AM20.1B4, UG26.1B6 and EL08.1D2 (Figure 5.6). However, the
haematopoietic activity of the EBs in these experiments was assessed after only six
days of differentiation; it may be interesting to extend the culture especially because
the increase in CFU-A activity caused by co-culture on UG26.1B6 cells was not
detected at day six. However, Harvey and Dzierzak (Harvey and Dzierzak, 2004)
demonstrated that the support of haematopoietic progenitors, isolated from Ell
aorta, was more efficient in contact co-cultures using UG26.1B6 cells than non-
contact co-cultures. This was also observed in co-culture experiments with two other
stroma! cell lines derived from the urogenital ridge. Furthermore, contact with the
UG stromal clones (including UG26.1B6) was essential for the maintenance and
expansion of midgestation aortic HSCs. Another group (Xu et al., 1998)
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demonstrated that the expansion of clonogenic progenitors (CFU-GM, BFU-E and
CFU-mix) from human cord blood-derived CD34+ cells by the El0.5 AGM region
stromal cell line AGM-S3 was dependent on direct cell-cell contact. Ohneda et al
(Ohneda et al., 1998) reported that lin"CD34+Sca-l+c-kit+ foetal liver FISCs were
expanded 2,600 fold after direct co-culture on the AGM region derived endothelial
cell line DAS 104-4, but only 70 fold after non-contact co-culture, and only the cells
harvested from contact co-cultures were capable of repopulating the haematopoietic
system of lethally irradiated adult mice. It would also be interesting to investigate
the role of cell-cell contact in the increase in cardiomyocyte differentiation resulting
from EB and UG26.1B6 clone co-culture. Again the possibility of a high
concentration of short-range secreted molecules cannot be ruled out.
5.5.4 What are the phenotypes of the cells responsible for the
haematopoietic-promoting activity of differentiating ES cells?
Confirming the findings of both Oostendorp et al (Oostendorp et al., 2002a;
Oostendorp et al., 2002b) and Charbord et al (Charbord et al., 2002), the stromal cell
lines AM20.1B4, UG26.1B6 and EL08.1D2 do not express endothelial or
haematopoietic lineage surface antigens, but they do express CD44, V-CAM,
integrin subunits a5 and (3,and low levels of Sca-1 (Figure 5.3 and Table 5.1).
Similar observations have been made on examining stromal cell line AGM-S3 (Xu et
al., 1998). CD44, VLA-4 and VLA-5 (consisting of integrin subunits a4|3, and a5(3,,
respectively) and V-CAM have been found to play important roles in haematopoietic
development by allowing haematopoietic progenitors to interact with the stromal cell
and extra-cellular matrix components of their "niches" (Chan and Watt, 2001). Sca-1
has been associated with the haematopoietic supporting activity of stroma (Remy-
Martin et al., 1999; Satoh et al., 1997). However, although there is a variable effect
of co-culture with the stromal cell lines both on the differentiation of ES cells
observed in the present study and on embryonic and adult haematopoietic
progenitors in other studies (Charbord et ai., 2002; Oostendorp et al., 2002a;
Oostendorp et al., 2002b), no overt correlation to the levels of membrane antigen
expression was found. It is unlikely the higher expression of integrin a5 (CD49e) is
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solely responsible for the inductive properties of the AM20.1B4 stromal cell line.
Interestingly, the AM20.1B4 cell line was the only clone (out of the three used in this
study), on which surface expression of SCF was detected by flow cytometry
(Oostendorp et al., 2002b), which is also in support of a direct cell-cell contact
dependent mechanism.
Although the conditioned medium collected from the stromal cell lines had
no effect on ES cell differentiation in this study, the production of haematopoietic
cytokines is nonetheless interesting. The stromal cell lines were found to express the
transcripts of several haematopoietic cytokines including TPO, SCF, FL, G-CSF, IL-
1(3,11-6, II-11 and Oncostatin M (Oostendorp et al., 2002a; Oostendorp et al., 2002b).
Again there was no correlation to the cytokine profile and haematopoietic supporting
activity of the supernatants taken from the cell lines. 11-3 was not detected in any of
the cell lines examined by RT-PCR but this may not be significant to the
haematopoietic inducing function of the cell lines because 11-3 acts in combination
with other cytokines and the inactivation of its receptor in vivo does not result in a
major haematopoietic defect (Nicola et al., 1996; Nishinakamura et al., 1996).
Interestingly, the three stromal cell lines used here expressed 11-6 and the Il-6a
receptor. 11-6 has recently been reported to be an important factor in the
haematopoietic-supporting activity of bone marrow stroma (Rodriguez Mdel et al.,
2004). The detection of low levels of LIF transcript in UG26.1B6 cells by RT-PCR
by Oostendorp and colleagues (Oostendorp et al., 2002b) was surprising since
passage on this cell line appears to promote differentiation of ES cells, as determined
by the loss of AP expressing colonies, at a faster rate than when cultured on gelatin
in the absence of LIF (Figure 5.8). However, the levels of LIF could be too low to
maintain ES cells in an undifferentiated state. EL08.1D2 do not appear to express
the LIF transcript and this data is unavailable for AM20.1B4 cells (Oostendorp et al.,
2002b). Another interesting observation by Oostendorp et al (Oostendorp et al.,
2002b) was the expression of TGF-|31 by most of the stromal cell lines tested
(though again AM20.1B4 cells were excluded from this analysis). TGF-|31 is
thought to have a strong negative effect on HSCs (Ohta et al., 1987) and it might
play a regulatory role in controlling numbers of early progenitors and perhaps help
explain the initial negative effect on haematopoietic differentiation of ES cells by the
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UG26.1B6 cells, which express high levels of TGF-|31. Co-culture of EBs on
UG26.1B6 cells greatly increased the differentiation to "beating" cardiomyocytes
(Figure 5.9). TGF-|31 is known to be involved in cardiac development and function
(Azhar et al., 2003) and induces cardiomyocyte differentiation of ES cells (Behfar et
al., 2002).
Taken together, these data show that a complex network of interactions and
signals controls the induction, proliferation and differentiation events during
haematopoietic development and that subtle differences in expression levels are more
likely to be responsible than single factors. Such an extensive panel of stromal cell
lines is a powerful tool for elucidating these interactions and for the isolation of
novel factors. For example, Ohneda et al (Ohneda et al., 2000) identified a novel
chemokine Weche from the AGM region derived endothelial cell line DAS 104-4.
5.5.5 Summary
It is important to note for the present study that the stromal cell lines
AM20.1B4, UG26.1B6 and EL08.1D2 were derived from embryos at different
developmental stages. The AM20.1B4 clone was derived from E10 AGM region,
whereas UG26.1B6 and EL08.1D2 cells were derived from Ell genital ridge and
liver respectively. Explant cultures of intact El0.5 AGM regions were more
effective at promoting the haematopoietic differentiation of ES cells than the El 1.5
equivalents, while liver explant cultures had no effect (Figure 4.3). Perhaps EB and
stromal cell line co-cultures merely reflect this observation.
In summary, co-culture experiments with the stromal cell lines and primary
cultures of dissociated AGM regions have shown that (i) both induction and
proliferation of haematopoietic progenitors contribute to the increase in CFU-A
activity of differentiating ES cells, (ii) the factor(s) responsible are dependent on
direct cell-cell contact and (iii) no obvious correlation to a specific cell phenotype
has been established. However, explant cultures of intact AGM regions provide the
best microenvironment for the haematopoietic differentiation of ES cells; after six
days of differentiation CFU-A activity is increased 20 fold compared to control EBs
cultured alone (Figure 4.4).
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Further investigations are underway to elucidate the time course of
haematopoietic progenitor induction/proliferation by these three stromal cell lines
during ES cell differentiation by a combination of colony assays and co-culture of
ES cells transgenic for reporter genes under the control of loci associated with
haematopoietic commitment and differentiation, such as brachyury, Flkl, Tall/Scl,
c-kit and Amll/Runxl. The possibility of using the stromal cells as an induction
screen for the selection of genes involved in early haematopoietic commitment
identified by gene trapping strategies is also being explored.
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Chapter Six: Investigating the Ubc7 null phenotype
6.1 Aim
To investigate a potential haematopoietic phenotype of a mutant deficient in
the mouse homologue to the yeast ubiquitin conjugating enzyme (Ubc7).
6.2 Introduction
During a screen designed to identify novel developmentally regulated genes
using a gene trap strategy, one of the integrations, GT246, trapped the Ubc7 gene
and functionally disrupted its encoded protein. The GT246 ES cells were injected
into blastocysts and transmitted the gene trap through the germline. Generation of
homozygous animals showed that absence of mUbc7 resulted in an embryonic lethal
phenotype. The cause of a lethal phenotype can be difficult to dissect out. Strategies
can be implemented to do this, such as tissue restricted or inducible deletions or the
generation of chimeras with ES cells homozygous null for the gene trap integration
to examine whether any lineages are devoid of ES cell progeny, but they can be
difficult, time consuming and expensive. A rapid in vitro approach would be useful.
It was previously noted that some of the homozygous mutant embryos
appeared anaemic, so haematopoietic tissues (yolk sac and AGM region) were
examined. Two observations made from the experiments described in this thesis
could be applied to rapidly investigate a potential haematopoietic defect in the
mutants in vitro. First, the increase in CFU-A progenitors observed in AGM region
explant cultures (see Chapter 3) and second, the ability of the AGM region to
enhance the haematopoietic differentiation of ES cells in co-culture (see Chapter 4).
It was postulated that a mutation affecting the generation and/or expansion of early
haematopoietic progenitors would affect the formation of colonies in the CFU-A
assay. Subsequently, distinguishing between a defect intrinsic to the
HSC/progenitors, or a non-autonomous defect in the inductive/supportive elements
of the stromal rnicroenvironrnent, could potentially be done by investigating the
capacity of the mutant AGM region to increase the haematopoietic potential of
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normal ES cells during in vitro co-culture. This chapter describes the experiments,
which were carried out to identify the cause of death in the mutant embryos.
The gene trap screen, the identification of the trapped sequence and the initial
characterisation of the phenotype in vivo were done by Dr Julie Wallis under the
direction of Dr Lesley Forrester.
6.2.1 Background
Mutational analysis has been important for our understanding of embryonic
development and the genes involved. Random mutational strategies using
irradiation, which causes large chromosomal rearrangements (Russell, 1951), or
chemical agents such as ENU, which induces point mutations (Russell et al., 1979)
have generated a large number of mutants (Balling, 2001; Justice et al., 1999;
Thomas et al., 1998). Such screens are phenotype driven looking primarily for
mutants with specific phenotypes before investigating the genetic cause. Similarly,
random insertional mutagenesis with retroviral vectors has resulted in a number of
transgenic mouse strains, but this strategy often results in multiple integrations and a
tendency for integration into specific regions. Directed mutagenesis by homologous
recombination in ES cells to "knock-out" specific sequences have been very useful,
but prior knowledge of the genomic structure is essential to construct the targeting
vectors. Several genetic loci have also been identified using entrapment strategies,
such as gene trapping (see section 6.2.1.1).
6.2.1.1Gene trapping
Gene trapping is a technique, which is used to identify and characterise the
function of novel genes. The random insertion of a non-homologous construct,
containing a promoterless reporter gene (e.g. LacZ), into the intron of an active gene
in ES cells generates a fusion between the reporter gene and the endogenous trapped
gene (Figure 6.1). There are three important consequences of such insertion events:
(i) expression of the reporter gene is controlled by the endogenous gene, (ii) the
fusion transcript generated allows the endogenous gene sequence to be cloned and








Figure 6.1 Gene trapping, (a) A gene trap vector containing a splice
acceptor, |3-geo (Lac Z reporter fused to the neomycin resistance gene) and a
polyadenylation signal integrates into an intron of a gene at random, (b) The
gene trap is now under transcriptional control of the endogenous promoters
and enhancers. The presence of the splice acceptor in the construct and the
endogenous splice donor results in a fusion transcript between the trapped
gene and |3-geo, which is (c) translated to from a fusion protein. The trapped
protein is often truncated, depending on the site of integration. E = enhancer,
P = promoter, SA = splice acceptor, SD = splice donor
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the biological consequences may be analysed after germ-line transmission. Several
important genes have been identified using gene trapping strategies for example
Hs2st, encoding heparan sulfate 2-sulfotransferase the transcripts of which were
disrupted by the vector integration resulting in renal agenesis (Bullock et al., 1998).
A concerted international effort is being made to achieve saturation of the
mouse genome by generating gene trap integrations representing all of the ca. 30,000
genes. A biotechnology company, Lexicon Genetics, has created to date the largest
library of ES cell lines (OmniBank; http://www.lexicon-genetics.com). They claim
to have achieved close to 60% coverage of the genome in 200,000 tags. Several
academic groups initiated the International Gene Trapping Consortium (IGTC;
http://www.igtc.ca) and are making their trapped ES cell lines available in the public
domain without restriction. So far that library covers 32% of the genome in 27,000
tags and, one fifth of those are not represented by Lexicon (Skarnes et al., 2004).
Trapped genes are identified or characterised by (i) the sequence around the
integration site, (ii) the expression pattern in heterozygous mice after germline
transmission through chimeras or (iii) the phenotype, if any, of animals homozygous
for the integration after breeding heterozygotes (Gossler et al., 1989; Skarnes et al.,
1992). The in vivo approaches are very laborious and expensive, particularly
because only 15-30% of the integrations, which have randomly trapped genes
expressed in undifferentiated ES cells, exhibit restricted expression patterns during
embryogenesis (Friedrich and Soriano, 1991; Wurst et al., 1995). The unique
capacity of ES cells for multulineage differentiation in vitro has been exploited to
develop screening strategies to select gene trap clones for germline transmission that
are likely to be involved in the development of a particular lineage (Hirashima et al.,
2004; Stanford et al., 1998).
An in vitro pre-selection screen for genes responsive to retinoic acid (RA)
was performed to enrich for insertions into genes that are involved in embryogenesis
(Forrester et al., 1996). RA, the active metabolite of vitamin A, is known to have a
profound effect on development in vivo. The application of exogenous RA to
embryos (Conlon and Rossant, 1992; Kessel and Gruss, 1991; Morriss-Kay et al.,
1991) or differentiating EC cells in culture (Kondo et al., 1992) can alter the
expression of developmentally regulated genes and is therefore applied to in vitro
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models of tissue specification and differentiation using ES cells. For example RA
enhances differentiation down neural lineages and represses commitment to
haematopoietic or, at certain concentrations, cardiac fates (Bain et al., 1996; Wobus
et al., 1997). The screen that resulted in the trapping of GT246 was designed to
enrich for genes involved in cardiogenesis and, as described below, colonies where
(3-galactosidase activity was repressed by RA treatment were picked for further
analysis.
6.2.1.2 The GT246 gene trap event
Gene trap vectors pGTO, 1 and 2, containing an En-2 splice acceptor site (in a
different reading frame in each of the three constructs) fused to (3-geo (LacZ reporter
fused to the neomycin resistance gene) (Figure 6.2a), were introduced into El4 ES
cells by electroporation. Electroporated cells were plated in the presence of G418.
Resistant colonies were picked, and replicate cultures were treated with RA. Clones
where the expression of LacZ was suppressed by the addition of RA were then
differentiated into "beating" cardiomyocytes, which were recorded on video and then
again stained with X-gal. Those clones where (3-gal was expressed in the "beating"
regions were selected for further analysis.
Endogenous gene sequences upstream of the gene trap vector's fi-geo
sequence were isolated by Rapid Amplification of cDNA Ends (RACE) -PCR
cloning. A 115bp DNA sequence of one clone, GT246, was used to search the
mouse Expressed Sequence Tag (EST) database and a 2030bp contig was
constructed from these ESTs. Interestingly, there appeared to be two contigs, one
had a 925bp alternatively spliced 3' end. A BLAST search of the predicted 152
amino acid (aa) sequence identified it as the mouse ubiquitin conjugating enzyme
homologous to Ubc7 in S. cerevisiae (GenBank™ accession number X 69100) with
63% identity. MUbc7 is highly conserved showing 94% identity to the human E2G2
protein (GenBank™ accession number AF 296657), 74% identity to Ubcl4
(GenBank™ accession number NP 493381) in C. elegans and 58% identity to Ubcl3
(GenBank™ accession number T 45703) in A. thaliana. The genomic structure
consisting of six exons was obtained from the UCSC web browser
(http://www.genome.ucsc.edu) (Figure 6.2) and is located on chromosome 10. A
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Figure 6.2 Consequences of the gene trap integration GT246 into the mouse
ubiquitin conjugating enzyme Ubc7. (a) Schematic representation of the genomic
structure of Ubc7. The site of integration of the gene trap vector between exons 1 and
2 is shown, (b) Northern blot showing the relative levels of Ubc7 mRNA in wildtype,
heterozygous and homozygous GT246 embryos. The probe was a P32dATP labelled
1.1 kb EcoRI/Notl fragment of EST W18096(J 131). 10mg E10.5 RNA was loaded in
each lane except the second -/- lane, where 10.9mg was loaded. GAPDH was used as
a control. The gene trapping, RACE-rCR, cloning, sequence analysis and Northern
hybridisation was done by Dr Julie Wallis. aa = amino acid, +/+ = wildtype, +/- =
mUbc7Gt246For/+ -I- = mUbc7Gt246For/Gt246For
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165aa splice variant of mUbc7, which differs at the 3' end (GenBank™ accession
number AAH 10321), has been reported to play a role in the degradation of
unassembled T cell receptor subunits from the endoplasmic reticulum (Tiwari and
Weissman, 2001).
The gene trap vector integrated into an intron and was spliced onto the end of
exon 1 at aal5, upstream of the predicted catalytic domain (aa24-141) of the 152aa
protein producing a functional knockout (Figure 6.2). Northern analysis, using a
probe against the 3' end of the gene showed complete loss of the Ubc7 transcript in
the homozygous embryos, and lower levels of expression in the heterozygotes
compared to wildtype (Figure 6.2(b)).
6.2.1.3 The Ubc7/E2G2 ubiquitin conjugating enzyme
The ubiquitin conjugating enzymes (Ubc or E2) are constituents of the
ubiquitin-proteosome pathway, a major system for the selective breakdown of
proteins in eukaryotes. Target proteins are conjugated to the activated ubiquitin
polypeptide as a tag for degradation by the 26S proteosome complex. This process
involves the sequential action of three classes of enzymes. First the ubiquitin
activating enzyme (Uba or El) forms a thiolester bond with the C terminus of
ubiquitin, which is transferred to a specific cysteine residue on the E2. E2 enzymes
donate ubiquitin to the target protein by catalysing the formation of an isopeptide
bond, directly or with the involvement of an ubiquitin-protein ligase enzyme (Ubr or
E3) (Figure 6.3). Targets of this pathway are proteins whose levels need to be
tightly regulated, including cyclins, cyclin-dependent kinase inhibitors, transcription
factors, the tumour suppresser protein p53 and various oncoproteins (Ciechanover,
2003; Pickart, 2004).
6.2.1.4 The mUbcTphenotype
Animals homozygous for the GT246 gene trap integration (ubC7G,246For/G,246F"r)
did not survive and the embryos died around day 11.5 of gestation on both inbred
(129) and outbred (MF1) backgrounds. Staining of E8.5 and E10.5 embryos with X-
gal showed LacZ expression was ubiquitous with higher levels in the forebrain














Figure G.3 Ubiquitin-dependent protein degradation pathway
(a) E8.5 (b) E9.5
Figure 6.4 Expression and phenotype of the GT246 gene trap integration
into mUbc7. Heterozygous and homozygous embryos at E8.5 and E10.5
stained with X-gal shows the ubiquitous expression of of the LacZ reporter with
higher levels in the forebrain. (a) At E8.5 the allantois of Ubc7-/- embryos
appears shortened and cylindrical in shape compared to heterozygous embryos
which are phenotypically normal, (b) At E9.5 the neural tube has failed to close
in Ubc7/- embryos. X-gal staining was done by Julie Wallis. +/+ = wildtype, +/- =
mUbc7Gt246For/+, -I- = mUbc7Gt246For/Gt246Fo' al = allantois, fb = forebrain, nt =
neural tube
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E8.5 the allantois appears shortened and cylindrical in shape (Figure 6.4(a)). At
E10.5 the homozygotes have an abnormal neural tube, which has failed to close
(Figure 6.4(b)). Heterozygous embryos look phenotypically normal and survive
(Table 6.1). Histological sections of the E10.5 head revealed that the
neuroepithelium of the mutant embryos is defined and smooth and does not appear to
be damaged. Wholemount in situ hybridisation with a probe against Wnt8B shows
that the forebrain in the mutant is specified but the neural folds fail to fuse (Figure
6.5).
It seems unlikely that the early embryonic death of the ujjCyGt246ForlGt246For
mice is due to the complete failure of neural tube closure. Of the fifty known single
gene mutations that result in neural tube defects (NTD) in mice, most also cause
severe embryonic lethal syndromes, but the NTD is a non-specific feature (Copp et
al., 2003; Juriloff and Harris, 2000). Furthermore, the absence of a protein, such as
Ubc7, with an essential role in a basic cellular pathway could be hypothesised to
effect multiple distinct tissues or biological systems in an organism.
6.2.1.5 Possible haematopoietic phenotype
The rare embryos that survived beyond El 1.5 appeared to be anaemic, which
indicated that Ubc7 may be involved in haematopoiesis. It has been reported that
haematopoietic progenitors and bone marrow stroma have binding sites for ubiquitin,
which may participate in the homing and binding of haematopoietic cells to the
stroma of the bone marrow and spleen (Parakh and Kannan, 1993). Ubiquitin may
also be involved in the binding of haematopoietic cells to the stroma in the early
embryo, which would by mediated by an ubiquitin conjugating enzyme, such as
Ubc7. Therefore, the absence of Ubc7 could result in a failure to conjugate ubiquitin
to the haematopoietic or stromal cells so that they were unable to bind to each other,
disrupting haematopoiesis.
Gene targeting studies have revealed many genes involved in the generation
and maintenance of haematopoiesis (reviewed in section 6.5 and Chapter 1:
Introduction). The main haematopoietic defects resulting from the absence of these
genes are threefold: (i) disruption of primitive and definitive haematopoiesis, (ii)






E9.5 6 14 8
E10.5 24 41 20
E11.5 4 12 0
adult (6-8 wks)* 61 105 0
Table 6.1 Frequencies of midgestation embryos and adult mice according to
genotype. +/+ = wildtype, +/- = mUbc7Gt246For/+, -I- = mUbc7Gt246For/Gt246For, wks =
weeks, * = age when genotyped
Figure 6.5 Expression of Wnt8B at E10.5 highlights failure of neural tube
closure in homozygous embryos. In situ hybridisation with a probe against Wnt 86,
which is expressed in a restricted pattern where the neural folds meet and fuse to form
the dorsal midline of the prosencephalon of the developing forebrain. +/+ = wildtype, -/-
= mUbc7Gt246For/Gt246For
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precursor migration and colonisation. This chapter describes the experiments
performed to examine the mutant embryos for a putative haematopoietic phenotype.
6.3 Experimental approach
• Determine whether there is a defect in primitive haematopoiesis by comparing
the numbers of haematopoietic progenitors in the yolk sacs of wildtype,
heterozygous or homozygous embryos at E9.5 and El0.5, as measured by the
CFU-A assay.
• Determine whether there is a defect in definitive haematopoiesis by comparing
the numbers of haematopoietic progenitors in the AGM regions of wildtype,




To measure the level of primitive haematopoietic activity in the mutant
IjfyCyG'246For/G,246For embryos compared to their wildtype and heterozygous littermates,
the CFU-A assay was set up with cells isolated from individual dissected yolk sacs
from E9.5 and EIO.5 embryos. Ubc7G'246For/G,246For embryos could be identified
immediately on dissection by the open neural tube, but all of the embryos were
genotyped by the level of (3-galactosidase activity in the head after staining with X-
gal (see Chapter 2: Materials and Methods, section 2.9).
Initially, the intact yolk sacs were viewed under a dissecting microscope to
determine whether those from homozygous embryos appeared more anaemic in
comparison to those from wildtype or heterozygous embryos, potentially indicating
defective erythropoiesis. Although the apparent development of the vasculature and
the "redness" visible within the vessels varied between the embryos (particularly at
El0.5), no obvious correlation to genotype was observed (data not shown) and
further quantitation of these observations was not carried out.
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There was also no significant difference in the CFU-A activity of yolk sacs
from wildtype, heterozygous or homozygous null littermates at 9.5 and 10.5 days of
gestation (Figure 6.6 and Table 6.2). At E9.5 the number of CFU-A colonies (per
3xl04 cells) ranged from 0.3 to 3.7 from wildtype-, 0 to 0.3 from heterozygous- and
0 to 14.5 in homozygous yolk sacs. The numbers of CFU-A colonies (per 3xl04
cells) in the yolk sacs from El0.5 littermates showed a high level of variation, which
was irrespective of genotype ranging from 0.3 to 103.3 from wildtype-, 1 to 124.7
from heterozygous- and 0 to 137 from homozygous embryos. The CFU-A activity in
yolk sacs at E9.5 was much lower than at El 0.5. A similar time course has also been
shown using the HPP-CFC assay (Palis and Yoder, 2001). Different strains were
used as the sources of the yolk sacs for the two time points, E9.5 yolk sacs were
dissected from F1 CBA x 129 embryos, while outbred MF1 mice were used for
experiments at E10.5, because although the initial experiments were done on 129/Sv
x CBA/Ca mice, the outbred MF1 mice were used subsequently as they produce
larger litters. The variation between the two experiments conducted with E10.5 yolk
sacs (illustrated respectively by red and blue open circles in Figure 6.6(b)) could
reflect a slight difference in gestational age of the litters or variable quality of the
disassociation of the yolk sacs for plating in the CFU-A assay.
6.4.2 Definitive haematopoiesis
Ubc7G,246For'Gt246For embryos die prior to foetal liver haematopoiesis, so in order
to determine whether there was a defect in definitive haematopoietic activity in the
mutant embryos compared to their wildtype and heterozygous littermates, the AGM
region was examined. In the AGM region, the production of HSCs peaks by day
11.5 of gestation (see Chapter 1: Introduction) as does the CFU-A activity (Figure
3.1). Here the CFU-A assay was again used to measure haematopoietic activity,
however no viable homozygous embryos were obtained for analysis at El 1.5.
Therefore, AGM regions dissected from El0.5 embryos were used, but at this age the
number of detectable CFU-A progenitors in the AGM region is very low (Figure
3.1). CFU-A activity in the AGM region increases during organ culture (Figure


















































































































































































Figure 6.6 Primitive haematopoiesis in Ubc7 deficient embryos. CFU-A
activity in yolk sacs dissected from (a) E9.5 CBA x 129 (b) E10.5 MF1
embryos. Each data point represents the number of colonies per 3x104 cells
from individual yolk sacs. Bars f-) show the mean number of colonies. The
number of yolk sacs of each genotype analysed is shown. +/+ = wildtype, +/- =
mUbC/Gl246Fu,/* -I- — mUbC/G^24QFuitASl246Fw
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measurable levels. The experiments were done using both outbred (MF1) and F1
(129/Sv x CBA/Ca) mouse strains. All the data are summarised in Table 6.1.
In the outbred (MF1) strain the number of CFU-A colonies (per 3xl04 cells)
in E10.5 AGM regions after six days in organ culture ranged from 11.3 to 114.7 from
wildtype-, 23.3 to 129.7 from heterozygous- and 64 to 106 from homozygous
littermates (Figure 6.7(a)). No significant difference was found between the
homozygous and wildtype or heterozygous littermates (p < 0.81 and p < 0.27
respectively) according to the Mann-Whitney U Test.
In the F1 (CBA x 129) mice there were significantly fewer CFU-A colonies
(per 3xl04 cells) detected in the cultured AGM regions of ubcT0'246^10'24^ embryos
(0 to 42.3) compared to wildtype (76 to 191) and heterozygous (0 to 240.5)
littermates, p < 0.003 and p < 0.001 respectively as determined by the Mann-
Whitney U Test (Figure 6.7(b)).
Cultured AGM regions from E9.5 embryos were then analysed to rule out the
possibility that the lower overall CFU-A activity in the F1 at E10.5 was not simply
because the embryos were dying, although those embryos had been excluded from
the analysis. The data from MF1 and CBA x 129 embryos were combined because
the number of embryos obtained was small. At E9.5 there were significantly fewer
CFU-A colonies (per 3xl04 cells) from homozygous null AGM regions after six days
in culture (0 to 4.7) compared to wildtype (3.3 to 96) and heterozygous embryos (1
to 77.3), p < 0.05 and p < 0.016 respectively as determined by the Mann-Whitney U
Test (Figure 6.8).
6.4.3 Potential cardiac phenotype
Analysis of embryos at E9.5 reveals a consistent heart defect associated with
loss of Ubc function. A comparison of wild type or heterozygous control embryos
with (j/yCyGt246Fnr/Gt246For embryos, identified a subtle rightward displacement of the left
ventricle and bulbo-ventricular groove (data not shown). Furthermore, one of the
four homozygous null embryos examined at E9.5 had additional heart defects




















































Figure 6.7 Definitive haematopoiesis in Ubc7 deficient embryos at E10.5.
CFU-A activity in cultured E10.5 AGM regions dissected from (a) outbred MF1
and (b) F1 CBA x 129 embryos. Each data point represents the number of
colonies per 3x104 cells from individual AGM regions cultured for 6 days. Bars (-)
show the mean number of coionies. The number of aGm regions of each
genotype analysed is shown. P values are indicated for homozygous embryos
against wildtype (+/+p) and heterozygous (+/-p) embryos respectively. +/+ =










































Figure 6.8 Definitive haematopoiesis in Ubc7deficient embryos at E9.5.
CFU-A activity in cultured E9.5 AGM regions dissected from outbred MF1 p) and
F1 CBA x 129 <Q ) embryos. Each data point represents the number of colonies
per 3x104 cells from individual AGM regions cultured for 6 days. Bars (_ ) show
mean number of colonies. The number of AGM regions of each genotype
analysed is shown. P values are indicated for homozygous embryos against
wildtype (+/+p) and heterozygous (+/"p) embryos respectively. +/+ = wildtype, +/- =
mUbc7Gt246For/+ -/- = mUbc7Gt246For/Gt246For
+/+ -/-
A-V
Figure 6.9 Cardiac defect in Ubc7 deficient embryos. Embryos at
E9.5 showing normal wildtype heart and defect in mutant. The bulbus
cordis and outflow tract region are displaced such that they sit rostral of
the left ventricle and not right lateral as in controls. In addition, the A-V
canal fails to form. The lower panels show the heart region as indicated
+/+ = wildtype, -/- = mUbc7Gt246For/Gt246For, be = bulbus cordis
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sit rostral of the left ventricle and not right lateral as in controls. The atrio¬
ventricular (A-V) canal also fails to form (Alistair Watt, personal communication).
The time of death coincides with that of known genetic mutations affecting
the looping of the heart tube during development (Lin et al., 1997; Lyons et al.,
1995; Niederreither et al., 2001), but histological sections are needed to confirm
whether the heart is abnormal in these embryos.
6.5 Discussion
Haematopoiesis in the early embryo is sustained by yolk sac-derived
precursors (erythromyeloid cells) until haematopoiesis from intraembryonic sites is
initiated. Null mutations affecting primitive haematopoiesis are normally lethal
between E8.5 to 10.5 for example, Flkl (Shalaby et al., 1995), Tall/Scl (Robb et al.,
1995), Lmo2 (Warren et al., 1994) which is slightly earlier than the mutation caused
by the GT246 gene trap integration into the Ubc7 gene. However GATA-1 deficient
embryos die at E10.5 to 11.5 due to an arrest in primitive erythropoiesis (Pevny et
al., 1991), so a primitive haematopoietic defect was considered possible. The data
demonstrate however that Ubc7 deficiency is not detrimental to primitive, yolk sac-
derived haematopoiesis.
Definitive, adult-type HSCs are generated from the AGM region of the
midgestation embryo and subsequently colonise the other haematopoietic organ
rudiments, such as the foetal liver. Targeted disruption of genes that affect definitive
haematopoiesis usually die during mid to late gestation (although some are viable
until birth or beyond) depending on the nature of the defect. For example, deficiency
of the transcription factor GATA2 affects both primitive and definitive
haematopoiesis leading to early embryonic death around El0.5 to 11.5 from
defective expansion of the various lineages (Tsai et al., 1994). CBF/5 null embryos
die between El 1.5 and 14.5 with haemorrhaging of the CNS and a block in foetal
liver haematopoiesis (Wang et al., 1996b). AMLl/Runxl/Cbfa.2 null embryos die
around El 1.5 to 13 from a similar phenotype to CBFp' embryos (Wang et al.,
1996a). It has been shown that AMLl/Runxl is required for the formation of the
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clusters of haematopoietic cells found on the ventral wall of the dorsal aorta of the
AGM region (North et al., 1999).
A potential lethal phenotype involving definitive haematopoiesis is unlikely,
but cannot be ruled out from these experiments. CFU-A activity in [jijC-/G'246For/G,246For
AGM regions at E10.5 after explant culture was reduced, but only in the F1 (129/Sv
x CBA/Ca) embryos and not on an outbred (MF1) background. CFU-A activity in
the AGM regions from mutant E9.5 embryos was decreased in both strains, but
limited numbers were available for analysis. One possibility for the observed
reduction in homozygous embryos at E9.5 is that the development of intraembryonic
haematopoiesis is delayed and subsequently recovers but only in the outbred animals.
Although smaller than their heterozygous and wildtype littermates, homozygous
embryos did not appear morphologically retarded, but the numbers of somite pairs
should be counted to confirm this.
Since no consistent haematopoietic defect was observed in the mutant AGM
regions, it was not considered important to set up ES cell co-culture experiments to
test the stromal microenvironment (see Introduction to this chapter). It may
nevertheless be interesting find out if the F1 (129/Sv x CBA/Ca) homozygous null
AGM regions are impaired in their ability to enhance the haematopoietic
differentiation of ES cells compared to on an outbred MF1 background.
Further in vitro experiments, including colony assays other than the CFU-A,
which measure more mature haematopoietic progenitors, such as the CFC-mix, GM-
CFC or CFU-E, could be performed on the AGM regions of these mutant embryos
for a more detailed investigation of their haematopoiesis. In vitro haematopoietic
analyses may be misleading, haematopoietic progenitors isolated from Mil deficient
AGM regions after organ culture could differentiate into macrophages in vitro, but
were unable to reconstitute sublethally irradiated RAGyC1 recipients (Ernst et al.,
2004). The in vivo CFU-S or competitive repopulation assays could be used for
quantitative analysis on short term or long term HSCs respectively.
These experiments do not assess whether there is a defect in the migration of
AGM region derived HSCs to the foetal liver or a defect in the hepatic environment
causing impaired foetal liver haematopoiesis, but one would expect the embryos to
survive for longer if either were the case. For example HSCs lacking (31 integrin can
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differentiate into different lineages but are unable to colonise the foetal liver or adult
haematopoietic organs (Hirsch et al., 1996; Potocnik et al., 2000). Embryos
homozygous mutant for jumonji, encoding a putative transcription factor, (also
generated by a gene trapping strategy) die between E10.5 and 15.5 exhibiting
defective definitive haematopoiesis in the foetal liver (these animals also have a
neural tube defect, which is dependent on genetic background, (Kitajima et al.,
1999). Jumonji is not expressed in wildtype HSCs isolated from foetal liver, but it is
expressed in foetal liver fibroblasts, and mutant jumonji deficient HSCs reconstitute
irradiated adult recipients, indicating a defective hepatic environment for
haematopoiesis. Interestingly, the authors report of unpublished data purporting
normal development of haematopoietic cells in AGM region explant cultures. Both
of these mutations result in an accumulation of haematopoietic precursors in the
circulation; it would be interesting to find if such a phenomenon is evident in
Uhc7Gt246ForlG,246For embryos.
Importantly, the gene trap integration into the mUbc7 gene resulted in a
functional disruption of the protein and the embryonic lethal phenotype was
penetrant. In contrast, the reduced haematopoietic activity measured by the CFU-A
assay in AGM regions after organ culture was strain dependent, observed only in F1
129/Sv x CBA/Ca embryos. Therefore the cause of death in the mutant embryos is
likely to be something other than a haematopoietic defect.
There appeared to be a cardiac defect in the homozygous mutant embryos.
The heart develops from bilaterally symmetric cardiogenic primordia that coalesce at
the midline to form a primitive heart tube. At E8.5 the heart tube initiates rightward
looping which positions the chambers. Further maturation of the looped cardiac tube
gives rise to the future right and left ventricles and the common atrial chamber. The
subtle change in cardiac morphology observed in the [j/yCyG'246For/G'246For embryos at
E9.5 could be a result of looping defects in the developing heart, which in turn may
be caused by abnormal rates in cell proliferation. The cell cycle is one of the many
processes in which the ubiquitin proteosome-dependent degradation pathway has
been shown to be involved (Ciechanover, 2003). Furthermore mutations affecting
looping of the heart tube are normally lethal around E10.5 (Kitajima et al., 1999; Fin
et al., 1997; Fyons et al., 1995; Niederreither et al., 2001), but less severe defects
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could survive longer in utero. The apparent cardiac defect is very subtle, which
could explain why it was not picked up previously even though the gene trap screen
was designed to identify novel cardiac genes, and thus histological sections are
needed to confirm this observation.
Finding the defects in these mutant embryos is difficult because of the
ubiquitous expression of the gene. In an attempt to address the biological function of
Ubc7, it would be useful to identify its target proteins. To this end a proteomics
approach is being taken and 2D gel analysis is being performed on proteins extracted
from E9.5 and 10.5 embryos, based on the assumption that a deficiency in an
ubiquitin conjugating enzyme may lead to a build-up of target proteins that should
otherwise have been degraded. For example, mutations in the PARK2 gene,
encoding the E3 ubiquitin ligase parkin, causes autosomal recessive juvenile
Parkinsonism (AR-JP), which is one of the common familial form of Parkinson's
disease. An accumulation of target proteins is thought to be one component leading
to apoptosis of dopaminergic neurons in the pathogenesis of the disease (Coelln et
al., in press). Potential target proteins from the 2D gel electrophoresis could then be
identified by mass spectrometry.
mUbc7 is the first specific E2 implemented in endoplasmic reticulum-
associated degradation (ERAD) in mammalian cells (Tiwari and Weissman, 2001).
The ERAD pathway is a quality control mechanism which, guards against the
accumulation of aberrant proteins by ensuring their proteolysis (McCracken and
Brodsky, 2003). ERAD substrates are selected in the ER and are "retro-translocated"
into the cytoplasm for degradation by the proteosome. One mechanism for the
extraction of the target proteins from the ER is through polyubiquitinisation by the
enzymes of the ubiquitin dependent degradation pathway. Tiwari and Weissman
(2001) found mUbc7 to be membrane associated by co-localisation with mUbc6 and
overexpression of a catalytically inactive form of mUbc7 delayed the degradation of
T-cell receptor subunits (TCRa and CD3-6) from the ER.
In addition to its function in T-cell receptor subunit degradation in adult mice
described above, the gene trap integration into mUbc7 wili eventually lead to the





7.1 Summary and Prospective
The data from this study show that the differentiation of highly proliferative
haematopoietic progenitors from ES cells, as measured by the CFU-A and HPP-CFC
assays, is dramatically enhanced by embryonic AGM region co-culture. This
increase is likely to be due to at least proliferation and perhaps also de novo
induction of early progenitors within EBs. Analysis of replating efficiencies from
CFU-A colonies from co-cultured EBs would show self-renewal capacity and be
more indicative of repopulation potential in vivo. A comparison of self-renewal
potential between EB-derived HPP-CFC and CFU-A would allow their relationship
to be examined further.
Cloned stromal cell lines from the AGM region are not as conducive to
haematopoietic differentiation of ES cells as intact embryonic organ rudiments and
the data suggest that inductive and/or proliferative factors are provided. The co-
culture system could be useful for identifying the factor(s) driving these processes.
Elaine Dzierzak and her colleagues are already investigating this by DNA microarray
on the stromal cell lines. The co-culture system is ideal for analysis by an array or
proteomics approach to investigate the inductive/proliferative factors affecting
haematopoietic development in EBs by stromal cell line- or intact AGM region
explant co-cultures. A stromal cell line based induction screen for candidate genes
identified by gene trapping is being designed.
Significant advances have recently been made by others in achieving
engraftment of ES-derived HSCs but experiments are underway to further investigate
the LTR-HSC activity of co-cultured EBs. Reliably and efficiently obtaining LTR-
HSC from ES cells is important not only for studying the factors involved in their
development but for exploring their potential future clinical use in cell therapies.
Linda Lako and her colleagues are currently employing this AGM region co-culture
system for the haematopoietic differentiation of human ES cells. The debate is
ongoing as to whether hES cells or multipotential aduit somatic stem cells will play a
larger or more useful role in stem cell-based therapies.
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Figure A.1 Strategy for generation of eGFP expressing ES cells #7a
and #97a. Cre-mediated excision of the stop cassette transforms silent
eGFP into active eGFP. (a) ES cells transfected with seGFP construct are
puromycin resistant and eGFP negative. After Cre-mediated recombination
the cells become puromycin sensitive and eGFP expressing. This strategy
was designed for the generation of silent eGFP mice by Dr Derek Gilchrist
and the activated ES cell lines #7a and #97a were a kind gift. Figure










Figure A.2 Time course of CFU-A and HPP-CFC activity in day
3 embryoid bodies after co-culture with AGM region. Numbers
of ( a) CFU-A and (b) HPP-CFC colonies/3x104 cells in EBs cultured
alone p ) and co-cultured (• ) with E10.5 AGM leyion for up to 7



















Figure A.3 NK cell activity against ES cells measured by a chromium-release
assay. NK cell activity against ES cells (EFC-1) was measured and compared to a
control NK sensitive cell line (K-562) by determining the ability of spleen mononuclear
cells to lyse the target cells. Target cells were loaded with radioactive chromium
(51Cr) and added to a dilution series of spleen mononuclear cells. After an incubation
period, the supernatants were harvested and the amount of intracellular51Cr released
into the supernatant was measured with a gamma counter. The amount of 51Cr
released is proportional to the lytic activity of the NK cells against the target cells. The
mean of the triplicate counts per minute (cpm) values were determined for each
effector to target (E:T) ratio and for the spontaneous and maximum release wells.
Percent specific target cell lysis is calculated for each E:T ratio as follows:
% specific lysis = experimental release cpm - spontaneous release cpm x 100
maximum release cpm - spontaneous release cpm
The NK assay was set up and analysed by Dr Martin Waterfall.









Figure A.4 Flow cytometric analysis of surface antigens associated with HSCs on
embryoid body ceiis after co-cuiture with embryonic AGM region. Histograms in
upper panels show the percentage of GFP+ EB-derived cells. Cells gated in M2 were
analysed for surface staining with antibodies against CD34, c-kit and Sca-1. The R2 gate




Figure A.5 Enlargement of Figure 5.8b.
